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The role of integrins in flavivirus infection 
by Vinicius Pinho dos Reis 
 
The Flavivirus genus (Flaviviridae family) comprises the most important arboviruses in the world such as 
dengue virus, West Nile virus (WNV), Zika virus (ZIKV), Japanese encephalitis virus and yellow fever virus 
(YFV). Every year, several outbreaks caused by flaviviruses are reported worldwide (i.e.: ZIKV and YFV 
outbreaks in South America) with a huge impact on economy and public health. In the last few decades, 
many aspects of the flavivirus biology and the interaction of flaviviruses with host cells have been 
elucidated. However, many underlying mechanisms concerning receptor usage, entry process and viral 
interaction with host cell factors are still not completely understood. Integrins, the major class of cell 
adhesion molecules have been implicated in the infectious cycle of different viruses including flaviviruses. 
A previous report proposed that a particular integrin, the αVβ3 integrin, might act as a cellular receptor 
for WNV. However, this hypothesis was not confirmed by other groups.  
In the present study, murine cell lines lacking the expression of one or more integrin subunits were used 
to evaluate the involvement of different integrins in the flavivirus infection cycle. Mouse fibroblasts lacking 
the expression of β1 integrin (MKF-β1-/-) or β3 integrin (MEF-β3-/-) subunits or αVβ3 integrin (MEF-αVβ3-/-
) as well as their corresponding wild-type cells were utilized. A second model using Chinese hamster ovary 
cells (CHO-K1), a cell line that has been described to be refractory to some flaviviruses, were modified to 
express either αV (CHO-αV+/+) or β3 (CHO-β3+/+) integrin subunits. All cell lines were first characterized by 
confocal laser microscopy, flow cytometry and functional assays prior to infection to assess their integrin 
expression. The cell lines were then inoculated with different flaviviruses of public health relevance: WNV, 
YFV-17D, Usutu virus (USUV), Langat virus (LGTV) and ZIKV. Infection assays were designed in order to 
evaluate whether integrins influence i) cell susceptibility; ii) binding; iii) internalization and iv) replication 
of the investigated flaviviruses. Our findings clearly demonstrate that β1, β3 and αVβ3 integrins do not act 
as flavivirus cellular receptor or attachment factor since their ablation does not completely abrogate 
flavivirus infection in the investigated cell lines. Flavivirus binding to the cell surface of MEFs, MKFs and 
CHO cells was not disturbed by the genomic deletion of the above-mentioned integrins. The deletion of 
β1 and β3 integrin subunit did not affect internalization of any of the flaviviruses tested. In contrast to 
that, loss of αVβ3 integrin in the MEF-αVβ3-/- cells showed a statistically significant decrease in WNV and 
USUV internalization while ZIKV, YFV-17D and LGTV internalization remained unaffected suggesting that 
αVβ3 integrin might be involved in the internalization process of at least some flaviviruses. 
 
ix 
On the other hand, flavivirus replication was substantially impaired in the integrin-deficient cell lines in 
comparison to their corresponding wild-type cells. Both, MEF-β3-/- and MKF-β1-/- cells showed a 
statistically significant reduction on viral load for all flaviviruses tested in comparison to their respective 
wild-type cells. The MEF-αVβ3-/- cells in particular, showed a strong inhibition of flavivirus replication with 
a reduction of up to 99% on viral loads for all flaviviruses tested. Levels of flavivirus negative-strand RNA 
were substantially decreased in MEF-αVβ3-/- cells indicating that integrins might influence flavivirus RNA 
replication. The ectopic expression of either αV or β3 integrin subunits in CHO cells slightly increased the 
replication of all flaviviruses tested. Taken together, this is the first report highlighting the involvement of 
integrins in ZIKV, USUV, LGTV and YFV infection. The results strongly indicate that the investigated 
integrins play an important role in flavivirus infection and might represent a novel host cell factor that 
enhances flavivirus replication. Although the exact mechanism of interaction between integrins and 
flaviviruses is currently unknown, the results provided in this study deepen our insight into flavivirus - host 













The role of integrins in flavivirus infection 
von Vinicius Pinho dos Reis 
 
Die Gattung der Flaviviren (Familie Flaviviridae) beinhaltet einige der wichtigsten Arboviren weltweit, 
beispielsweise das Dengue Virus, das West-Nil Virus (WNV), das Zika Virus (ZIKV), das Japanische-
Enzephalitis Virus sowie das Gelbfieber Virus (YFV). Jedes Jahr kommt es zu zahlreichen, durch Flaviviren 
verursachten Ausbrüchen (u.a. Zika und Gelbfieber Virus Ausbrüche in Südamerika), die mit immensen 
Auswirkungen auf die Ökonomie und das öffentliche Gesundheitswesen einhergehen. Obwohl die 
Interaktion von Flaviviren mit verschiedenen Wirtszellen in den letzten Jahrzehnten intensiv untersucht 
wurde und wichtige Fragen in der Flavivirus Biologie bereits geklärt werden konnten, sind viele 
zugrundeliegende Mechanismen, u.a. die virale Rezeptornutzung, der Eintrittsprozess sowie die 
Interaktion mit verschiedenen Wirtszellfaktoren nicht vollständig verstanden. Integrine, eine der 
wichtigsten Klasse von Zelladhäsionsmolekülen, wurden bereits in der Literatur beschrieben, eine Rolle im 
Infektionszyklus verschiedener Viren, u.a. auch der Flaviviren, zu spielen. Es gibt zudem Hinweise, dass ein 
bestimmtes Integrin, das αVβ3 Integrin, als Zellrezeptor für WNV fungieren kann, wobei diese Hypothese 
bislang nicht weiter bestätigt werden konnte. In dieser Arbeit wurde der Einfluss von bestimmten 
Integrinen auf die Flavivirusinfektion in verschiedenen, genetisch modifizierten Maus- und 
Hamsterzelllinien untersucht. Hierfür wurden zum einen Mausfibroblasten verwendet, die für die 
Expression von β1 oder β3 Integrin Untereinheiten oder für das αVβ3 Integrin deletiert sind (MKF-β1-/-; 
MEF-β3-/- und MEF-αVβ3-/-), um diese in Infektionsexperimenten mit den entsprechenden Wildtypzellen 
zu vergleichen. Zum anderen wurde die Chinese Hamster Ovary (CHO) Zelllinie genutzt, welche in der 
Literatur als refraktär gegenüber bestimmten Flaviviren beschrieben wurde. Diese Zelllinie wurde im 
Rahmen der Studie genetisch so modifiziert, dass entweder die αV (CHO-αV+/+) oder die β3 (CHO-β3+/+) 
Integrin Untereinheit exprimiert wurde. Alle rekombinanten Zelllinien sowie deren Wildtyp wurden mittels 
Konfokalmikroskopie, Durchflusszytometrie und funktionalen Assays bezüglich der Integrinexpression 
charakterisiert. Anschließend wurden die Zellen mit den folgenden, Public Health relevanten Flaviviren 
inokuliert: WNV, YFV, ZIKV, Usutu Virus (USUV) und Langat Virus (LGTV). In diesen Experimenten wurde 
der Einfluss der beschriebenen Integrine auf i) zelluläre Empfänglichkeit; ii) Bindung; iii) Internalisierung 
und iv) Replikation der verwendeten Flaviviren untersucht. Die Ergebnisse der Studie zeigen, dass die 
untersuchten Integrine in den verwendeten Maus- und Hamsterzelllinien weder als Zellrezeptor noch als 
Attachment-Faktor dienen. Die fehlende Expression der Integrine verhindert in keinem Fall die Infektion 
der Zellen. Unabhängig von der Integrinexpression können alle untersuchten Flaviviren an die 
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entsprechenden Zellen binden und internalisiert werden. Die Deletion der β1 und β3 Integrin 
Untereinheiten zeigt keinen Effekt auf die Internalisierung der untersuchten Flaviviren. Das Fehlen des 
αVβ3 Integrins in den MEF-αVβ3-/- Zellen hingegen resultiert in einem statistisch signifikanten Unterschied 
in der Internalisierung von WNV und USUV im Vergleich zu den entsprechenden Wildtypzellen während 
die Internalisierung von ZIKV, YFV-17D und LGTV unbeeinträchtigt bleibt. Diese Ergebnisse deuten darauf 
hin, dass αVβ3 Integrin in die Internalisierung bestimmter Flaviviren involviert sein könnte.  
Die Flavivirusreplikation zeigt sich in den Integrin-defizienten Zellen in dieser Studie stark beeinträchtigt 
im Vergleich zu den Wildtypzellen. Die Deletion der β1 und β3 Untereinheiten resultiert in einer statistisch 
signifikant verminderten Replikation in den entsprechenden Mausfibroblasten. Eine noch deutlichere 
Beeinträchtigung der Replikation aller untersuchter Flaviviren mit einer Reduktion der Viruslast um bis zu 
99% wird zudem in den MEF-αVβ3-/- Zellen beobachtet. Diese Ergebnisse werden zusätzlich durch deutlich 
reduzierte Mengen an detektierbarer Negativstrang-RNA in den MEF-αVβ3-/- Zellen unterstützt, was auf 
einen Einfluss der Integrine auf die Flavivirusreplikation hinweist. Die ektopische Expression der 
beschriebenen Integrine in CHO Zellen resultiert ebenfalls in einem leichten Anstieg der 
Flavivirusreplikation. Insgesamt ist dies der erste Bericht, der die Beteiligung von Integrinen in ZIKV, USUV, 
LGTV und YFV Infektionen beschreibt. Die Ergebnisse dieser Studie deuten stark darauf hin, dass 
bestimmte Integrine eine entscheidende Rolle in der Flavivirusinfektion spielen und möglicherweise einen 
neuen Wirtszellfaktor für Flaviviren darstellen. Auch wenn ein eindeutiger Mechanismus für die 
Interaktion von Integrinen mit Flaviviren bislang nicht bekannt ist, können die gewonnenen Ergebnisse 














1.1) Arboviruses: a brief overview 
 
Arthropod-borne viruses, or in short arboviruses, are a group of viruses transmitted by arthropods such as 
mosquitoes, ticks and sandflies (Kuno et al., 2005). According to the World Health Organization (WHO) 
arboviruses possess the ability to replicate in their arthropod vectors as well as in their vertebrate hosts 
leading to efficient virus amplification that enables subsequent transmission to a new host (WHO, 1985).  
Up to now, there are more than 530 arboviruses described, of which more than 100 cause disease in 
humans. In addition, a majority of arboviruses are considered to be zoonotic viruses (Gubler, 2001; 
Lequime et al., 2016; Liang et al., 2015). Arboviruses belong mainly to eight virus families namely 
Peribunyaviridae, Phenuiviridae, Nairoviridae, Togaviridae, Reoviridae, Asfarviridae, Rhabdoviridae and 
Flaviviridae (Adams et al., 2017; Lequime et al., 2016; Liang et al., 2015; Weaver et al., 2010).  
Arboviruses are maintained in the nature in enzootic cycles which include non-human vertebrates 
(especially birds, non-human primates and rodents) as their reservoir hosts and arthropods as vectors. In 
some cases, arboviruses may have more than one vertebrate host or arthropod vector (Davis et al., 2008; 
Weaver et al., 2004). In most of the cases, humans, domestic animals, livestock and a variety of wild 
animals are considered incidental hosts that sustain low and short viremia, which does not contribute to 
the ongoing arbovirus cycle (Gubler, 2001). In case of infections with dengue virus (DENV), yellow fever 
virus (YFV), Zika virus (ZIKV) and some alphaviruses, humans and primates may develop high viremia and 
clinical symptoms leading to potential infection of mosquitoes which then contributes to the maintenance 
of the arbovirus cycle in nature (Gubler, 2001).  
Arboviral diseases are found in all six continents (with the exception of the Arctic and Antarctic) and billions 
of people are living in areas with high risk of arboviral transmission and disease (Beck et al., 2013; Huang 
et al., 2014). In the particular context of flaviviruses, DENV, the most important arbovirus in the world, is 
today present in 128 countries, with more than 4 billion of people living in areas with its transmission 
(Duong et al., 2015). Every year, several flavivirus outbreaks are reported around the world: ZIKV, DENV 
and YFV in South America; West Nile virus (WNV), St. Louis encephalitis virus (SLEV) and Powassan virus 
(POWV) in North America; Usutu virus (USUV), WNV, Tick Borne encephalitis virus (TBEV) and Louping ill 
virus (LIV) in Europe; Japanese encephalitis virus (JEV), DENV and ZIKV in Asia; Murray Valley encephalitis 
virus (MVEV), WNV and DENV in Australia and YFV, DENV, WNV and several other flaviviruses in Africa 
(Artsob, 2000; Beck et al., 2013; Lima-Camara, 2016; Lindsey et al., 2014; Mackenzie et al., 2009; Smith et 
al., 2011; Tompkins et al., 2013).  
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1.2) The Flaviviridae family 
 
Although the theory that mosquitoes could transmit diseases was first proposed in 1881 by Carlos Finnlay, 
a Cuban physician, it was Walter Reed who isolated the first human arbovirus, the YFV, at the beginning 
of the 1900’s and empirically demonstrated that YFV is a mosquito-borne virus (Tomori, 2004). The family’s 
name came from the latin word flavus that means yellow, in reference to the yellow fever disease (Huang 
et al., 2014). Today, the Flaviviridae family comprises more than 60 viral species distributed along the four 
genera: Flavivirus, Pestivirus, Hepacivirus and Pegivirus (Figure 1) (Simmonds et al., 2017). The Pestivirus 
genus includes among others the bovine viral diarrhea virus (BVDV) and the classic swine fever virus 
(CSFV); the Hepacivirus genus includes the Hepatitis C virus (HCV) as well as canine, equine and rodent 
hepaciviruses and the Pegivirus genus includes human, rodent, bat, equine and simian pegiviruses (Drexler 
et al., 2013; Lindenbach, 2013). 
 
 
Figure 1: Phylogenetic classification of the Flaviviridae family. The phylogenetic tree shows the four genera included 
within the Flaviviridae family: Flavivirus, Pestivirus, Hepacivirus and Pegivirus. Figure source: Simmonds et al.,(2017). 
Originally published in https://talk.ictvonline.org/ictv-reports/ictv_online_report/positive-sense-rna-
viruses/w/flaviviridae (no modifications) This picture is under Creative Commons Attribution 4.0 (CC.BY-SY.4.0).  
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1.3) The Flavivirus genus 
1.3.1) Taxonomy and classification  
 
The Flavivirus genus is represented by more than 70 viruses and most of them are arboviruses of medical 
and veterinary importance such as DENV, WNV, TBEV, JEV, ZIKV and YFV as the prototype of this genus 
(Huang et al., 2014; Simmonds et al., 2017). Phylogenetic studies divided the Flavivirus genus in three 
major clades according to their mechanism of transmission and genetic similarity: mosquito-borne 
flaviviruses (MBFV), tick-borne flaviviruses (TBFV) and no-known vector flaviviruses (NKVF) (Gaunt et al., 
2001; Lindenbach, 2013). More recently, an additional group has been included and named insect-specific 
flaviviruses (ISF) (Blitvich et al., 2015). The MBFV clade includes important pathogens of human and 
animals which may be also classified according to the disease they cause: i) hemorrhagic disease viruses 
(DENV and YFV); ii) neurotropic and encephalitis viruses (WNV, JEV, SLEV and ZIKV) and iii) acute febrile 
disease viruses (DENV, ZIKV, WNV) (Grard et al., 2007; Lindenbach, 2013). Infections with some members 
of the TBFV clade might lead to encephalitis and neurological manifestations (LIV, TBEV and POWV) as well 
as to hemorrhagic fever (Omsk hemorrhagic fever virus; OHFV, Kyasanur forest disease virus; KFDV) (Grard 
et al., 2007). The NKVF clade includes several flaviviruses such as the Yokose virus, Entebbe bat virus and 
the Modoc virus. Their biology and disease manifestation in humans and animals are unclear (Blitvich et 
al., 2017).  
Another flavivirus classification is based on antigenic similarity and the presence of serological cross-
reactivity. WNV, JEV and USUV are classified into the Japanese Encephalitis complex; LIV, TBEV and KFDV 
are classified into the TBEV complex, ZIKV is grouped into the Spondweni serocomplex and DENV is 
grouped in a separated complex (Calisher et al., 1989; Kuno et al., 1998). 
 
1.3.2) Structure and physical properties of flaviviruses 
 
Virions are spherical and enveloped and contain an icosahedral nucleocapsid that surrounds the virus 
genome (Figure 2 A and B). They have a diameter of around 40-60 nm and are structurally composed by 
multiple copies of the capsid (C) protein, the envelope (E) protein and the membrane (M) protein (Figure 
2 A and B) (Lindenbach, 2013; Oliveira et al., 2017; Schweitzer et al., 2009). The nucleocapsid is assembled 
by multiple copies of the C protein (12-14 kDa). The largest structural protein, the E protein (50-54 kDa), 
is highly glycosylated, responsible to interact with cellular receptors and elicits most of the neutralizing 
antibodies against the virus. The M protein is synthesized as a precursor-membrane protein (prM) of 18-
20 kDa and is also highly glycosylated. Together with the E protein, it is responsible to form the outer 
surface of the virions. Its cleavage from prM to M is mediated by furin and constitutes an important step 
in virus maturation (Chambers et al., 1990; Lindenbach, 2013). 
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The virus particle can be displayed in two physical states: mature particles (fully prM cleavage) and 
immature particles (no prM cleavage) (Pierson et al., 2012). The immature particles (Figure 2 C) show 
approximately 60 spikes that are E/prM protein trimers while the mature particles are smooth and plane 
(Figure 2 D) with no spike projections on the surface (Pierson et al., 2012). 
Like most enveloped viruses, the flavivirus particle is sensitive to low pH, detergents, alcohols, aldehydes 




Figure 2: Schematical representation of flavivirus particles. Sagittal illustration showing the C protein, M protein as 
well as dimers of the E protein and the +ssRNA genome inside the capsid (A); outer surface of a mature virion (B); 
immature virus particle is depicted showing a rough structure of accumulated prM proteins (C) and smooth mature 
flavivirus particle (E). References: Figure 2 A and 2 B: http://viralzone.expasy.org/24?outline=all_by_species, 
modified. This picture is under Creative Commons Attribution 4.0 (CC.BY-NC.4.0); image 2 C and 2 D: Simmonds et 
al., 2017, (no modifications). Republished with permission from Microbiology Society from Simmonds et al. 2017 
DOI: https://doi.org/10.1099/jgv.0.000672. 
 
1.3.3) Genome organization 
 
The flavivirus genome is a single stranded RNA of positive polarity (+ssRNA) with approximately 11 Kb 
(9,500 to-12,500 nucleotides) that encodes for 10 proteins: three structural (C-prM-E) and seven non-
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structural proteins (NS1-NS2a-NS2b-NS3-NS4a-NS4b-NS5; Figure 3) (Bollati et al., 2010). The viral RNA 
functions as a messenger RNA (mRNA) and is immediately translated into a polyprotein (Mukhopadhyay 
et al., 2005). The genome is arranged into a single open reading frame (ORF) that encodes a polyprotein 
of 3,300 to 3,500 amino acids which is cleaved by viral and host proteases (Chambers et al., 1990).  
The flavivirus genome is flanked by non-coding regions (NCR), with the 5’ region being generally smaller 
than the 3’ region (Chambers et al., 1990; Gebhard et al., 2011). The majority of flavivirus genomes lack a 
polyadenylation tail (poly A) at the 3’ region. The only exception found among the flavivirus genomes is a 
European strain of TBEV (strain Neudörfl) that harbors a poly A tail in the 3’ region. The function of the 
poly A tail in this specific strain of TBEV is still unclear (Asghar et al., 2016; Mandl et al., 1991). At the 5’ 
region of all flaviviruses a type I cap structure (m7GpppAmp) is found (Gebhard et al., 2011). In general, 
for most of the flaviviruses, in both 5’ and 3’ regions the RNA shows secondary structures resembling 





Figure 3: Genome organization for the members of the Flavivirus genus. The +ssRNA contains two non-coding regions 
at the 5’ and 3’ ends flanking a single open reading frame (ORF) that encodes a single polyprotein. The polyprotein is 
cleaved by viral and host proteases (arrows) resulting in three structural proteins (C-prM-E) and seven non-structural 
proteins (NS1-NS2a-NS2b-NS3-NS4a-NS4b-NS5). The structural protein encoding sequences are located downstream 
of the 5’ end and the non structural protein encoding sequences upstream of the 3’ end. Reference: Originally 
published in http://viralzone.expasy.org/24?outline=all_by_species, modified. This picture is under Creative 
Commons Attribution 4.0 (CC.BY-NC.4.0). 
 
1.3.4) Functions of structural and non-structural proteins 
1.3.4.1) Structural proteins 
 
The C protein has the major function to shape the viral particle and to protect the viral RNA from 
degradation. However, other functions of the C protein still remain broadly unknown (Oliveira et al., 2017). 
It is unclear how and at which point of the flavivirus replication the C protein recruits and packs the viral 
RNA (Samsa et al., 2009). A study demonstrated that regions within the alpha-4 helix of the C protein are 
responsible for RNA packing (Ma et al., 2004). The C protein was also found in the nucleus of infected cells 
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and is reported to interact with nuclear proteins and enhances replication of JEV (Mori et al., 2005; Tsuda 
et al., 2006). In addition to that, WNV C protein might interact with other cellular proteins and may induce 
apoptosis (Yang et al., 2002). Since many functions and underlying mechanisms associated with the C 
protein have been studied in recent years, the C protein has been considered as an important target for 
antiviral drug design (Oliveira et al., 2017). 
The prM/M protein is associated with the E protein building heterodimers that are anchored into the lipid 
bilayers to form the outer viral surface (Zhang et al., 2003). Studies have demonstrated the prM/M protein 
to be involved in apoptosis induction and interactions with host cells during virus entry, replication and 
assembly (Brabant et al., 2009; Brault et al., 2011; Catteau et al., 2003; Gao et al., 2010; Wong et al., 2012). 
During the infection, antibodies are raised against the prM protein. Interestingly, those antibodies were 
reported to mediate entry of immature WNV and DENV virions via Fc receptor, thus enhancing the virus 
infection via a phenomenon known as antibody-dependent enhancement (ADE) (Colpitts et al., 2011; 
Halstead, 1979; Rodenhuis-Zybert et al., 2010a). However, it has not been elucidated whether the 
presence of those antibodies might be associated with a poor prognosis or with severe clinical 
manifestations of DENV infection (Rodenhuis-Zybert et al., 2015). 
The flavivirus E protein is a transmembrane protein and a class II fusion protein. Structurally, the E protein 
has three domains: E-DI, E-DII and E-DIII. In response to an acidic pH, the E protein undergoes irreversible 
conformational changes that eventually lead to the fusion of the virus particle with the endosomal 
membrane and consequently genome delivery into the cytoplasm (Kielian, 2014; Modis et al., 2004; Smit 
et al., 2011). The E-DI is the central domain of the E protein structure. E-DII contains a hydrophobic fusion 
loop, a peptide that is responsible for viral fusion with the cell membrane (Zhang et al., 2004). In the 
immature virus particle, the fusion loop is covered by a portion of prM peptides impairing the virus fusion 
(Li et al., 2008; Lindenbach, 2013). Studies on DENV and WNV have demonstrated that antibodies raised 
against the fusion loop are highly cross-reactive and might trigger ADE and internalization of immature 
particles via Fc receptor (Lai et al., 2008; Rodenhuis-Zybert et al., 2011a). Finally, the E-DIII is an 
immunoglobulin like domain and the most exposed domain of the E protein, forming projections along the 
virion. It also contains the receptor binding domain that mediates binding to the host cell (Lindenbach, 
2013; Zhang et al., 2004). Interestingly, some flaviviruses such as MVEV, YFV-17D and JEV have an integrin 
binding motif in their E-DIII, namely the RGD (Arg-Gly-Asp) motif, raising speculations that these viruses 
might use integrins as cellular receptors (van der Most et al., 1999). In addition to that, among all other E 
protein domains, E-DIII is the most immunogenic domain and forms a major target for neutralizing 
antibodies. This domain has thus been used in several vaccine candidates as a target for antiviral drugs 
and as antigen in serological assays (Chavez et al., 2010; Perera et al., 2008). A vaccine harboring the YFV-
17D backbone and the structural proteins of WNV is commercially available for horses. For humans, DENV 
 
7 
and JEV chimeric-based vaccines are available (Arroyo et al., 2004; Chin et al., 2013; Guy et al., 2015; 
Monath et al., 2002).  
 
1.3.4.2) Non-structural proteins 
 
The non-structural (NS) 1 protein is highly glycosylated and highly conserved among flaviviruses. Upon 
infection, the NS1 protein may be localized intracellularly or may be secreted. The NS1 protein is dimeric 
in case of intracellular localization and hexameric when secreted. The intracellular form of NS1 seems to 
be involved in immune evasion and interacts with host cell proteins (Rastogi et al., 2016; Somnuke et al., 
2011). In association with NS4b, NS1 is also reported to be involved in virus replication (Muller et al., 2013; 
Rastogi et al., 2016). The secreted form of NS1 is highly immunogenic and has been detected in antigen 
capture based assays during early infection. Furthermore, some authors have proposed that NS1 is a 
biomarker and that high levels of anti-DENV NS1 antibodies might be correlated with more severe disease 
(Hermann et al., 2014; Paranavitane et al., 2014; Singh et al., 2010). Several studies have also 
demonstrated that soluble NS1 from different flaviviruses can inhibit the complement system by 
interacting with C4b complement protein and factor H (Avirutnan et al., 2010; Avirutnan et al., 2011; 
Chung et al., 2006).  
The NS2 protein is cleaved into two different proteins: NS2A and NS2B. The NS2A is a hydrophobic protein 
that is involved in RNA replication and virus assembly (Leung et al., 2008; Lindenbach, 2013). NS2A was 
also reported to interact with the 3’ NCR of the viral genome and to modulate the interferon responses 
(Liu et al., 2005; Mackenzie et al., 1998). NS2B interacts as a cofactor with NS3 and this complex has been 
demonstrated to be the main viral protease and is involved in the processing of viral structural proteins 
(Bessaud et al., 2006; Murray et al., 2008). This complex has been targeted as candidate for antiviral drugs 
(Aguilera-Pesantes et al., 2017). The NS3 is a multifunctional protein involved in RNA replication. Studies 
further demonstrated protease, helicase and NTPase activities of this protein (Lindenbach, 2013; Wu et 
al., 2005). A study with YFV demonstrated that NS3 alone is also involved in virus assembly (Patkar et al., 
2008). 
Similar to NS2, the NS4 protein is cleaved into two proteins: NS4A and NS4B. Although their exact functions 
are unclear, both proteins are membrane associated and have been shown to be linked to flavivirus 
replication complexes (FRC) (Lindenbach, 2013; Miller et al., 2007; Nemesio et al., 2012). A study 
suggested that the NS4A of WNV is an essential co-factor for NS3, leading to NS3 helicase activity (Shiryaev 
et al., 2009).  
The NS5 protein is the largest flavivirus protein (103 kDa) and the most conserved protein among the 
flaviviruses (Lindenbach, 2013). Due to its high similarity among the members of Flavivirus genus, the NS5 
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protein nucleotide sequence is widely used for phylogenetic and flavivirus evolution analysis (Baleotti et 
al., 2003; Kuno et al., 1998). Several functions have been attributed to NS5. The most important one is its 
RNA-dependent RNA polymerase (RdRp) activity. In this case, NS5 plays an essential role in the RNA 
replication, being involved in the synthesis of both negative and positive strand RNAs during the flavivirus 
replication cycle (Bollati et al., 2010; Klema et al., 2015). Another important function associated to NS5 is 
its methyltransferase activity being important for adding the cap structure to the 5’ NCR (Ray et al., 2006). 
This process constitutes an important mechanism of viral immune evasion not only for flaviviruses but for 
other viruses as well (Dong et al., 2014).  
 
1.4) Flavivirus interaction with the host cell 
1.4.1) Flavivirus entry into the host cell 
 
The flavivirus entry is a complex process involving the usage of multiple receptors and accessory 
molecules. Initially, virions bind to the host cell via electrostatic, non-specific and low affinity interactions 
with cell membrane molecules. The interaction with those molecules does not mediate virus entry but 
virus attachment leading to accumulation of virions on the cell membrane (Grove et al., 2011; Smit et al., 
2011). Upon attachment, flaviviruses move along the cell membrane in order to find their specific 
receptor(s) that will mediate entry into the host cell. Flaviviruses mainly enter the host cell by receptor-
mediated endocytosis, i.e. clathrin-mediated endocytosis (Kaufmann et al., 2011; Smit et al., 2011; van der 
Schaar et al., 2008). However, alternative routes have been reported by other authors. For example, DENV 
might enter the cells alternatively by caveolae, dynamin or macropinocytosis (Acosta et al., 2009; 
Suksanpaisan et al., 2009). WNV has been described to enter the cell by lipid rafts (Medigeshi et al., 2008). 
A study with TBEV suggested an alternative entry route by macropinocytosis in Caco-2 cells (Yu et al., 
2014).  
Flavivirus internalization is a relatively fast event according to two studies with DENV and WNV, 
demonstrating that virions were internalized within less than five minutes after binding to a cellular 
receptor (Chu et al., 2004a; van der Schaar et al., 2008). Upon internalization, virions are located in the 
early and late endosomes until they finally fuse with the lysosomes (Smit et al., 2011; Yamauchi et al., 
2013). The intracellular trafficking of the virion along the endosomes is controlled by a group of GTPases 
called Rab (Jordens et al., 2005; Yamauchi et al., 2013). Rab 5 and Rab 7 proteins have been shown to be 
required for DENV and WNV entry into Hela cells (Krishnan et al., 2007).  
Fusion of late endosomes with the lysosomes causes endosomal acidification leading to pH-dependent 
irreversible changes in the E protein conformation and consequently, to fusion of the viral and endosomal 
membrane (Kaufmann et al., 2011). Studies demonstrated that the E protein changed its conformation by 
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mild-acidic environment (pH 5.0 to 6.0) leading to E protein trimerization and consequently fusion loop 
exposition (Stiasny et al., 2007). Treatment with drugs that inhibit endosomal acidification such as 
chloroquine led to inhibition of DENV-2 fusion and consequently replication in both in vitro and in vivo 
models (Farias et al., 2013; Farias et al., 2014; Farias et al., 2015). Other in vitro studies using drugs that 
inhibited endosomal acidification also showed inhibition of WNV and JEV replication (Chu et al., 2006; Chu 
et al., 2004a; Kalia et al., 2013). Fusion of the viral and endosomal membrane is then followed by virus 
uncoating and releasing the viral RNA into the cytoplasm where the replication cycle is initiated 
(Mukhopadhyay et al., 2005; van der Schaar et al., 2008). 
 
1.4.2) Flavivirus replication 
 
Flavivirus replication takes place in membrane-induced vesicles located in the cytoplasm of infected cells 
(Bartholomeusz et al., 1999; Brinton, 2013; Romero-Brey et al., 2014). Within the cytosol, the viral +ssRNA 
is immediately translated into a single polyprotein that is cleaved at first by host proteases (Murray et al., 
2008; Natarajan, 2010). The flavivirus non-structural proteins induce modifications in the cellular 
membranes of the endoplasmatic reticulum (ER), building compartments, the FRC. Inside the FRC, the viral 
proteins necessary to support viral replication accumulate and the viral RNA is then replicated (Klema et 
al., 2015; Saeedi et al., 2013). The NS5 then transcribes +ssRNA template into a negative-strand RNA and 
a transitory double strand RNA (dsRNA) structure is formed. Thus, the dsRNA is separated by NS3 helicase 
activity and the negative-strand RNA is used as template for the synthesis of new +ssRNA (Klema et al., 
2015; Natarajan, 2010). The newly synthesized +ssRNA is then translated into a single polyprotein that is 
cleaved by host and viral proteases. Following that, post-translational cleavage of C-prM-E proteins takes 
place mediated by the NS2B/NS3 complex and host proteases. The structural proteins remain anchored in 
the membrane of the ER while more +ssRNA is synthesized (Klema et al., 2015; Lindenbach, 2013). 
Assembly of new virus particles occurs in the lumen of the ER when the C protein physically interacts with 
the +ssRNA leading to packing of viral RNA and formation of the nucleocapsid. The nucleocapsid containing 
the viral RNA is budding through the ER which consists the prM-E protein heterodimers forming the 
immature virus particle (Fernandez-Garcia et al., 2009; Murray et al., 2008). In this immature state, the 
prM hides the fusion loop located at the E-DII protein to avoid self-fusion with the Golgi membranes during 
the trans-Golgi pathway. Following the trans-Golgi pathway, the prM protein is cleaved by furin exposing 
the fusion loop and dissociation of prM-E complexes giving the virions a status of mature particles (Heinz 
et al., 1994; Stadler et al., 1997; Yu et al., 2008; Zhang et al., 2003). Infectious mature virus particles are 
released by exocytosis pathway (Fernandez-Garcia et al., 2009). An overview of the flavivirus replication 




Figure 4: Flavivirus replication cycle. (A) After binding, flaviviruses are internalized by receptor mediated endocytosis 
(a), the low endosomal pH triggers irreversible changes in the E protein leading to fusion of viral membrane with 
endosome, uncoating and delivery of viral genome (b); the viral positive single stranded RNA (+ssRNA) is 
subsequently translated and replicated in the perinuclear region inside the flavivirus replication complex (c); virus 
assembly occurs in the endoplasmatic reticulum following a final glycosylation in the Golgi complex (e); the cleavage 
of prM to M and consequent final maturation is mediated by furin along the trans-Golgi network (f) and the virus is 
secreted by exocytosis (g). (B) The +ssRNA is immediately translated into a polyprotein that is cleaved first by host 
proteases and later by viral proteases. The +ssRNA is then transcribed in a negative-strand RNA and the viral genome 
acquires an intermediate double strand (ds) RNA state. The negative-strand RNA serves as a template for synthesis 
of new +ssRNA. A final 5’ CAP is added to the newly synthesized viral +ssRNA. References: Figure A: Reprinted from 
Rodenhuis-Zybert et al.,(2011b) with permission from Elsevier (Rodenhuis-Zybert et al. 2011b, DOI: 
https://doi.org/10.1016/j.tim.2011.02.002, modified; Figure B: Klema et al.,(2015),  no modifications. This picture is 







In North America, the circulation of WNV, SLEV and POWV have been reported in USA and Canada. DENV 
has been also reported in parts of USA (Texas, Hawai and Puerto Rico) and Mexico (Davis et al., 2008). In 
Central and South America, especially in Brazil, the circulation of several flaviviruses has been described, 
among them DENV, WNV, SLEV, ZIKV, YFV, Rocio virus, Bussuquara virus, Cacipacoré virus, Iguape virus 
and Ilhéus virus. Thereof, in particular DENV, ZIKV and YFV are of greater importance for publich health 
(Figueiredo, 2000; Zanluca et al., 2015). DENV is responsible for large outbreaks in Brazil and surrounding 
countries in South and Central America (Ramos-Castaneda et al., 2017). In 2015, ZIKV was first detected in 
the northeast from Brazil (Zanluca et al., 2015). In the following years, more than 210,000 cases of ZIKV 
infection were recorded with more than 10,000 suspected cases of microcephaly (Brazillian Ministry of 
Health - MS 2016a; Brazillian Ministry of Health - MS 2016b).  
In Europe, WNV, USUV and TBEV are the major flaviviruses circulating within the continent (Papa, 2017). 
In 2016, the European Center for Disease Control (ECDC) recorded 225 cases of WNV in humans with most 
of the cases in South and Southeast Europe (ECDC, 2016). USUV was first detected in 1996 in Italy, from a 
dead Eurasian blackbird (Turdus merula) (Weissenbock et al., 2013). Since then, USUV has been spreading 
throughout Europe and has been detected in birds in Austria, Belgium, Czech Republic, England, Germany, 
Greece, Hungary, Spain and Switzerland (Ashraf et al., 2015; Engel et al., 2016). TBEV is the causative agent 
of severe encephalitis in humans in Europe and its circulation is reported in 27 European countries. 
Although an effective vaccine is available, the number of cases have recently increased (Amicizia et al., 
2013).  
JEV, DENV, WNV, ZIKV, MVEV and Kunjin virus (KUJV) are the flaviviruses of major concern in Asia and 
Australia (Kindhauser et al., 2016; Mackenzie et al., 2009; Russell et al., 2000). JEV is present in 24 countries 
in Asia, Western Pacific and Northern Australia (Wang et al., 2015b). It is estimated that more than 67,000 
human cases of JEV infection occur every year (Campbell et al., 2011a). DENV represents a public health 
problem especially in Southeast Asia and the Western Pacific region with up to 187,000 cases in 2010 
(Murray et al., 2013). MVEV has caused sporadic encephalitis cases in humans in Australia (Russell et al., 
2000). KUJV is classified within the WNV group and has been reported to circulate in Australia. In general, 
most of the infections are asymptomatic and result in mild clinical manifestations (Prow, 2013). ZIKV is 
endemic in eight countries in Asia, but ZIKV infections seem to be very sporadic and outbreaks have been 
rarely reported (Kindhauser et al., 2016; Posen et al., 2016; Wiwanitkit, 2016). In the federal states of 
Micronesia, ZIKV is endemic with huge outbreaks in Yap Islands and French Polynesia. Serological surveys 
estimated that 73% of the Yap Island population have antibodies against ZIKV (Duffy et al., 2009). 
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1.6) Flavivirus transmission and ecology 
 
Most of the flaviviruses are maintained in nature by two distinct transmission cycles: the enzootic (= 
sylvatic) or urban (= human) cycle (Vasilakis et al., 2011). The sylvatic cycle involves mosquitoes and wild 
animals such as birds and/or non-human primates or, for TBFV, ticks, rodents and apparently wild deer 
(Mansfield et al., 2009; Weaver et al., 2004). The urban cycle, especially important for DENV, YFV and ZIKV, 
involves humans and the Aedes spp. mosquitoes in urban and peri-urban areas. In this case, humans play 
an important role in facilitating the infection of naïve mosquitoes (Vasilakis et al., 2011; Vasilakis et al., 
2017). 
 
1.6.1) Transmission vectors 
 
The majority of flaviviruses are transmitted by mosquitoes and only a few flaviviruses are transmitted by 
ticks (Huang et al., 2014; Lasala et al., 2010). Several studies have demonstrated that many mosquito 
species such as Aedes spp. and Culex spp. are susceptible to flaviviruses and transmit them to other hosts 
(Conway et al., 2014). Aedes aegypti and Aedes albopictus are the most widespread mosquitoes being 
found in the Americas, Africa, Europe, Asia and Australia and are competent vector of DENV, YFV, ZIKV and 
many other flaviviruses (Kraemer et al., 2015). Culex spp. have the similar global distribution as Aedes spp. 
and are vectors of WNV, KUJV, JEV, MVEV and SLEV (Prow, 2013; Samy et al., 2016).  
Ticks transmit flaviviruses such as TBEV, LIV, POWV, KFDV and OHFV (Dobler, 2010). The genus Ixodes spp. 
is globally widespread and responsible for the transmission of POWV, LIV and TBEV in North America, 
Europe and Asia (Dobler, 2010; Pettersson et al., 2014).  
Although the majority of flaviviruses are transmitted via arthropods, a small number of human infections 
happens without any vector. The majority of non-vectored infections occurs by blood transfusion, bone 
marrow as well as solid organ transplantations (Chen et al., 2016). Sexual transmission of flaviviruses has 
also been reported, especially for ZIKV (Foy et al., 2011; Grischott et al., 2016). Perinatal transmission of 
DENV and ZIKV was reported in endemic areas (Besnard et al., 2014; Chen et al., 2016; Grischott et al., 
2016). 
 
1.6.2) Flavivirus reservoirs 
 
Birds, rodents, other small mammals and some reptiles are known to be a reservoir for flaviviruses 
(Weaver et al., 2004). Humans, horses and some livestock and domestic animals are usually considered to 
be dead-end hosts as they normally do not transmit the virus to other vertebrates. Since they do not 
sustain strong and persistent viremia, these hosts do not function as a reservoir for re-infection of 
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mosquitoes which impedes the arbovirus transmission cycle (van den Hurk et al., 2009; Weaver et al., 
2004).  
Birds are the main reservoir for flaviviruses, especially for those that belong to the Japanese encephalitis 
serocomplex such as WNV, JEV and USUV. WNV infects more than 100 different bird species while JEV is 
able to infect more than 90 and USUV more than 30 bird species (Ashraf et al., 2015; Campbell et al., 2002; 
van den Hurk et al., 2009). This broad avian host range and the migratory behavior might contribute to the 
emergence and introduction of flaviviruses to new environments such as observed for WNV in North 
America and JEV in Australia (van den Hurk et al., 2009; Weaver et al., 2004). In general, flavivirus infection 
in birds leads to high and long-lasting viremia. For this reason birds are often considered to be amplifying 
hosts of many flaviviruses. For JEV, pigs may also act as amplifying hosts (van den Hurk et al., 2009; Weaver 
et al., 2004).  
Ticks are the main reservoir for TBEV nevertheless, rodents and other wildlife animals such as deers are 
important in the maintenance of TBEV in nature (Lindquist, 2014; Lindquist et al., 2008). Although the role 
of birds in the TBEV life cycle has not yet been unravelled, birds might spread TBEV infected ticks into 
distant areas (Mansfield et al., 2009). A study conducted by Waldenstrom et al.,(2007) found TBEV infected 
ticks on birds migrating from Western Russia to Sweden.  
Finally, although not considered reservoir, non-human primates are an important amplifying host for 
several flaviviruses such as DENV, ZIKV and in special for YFV in the Americas and Africa (Barrett et al., 
2007; Kuno et al., 2017).  
 
1.7) Flavivirus pathogenesis 
 
Following inoculation by mosquito or tick bite, flaviviruses initiate a prompt replication at the inoculation 
site infecting mainly fibroblasts, epithelial cells, resident macrophages and migratory dendritic cells 
(Langerhans cells) (Bustos-Arriaga et al., 2011; Samuel et al., 2006). This early replication in local tissues 
enables the flaviviruses to increase the viral load allowing further migration to target tissues/cells. Infected 
Langerhans cells and resident macrophages migrate to the draining lymph node where the virus initiates 
the spreading through the lymphatic system, consequently reaching the blood stream  and disseminating 
to the target cells and tissues (Kaufmann et al., 2011; Martina et al., 2009). 
Viremia in birds is detected within less than 24 hours after infection with a recent study demonstrating 
viremia even 30-45 minutes after infection (Gamino et al., 2013; Reisen et al., 2007). In humans, viremia 
for WNV and DENV is observed between 2-4 and 1-7 days after infection, respectively (Busch et al., 2008; 
Vaughn et al., 2000). 
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The mechanisms for neuroinvasion of neurotropic flaviviruses are poorly understood. There have been 
four routes proposed: i) hematogenic dissemination; ii) blood brain barrier disruption; iii) infected 
leukocyte mediated migration (“Trojan-horse”) and iv) transneural route (Sips et al., 2012; Suen et al., 
2014). The pathogenesis of hemorrhagic diseases observed in DENV, KFDV and OHFV infections seems to 
be rather immune-mediated than directly caused by the infection of endothelial cells. In this case, the 
strong activation of the immune response would alter the vascular permeability leading to hemorrhagic 
manifestations (Back et al., 2013). High levels of Tumor Necrosis Factor alpha, interleukin (IL-) 6 and IL-8 
were found in patients with dengue hemorrhagic fever (Martina et al., 2009). 
 
1.8) Clinical manifestations 
 
Flavivirus infections may lead to four distinct manifestations: i) asymptomatic infection (or sub-clinical 
infection); ii) acute febrile disease; iii) hemorrhagic fever and iv) meningoencephalitis (Cobo, 2016; 
Martina et al., 2009; Turtle et al., 2012). Asymptomatic infections account for approximately 80 % of 
flavivirus infection cases in humans in special for WNV and DENV (Hayes et al., 2005; Reiter, 2010). DENV, 
YFV and KFDV are more related to hemorrhagic fever and manifestations related to hemodynamic 
disorders (Holbrook, 2012; Martina et al., 2009). Most of the members of the Japanese encephalitis 
complex such as WNV, JEV, MVEV and SLEV are more reported to cause encephalitis in humans and 
animals (Niven et al., 2017; Turtle et al., 2012). Horses infected by WNV seem to develop neurological 
manifestations in more than 10% of the infections and less than 1% of humans develop neurological 
manifestations (Castillo-Olivares et al., 2004). Symptomatic USUV infections in humans are rare and more 
confined to immunocompromised individuals. However, antibodies against USUV were found in 
asymptomatic blood-donor individuals in Italy (Allering et al., 2012; Gaibani et al., 2012). POWV, LIV and 
TBEV infections result in most of the cases in neurological manifestations such as encephalitis and 
meningoradiculitis (Bogovic et al., 2015; Turtle et al., 2012). Several case reports have described atypical 
clinical manifestations of flavivirus infections especially in hyper-endemic areas such as South and North 
America, Asia and Australia. In case of DENV infections, hepatitis, pneumonia, optical neuritis, pancreatitis, 
nephritis and myocarditis have been reported (Gulati et al., 2007; Nimmagadda et al., 2014). Atypical 
clinical manifestations due to WNV infection are more related to central nervous system disorders. Those 
include acute flaccid paralysis, Guillain-Barré Syndrome, meningoradiculitis and a polio-like syndrome 
(Ahmed et al., 2000; Josekutty et al., 2013; Leis et al., 2012; Sejvar et al., 2003). Recently, ZIKV was linked 
to abnormal malformations in newborns (microcephaly) and spontaneous abortions as well as atypical 
clinical manifestations in adults such as the Guillain-Barré syndrome and encephalitis (Cao-Lormeau et al., 
2016; Martines et al., 2016; Paixao et al., 2016).  
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1.9) Flavivirus receptors and host cell factors 
 
During the initial steps of infection, viruses must cross the cell membrane to deliver their genome into the 
cytoplasm and complete the replication cycle. Prior to entry, viruses interact with a diverse repertoire of 
cellular molecules in order to find their receptor to mediate virus particle internalization, fusion and 
genome delivery (Bhella, 2015; Yamauchi et al., 2013). 
Over the last few decades, the knowledge concerning the mechanisms of flavivirus interaction with the 
host cells have increased dramatically. However, many aspects of these flavivirus-host interactions still 
remain unclear. To date, many flavivirus receptor candidates as well as host cell factors have been 
identified and suggested to interact with flaviviruses during the course of infection (Fernandez-Garcia et 
al., 2009; Pastorino et al., 2010; Perera-Lecoin et al., 2013).  
Host cell factors are defined as molecules that may interact with (flavi)viruses during the early steps of 
infection, during RNA replication or may be involved in virus assembly and egress (Foo et al., 2015; Wang 
et al., 2017; Ward et al., 2016).  
 
1.9.1) Flavivirus receptors  
 
According to the literature, flaviviruses might either use an ubiquitously expressed molecule or multiple 
receptor molecules to invade the host cell. In this process, molecules such as attachment factors and the 
putative receptor(s) act synergistically to promote flavivirus entry into the host cell (Perera-Lecoin et al., 
2013; Smit et al., 2011). 
Notably, glycoaminoglycans (GAG), in particular heparan sulfate, are widely expressed in most of cell lines 
and have been demonstrated to interact with flaviviruses during the initial steps of infection. Interactions 
between flavivirus particles and GAGs are mainly mediated by negatively charged carbohydrates such as 
GAGs that bind to the positively charged flavivirus E protein (Afratis et al., 2012; Perera-Lecoin et al., 2013; 
Smit et al., 2011). The importance of heparan sulfate on flavivirus binding to the cell surface was 
extensively demonstrated by several studies: heparin (a heparan sulfate analogue) or lactoferrin (a 
molecule that binds GAGs), were both able to block entry of several flaviviruses such as DENV, YFV, WNV, 
JEV ,TBEV and ZIKV (Chen et al., 2017; Chen et al., 1997; Chien et al., 2008; Germi et al., 2002; Hilgard et 
al., 2000; Kim et al., 2017; Kroschewski et al., 2003; Lee et al., 2004; Tan et al., 2017). Although the role of 
GAGs in flavivirus attachment and entry was extensively shown, this characteristic seems to be related to 
virus attenuation, adaptation to cell culture and loss of virulence in vivo as reported in some studies with 
DENV, JEV, MVEV and TBEV (Lee et al., 2002; Lee et al., 2006a; Mandl et al., 2001). 
Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) is a C-type lectin 
that has also been implicated to play a role in attachment and entry of WNV and DENV in human cell lines 
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such as monocytes and dendritic cells (Davis et al., 2006; Navarro-Sanchez et al., 2003; Tassaneetrithep et 
al., 2003). More recently, HEK293 cells expressing the DC-SIGN receptor were reported to greatly enhance 
ZIKV infection in up to 50% (Hamel et al., 2015). 
TIM and TAM receptors belong to a class of transmembrane phosphatidylserine binding receptors that 
have been involved in entry of several enveloped viruses including flaviviruses such as WNV, DENV, and 
ZIKV (Hamel et al., 2015; Jemielity et al., 2013; Meertens et al., 2012). In the case of ZIKV, a study 
demonstrated that both TIM and TAM mediated ZIKV entry into human fibroblasts with TAM being more 
effective in mediating ZIKV infection than TIM (Hamel et al., 2015). However, a recent study using a group 
of mice deficient for TAM receptors demonstrated that expression of TAM receptors are not required for 
ZIKV infection in vivo, reinforcing the multitude of flavivirus receptor usage and the hypothesis that 
flaviviruses use multiple receptors to gain access to the target cells (Hastings et al., 2017). 
The high affinity laminin receptor has been described to play a role in flavivirus entry in mammalian as 
well as in mosquito cells. A study conducted by Tio et al.,(2005) using a virus overlay binding protein assay 
identified that DENV serotypes 1, 2 and 3 but not DENV serotype 4 interacted with the laminin receptor. 
Thepparit et al.,(2004b) also identified the laminin receptor as potential DENV receptor in a human hepatic 
cell line (HepG2). In this study, entry of DENV serotype 1 into HepG2 cells was blocked by anti-laminin 
antibodies as well as by soluble laminin in a dose-dependent manner. Interestingly, this phenomenon was 
only shown for DENV serotype 1 but not for DENV serotypes 2, 3 and 4 serotypes in this study (Thepparit 
et al., 2004b). In C6/36 mosquito cells, soluble laminin and antibodies against the laminin receptor were 
shown to abrogate binding and internalization of DENV serotypes 3 and 4, but had no impact on DENV 
serotype 1 and 2 (Sakoonwatanyoo et al., 2006).  
Similarly, the laminin receptor has been identified to play a role in JEV entry into neural cells and anti-
laminin receptor antibodies disrupted JEV infection in up to 25% (Thongtan et al., 2012). Vimentin was 
also implicated to be involved in JEV binding and internalization. A study demonstrated that silencing the 
human vimentin gene greatly impaired the binding and entry of RP9, a pathogenic JEV strain (Liang et al., 
2011). 
 
1.9.2) Flavivirus host cell factors  
 
Over the last few years, several molecules have been reported as flavivirus host cell factors. Recently, a 
CRISPR genetic screening based strategy was used to unravel host cell factors for DENV and HCV in a 
hepatic human cell line (Huh 7) (Marceau et al., 2016). This study identified many families of proteins 
associated to the ER such as the translocon associated protein complex, ER associated protein degradation 
(ERAD) and oligosaccharyltransferase protein complex (OST) (Marceau et al., 2016). Further validation by 
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cell infection assays with several flaviviruses demonstrated that DENV, WNV, ZIKV and YFV replication was 
completely abrogated by the deletion of the above mentioned molecules, implicating that flaviviruses 
share mutual host cell factors (Marceau et al., 2016).  
More recently, a family of proteins called “reticulon” have been reported to be involved in flavivirus 
replication. This family of proteins is mostly found in the ER and is associated with the formation of vesicles 
and membranes in the ER (Aktepe et al., 2017). By downregulating the expression of reticulon 3.1A 
protein, the authors showed that WNV, ZIKV and DENV replication was substantially impaired but not 
completely abrogated. The authors suggested that the presence of this family of proteins in the ER is of 
great importance for the flavivirus membrane induced remodeling, a process that is essential for the 
flavivirus RNA replication (Aktepe et al., 2017). 
Another study reported a total of 96 genes to be involved in WNV replication using a large scale siRNA 
screening in Drosophila melanogaster cells (Yasunaga et al., 2014). Among those host cell factors, several 
identified proteins were involved in WNV endocytosis and endosomal acidification. Although lacking 
functional validation, this work provides important insights into the multitude of flavivirus host cell factors 
in different hosts (Yasunaga et al., 2014). 
The RNA binding protein AUF1 p45, a cellular chaperone, has been reported to be a common flavivirus 
host cell factor. Silencing of AUF1 p45 in Huh7 cells significantly dropped WNV, ZIKV and DENV replication 
by destabilizing the viral genome and impeding its cyclisation (Friedrich et al., 2017). 
The Golgi ERI3 protein belongs to a family of RNA binding proteins that was reported to be a host cell 
factor for DENV and YFV (Ward et al., 2016). Though ERI3 was not required for DENV and YFV RNA stability, 
the authors concluded that ERI3 is essential for flavivirus RNA synthesis (Ward et al., 2016). 
A class of ribosomal proteins including RPLP1 and RPLP2, has been found to be required for RNA translation 
of a number of flaviviruses such as DENV, ZIKV and YFV in human and mosquito cell lines (Campos et al., 
2017).  
 
1.10) Cell Adhesion molecules and their involvement in flavivirus infection 
1.10.1) Brief overview 
 
Tissues are composed of cells and an extracellular matrix (ECM) that is vital to sustain the architecture and 
conformation of the tissue (Gumbiner, 1996). The major function of cell adhesion molecules is to mediate 
contact between the cell surface and the ECM or mediate cell-cell contacts (Chothia et al., 1997). There 
are mainly four families of cell adhesion molecules: cadherins, immunoglobulins, selectins and integrins 
(Lodish H, 2000). The cadherins are a family of cell surface proteins that are important for shaping the 
tissue architecture. The major function of cadherins is to mediate cell-cell adhesion (Shapiro et al., 2009). 
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The immunoglobulin superfamily comprises molecules such as antibodies, major histocompatibility 
complex (MHC) and membrane associated proteins of T and B cell receptor complex (Wai Wong et al., 
2012). Immunoglobulin-like proteins are associated with cell adhesion functions. Representatives are 
neural cell adhesion molecule (NCAM), junctional cell adhesion molecule (JAM), intercellular cell adhesion 
molecule (ICAM) and vascular cell adhesion molecule (VCAM) (Aricescu et al., 2007). The selectin family of 
cell adhesion molecules is represented by P-, E-, and L-selectins that stand for platelet-, endothelial- and 
leukocyte- selectins, respectively. Their major function is to mediate leukocyte and platelet adhesion to 
the vascular endothelium (Bendas et al., 2012). Integrins were first described in 1986 when fibronectin 
was found to bind to a group of transmembrane proteins that functioned as respective receptors (Hynes, 
1987; Tamkun et al., 1986). The name “integrin” was then proposed to these newly discovered 
transmembrane proteins due to their ability to link the ECM with the cytoskeleton (Hynes, 2002; Hynes, 
2004). 
 
1.10.2) The integrin family 
 
Integrins are characterized as a large family of cell adhesion molecules expressed in almost all cell lines 
that display a diverse repertoire of integrins depending on their function and localization (Hynes, 2002). 
For example, while leukocytes express high levels of β2 integrin subunits (known as “leukocyte integrin”), 
epithelial cells and fibroblasts lack the expression of this integrin subunit (Harris et al., 2000). Integrins are 
expressed in mammalian cells as well as in sponges, corals, arthropods and nematodes and share a high 
degree of similarity among the species (Brower et al., 1997; Burke, 1999; Hughes, 2001).  
Integrins are heterodimeric molecules composed of two subunits, alpha (α) and beta (β). Both subunits 
are non-covalently bound. Up to now, there are 18 α subunits and 8 β subunits known that are able to 






Figure 5: The integrin family and their possible α and β integrin subunits combinations. There are 18 α integrin 
subunits and 8 β integrin subunits. The αβ integrin combination enables to form 24 distinct integrin molecules. The 
β1 integrin subunit is the more promiscuous integrin subunit enabling more possible combinations.  
 
 
Integrins are type I transmembrane molecules (Figure 6) with an ectodomain (extracellular part), a 
transmembrane domain and a short cytoplasmatic tail that is responsible for signal transduction (Hynes, 
2002; Ulmer, 2010). Integrins are allosteric proteins and can be found in three different states (Figure 6): 
i) inactive state (also called “bent” state) at which they show low affinity and are unable to bind the ligands 
(Figure 6 A); ii) “extended” state in which they show some affinity to the ligands (Figure 6 B) and iii) active 
state (“ligand occupied” state or “high affinity” state) in which they display a high affinity to the ligands 




Figure 6: Integrin structure and conformations: bent inactive integrin state (A); active, extended integrin state (B) and 
active, high affinity integrin state bound to the extracellular matrix (ECM); C). The α integrin subunit is represented 
in green while the β integrin subunit is represented in pink. Each integrin subunit is composed of a large extracellular 
domain, a transmembrane molecule and the cytoplasmatic tail. Reference: © Georgiadou et al.,(2017), modified. 
Originally published in The Journal of Cell Biology, 216:1107-1121. DOI: 10.1083/jcb.201609066. 
 
 
Integrins are also classified as metalloproteins because their functions are highly regulated by divalent 
cations such as Mg++, Mn++ and Ca++ (Zhang et al., 2012). Divalent cations in particular Mg++ and Mn++, have 
stimulatory effects on the integrin activation substantially increasing the integrin-ligand affinity. Opposite 
to that, Ca++ ions have inhibitory effects on the integrins. These stimulatory and inhibitory effects mediated 
by divalent cations are especially important in the case of leukocytes where the integrins are most of the 
time in the inactive state (Leitinger et al., 2000; Mitroulis et al., 2015; Zhang et al., 2012). 
The most important integrin functions are to mediate cell adhesion to the ECM and to transduce 
intracellular cell signaling (Harburger et al., 2009; Hynes, 2002). Since their discovery, several other 
important physiological functions have been attributed to integrins. Those functions include cell migration 
and differentiation during embryogenesis and organogenesis and leukocyte migration during 
inflammatory response (Darribere et al., 2000; Hyun et al., 2009; Lammermann et al., 2008; Merviel et al., 
2001; Schmidt et al., 2013b). Integrins are able to control cell mitosis by the activation of mitogen activated 
protein kinase (MAP) and many other intracellular proteins involved in the progression of cell cycle (Streuli, 
2009). On the other hand, integrins can also control the apoptotic mechanisms in different cells. Integrins 
can trigger anoikis, a type of apoptosis induced when cells are not properly attached to the ECM. This 
mechanism seems to be especially important to control tumor metastasis (Gilmore, 2005). Furthermore, 
integrins are involed in hemostasis, healing processes and platelets aggregation (Bennett, 2005; Bergmeier 






Since integrins are closely connected to the cytoskeleton, these connections mediate several cellular 
responses that will culminate in changes in cell morphology, adhesion and spreading (Calderwood et al., 
2000; Choquet et al., 1997). One classical example of cell response driven by cytoskeleton rearrangement 
is the formation of structures called focal adhesion sites. These structures consist of integrin 
agglomerations and intracellular signaling proteins that connect the ECM to the actin cytoskeleton 
(Wehrle-Haller et al., 2002; Wozniak et al., 2004). 
One important characteristic of integrins is their ability to bind to different ligands like fibronectin, 
vitronectin, fibrinogen, laminin, von Willebrand factor and collagen. The recognition of an integrin ligand 
is mediated by conserved amino acid sequences within the ligand (Humphries et al., 2006; Plow et al., 
2000). One of the main ligand motifs involved in the recognition by integrins is the RGD (Arg-Gly-Asp) motif 
which is found in fibronectin, vitronectin and fibrinogen. Another integrin ligand motif is GFOGER which is 
present in collagen (Humphries et al., 2006). 
 
1.10.3) Integrin signaling 
 
Integrin molecules are very specialized in transducing intracellular signaling via its cytoplasmatic tail 
leading to distinct changes in cell response (Harburger et al., 2009; Miranti et al., 2002). Integrins are called 
“bi-directional” molecules due to their ability to transduce signals from inside the cell (called “inside-out” 
signaling) or from outside of the cell (called “outside-in” signaling) (Hynes, 2002; Shen et al., 2012). Inside-
out signaling is particularly important in the context of leukocyte and platelet activation during immune 
and inflammatory responses. During this process, integrin activation increases the affinity to their ligands. 
Outside-in signaling happens in response to ligand binding to integrins subsequently leading to 
intracellular events that might end in different cell responses such as migration, differentiation, division 
or apoptosis (Harburger et al., 2009; Kim et al., 2011). Downstream intracellular signaling involves several 
molecules such as focal adhesion kinase (FAK) which is phosphorylated upon integrin activation and is a 
pivotal marker of integrin signaling (Mitra et al., 2005; Zhao et al., 2011) Several other intracellular 
signalling proteins have been reported to be involved in the integrin signaling such as Rho family proteins, 
Src-kinase family proteins, talin, kindlins, paxilin, vinculin and many others (Harburger et al., 2009).  
 
1.10.4) Integrins as virus receptors 
 
Since integrins are widely expressed in many cell lines, are conserved among the species and represent 
essential receptors involved in different important cellular processes, not surprising that viruses also 
explore the integrin machinery with several benefits for their infection cycle. Although some viruses 
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harbor canonical integrin ligand motifs, other viruses use the integrin machinery independently of these 
motifs (Hussein et al., 2015; Triantafilou et al., 2001) .  
Adenoviruses (Adenoviridae family, Mastadenovirus genus) are the classical example of virus-integrin 
interaction. These viruses can enter the cells by using αVβ3 or αVβ5 integrin. Many adenovirus strains 
harbor an RGD motif loop in the penton base that is reported to interact with integrins mediating 
adenovirus internalization (Nemerow et al., 2016; Wickham et al., 1993).  
Foot and mouth disease virus (FMDV – Picornaviridae family, Aphthovirus genus) is another example for 
an RGD-dependent manner integrin usage. FMDV was shown to interact with at least four RGD binding 
integrins (αvβ1, αvβ6, αvβ3 and αvβ8) to promote virus attachment and internalization (Berinstein et al., 
1995; Jackson et al., 2004; Jackson et al., 2002; Wang et al., 2015a). In one of these studies, ectopic 
expression of the αv integrin subunit in Chinese Hamster Ovary (CHO) cells, a cell line that is non-
permissive to FMDV infection, enabled FMDV binding to the cells and subsequent infection of the CHO 
cells (Jackson et al., 2002).  
Several herpesviruses of medical importance were shown to use integrins as cellular receptors. The 
Kaposi’s sarcoma associated herpesvirus (KSHV – Herspesviridae family, Rhadinovirus genus) was shown 
to use the α3β1 integrin, a laminin receptor, to mediate binding and entry in human foreskin fibroblasts 
(Akula et al., 2002). Another study reported that KSHV also interacts with αVβ3 integrin mediating 
attachment and entry into salivary gland epithelial cells (Garrigues et al., 2014). The human herpex simplex 
virus 1 (HHV-1 – Herpesviridae family, Simplexvirus genus) glycoprotein H (gH), a protein involved in 
herpesvirus fusion, harbors an RGD motif that was demonstrated to mediate binding to αVβ3 integrin in 
Vero and CHO cells (Parry et al., 2005). Another study demonstrated binding of soluble HHV-1 gH and 
glycoprotein L (gL) to αVβ6 and αVβ8 with high affinity reinforcing the physical interaction between HHV-
1 glycoproteins and integrins (Gianni et al., 2013). The human cytomegalovirus (HCMV – Herpesviridae 
family, Cytomegalovirus genus) glycoprotein B (gB) does not posses any canonical integrin ligand motif but 
holds a disintegrin-like domain instead which is a conserved motif known to be recognized by integrins 
(Feire et al., 2010). The disintegrin-like domain was found to interact directly with the β1 integrin subunit. 
Soluble recombinant gB fragments blocked HCMV infection (Feire et al., 2010). 
Hantaviruses (Hantaviridae family, Orthohantavirus genus) have a particular and distinct interaction with 
integrins. It was proposed that pathogenic hantaviruses such as Sin Nombre virus (SNV) and New York 1 
virus (NYV-1) use the β3 integrin subunit as cellular receptor while non-pathogenic hantaviruses like 
Prospect Hill virus (PHV) were shown to use β1 integrin subunit to infect the host cell (Gavrilovskaya et al., 
1999; Gavrilovskaya et al., 1998). These studies demonstrated that expression of both αIIbβ3 and αvβ3 
integrins rendered CHO cells permissive to SNV and NYV-1 but not PHV, indicating a particular usage of 
integrins by pathogenic hantaviruses (Gavrilovskaya et al., 1999; Gavrilovskaya et al., 1998).  
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The arbovirus Ross river virus (RRV – Togaviridae family, Alphavirus genus) was reported to use α1β1 
integrin as cellular receptor in human epithelial cells (HeLa) and mosquito cells (C6/36) (La Linn et al., 
2005). In this study, type IV collagen as well as monoclonal and polyclonal antibodies against the β1 
integrin subunit inhibited RRV infection. RRV was also shown to interacted physically with soluble α1β1 
integrin (La Linn et al., 2005).  
The CSFV (Flaviviridae family, Pestivirus genus) has been reported to upregulate the expression of β3 
integrin subunit in swine endothelial cells upon infection (Tang et al., 2010). More recently, Li et al., (2014) 
reported that expression of β3 integrin subunit enhanced CSFV infection and proliferation. By comparing 
a set of porcine cell lines, the authors demonstrated a more efficient virus infection and proliferation in 
cell lines expressing high amounts of β3 integrin subunit (Li et al., 2014).  
 
1.10.5) Integrins and flaviviruses 
 
The first study reporting the involvement of integrins in flavivirus infection goes back to 1997. The authors 
proposed that α3β1 integrin, a laminin receptor, could be involved in TBEV infection (Protopopova et al., 
1997).  
The presence of the integrin binding RGD motif in the E protein of YFV-17D, MVEV and JEV led to 
speculations whether these viruses might use integrins as a cellular receptor (van der Most et al., 1999). 
By introducing amino acid exchanges in the YFV-17D RGD motif, the authors demonstrated that those 
amino acid exchanges did not affect YFV-17D infection in human adrenal gland cells (SW13 cells) but rather 
resulted in instability of the YFV-17D E protein which consequently impaired virus spread at 37°C. 
Additionally, RGD modification to RAD and RAE strongly impaired the YFV-17D titers in mosquito C6/36 
cells. These results provided additional evidence of integrin interaction with flaviviruses (van der Most et 
al., 1999). 
In 2003, the isolation of a 105 kDa cellular protein from Vero and murine neuroblastoma cells was 
reported. The unidentified 105 kDa cellular protein interacted with WNV promoting virus binding and 
infection of the cells. In the same study, antibodies raised against the unknown 105 kDa protein strongly 
abrogated WNV and KUJV infection in Vero cells (Chu et al., 2003). Further characterization of the 
unknown 105 kDa protein by peptide sequencing revealed a member of the integrin family, namely the 
integrin αVβ3 (Chu et al., 2004b). The authors demonstrated that specific antibodies against the αV and 
β3 integrin subunits strongly impaired WNV binding to Vero cells by 50% and 60%, respectively. In addition, 
these antibodies inhibited WNV internalization in Vero cells by 50% (αV) and 75% (β3) (Chu et al., 2004b). 
Silencing of β3 integrin subunit in Hela cells reduced WNV entry by about 60%. Binding and infection of 
WNV in CS-1 melanoma cells, a WNV non-susceptible cell line that does not express the β3 integrin 
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subunit, was substantially increased upon ectopic expression of β3 integrin subunit. Finally, WNV binding 
to αVβ3 integrin triggered the FAK phosphorylation, giving reasonable evidence that integrin αVβ3 integrin 
might act as a putative WNV receptor (Chu et al., 2004b). Further studies demonstrated that WNV 
recombinant E-DIII protein bound with high specificity to αVβ3 but not to αVβ5 or heparan sulfate (Lee et 
al., 2006b). Moreover, treatment of β3 integrin expressing CS-1 cells with WNV recombinant E-DIII protein 
resulted in αVβ3-E-DIII complex formation and precipitation, suggesting that WNV E-DIII physically 
interacts with αVβ3 integrin (Lee et al., 2006b). In strong contrast to the results reported by other authors, 
Medigeshi et al. (2008) demonstrated that WNV entry into the host cell is completely independent of αVβ3 
integrin but instead depends on lipid-raft microdomains (Medigeshi et al., 2008). Using CS-1 cells as well 
as mouse embryonic fibroblasts (MEF) deficient for β3 integrin subunit and FAK, the authors showed that 
WNV infects CS-1 cells regardless of the αVβ3 integrin expression. Virus titers in both β3 integrin subunit 
and FAK deficient MEFs did not differ significantly from their respective wild type cell lines (Medigeshi et 
al., 2008).  
More recently, Schmidt et al.,(2013a) showed that the αV, β1 and β3 integrin subunit were not involved 
in WNV binding to MEFs. Furthermore, antibodies raised against the β1 and β3 integrin subunits did 
neither affect binding nor replication of WNV. However, the deletion of β1 and β3 integrin subunits, 
strongly impaired the replication of all WNV strains in the integrin deficient MEFs. Once the respective 
integrin subunit was rescued, WNV yields were recovered up to 90% (Schmidt et al., 2013a). Moreover, 
Fan et al., (2017) suggested that αVβ3 integrin could promote JEV infection in baby hamster kidney cells 
strain 21 (BHK-21). Downregulation of both, αV and β3 integrin subunits in BHK-21 cells reduced the JEV 
plaque formation by 4- fold and 2-fold in αV and β3 integrin subunit siRNA silenced BHK cells. Moreover, 
synthetic RGD peptides as well as antibodies raised against the αV and β3 integrin subunits reduced the 
plaque formation by up to 58% and 33%, respectively (Fan et al., 2017). Since CHO cells have been 
demonstrated to be not or only poorly permissive to several viral agents including flaviviruses (Berting et 
al., 2010) and to lack the expression of αV and β3 integrin subunits at the cell surface (Gianni et al., 2010a; 
Gianni et al., 2010b; Xu et al., 2011), Fan et al. (2017) established a CHO cell line expressing the β3 integrin 
subunit to investigate the involvement of this integrin in JEV infection. The expression of β3 integrin 
subunit increased JEV replication in CHO cells suggesting that this specific integrin subunit might play a 





The current knowledge on integrin usage by flaviviruses is scarce and most of the previous studies were 
performed with WNV and JEV. In these reports, integrins were demonstrated to be involved in WNV and 
JEV binding and internalization into the host cell as well as in RNA replication.  
To our knowledge, there are no other studies demonstrating the involvement of integrins in other 
flavivirus infections despite WNV and JEV. Therefore, the main objective of this study was to evaluate the 
potential role of selected integrins, the αVβ3 integrin and the β1 and β3 integrin subunits, for the infection 
cycle of several other medically important flaviviruses. 
For this purpose the study aimed: 
(i) to develop cell lines expressing the integrins and corresponding deficient cell lines, 
(ii)  to evaluate the potential of integrins as flavivirus receptor, 
(iii)  to prove the ability of integrin to act as flavivirus attachment factor, 
(iv) to investigate the potential role of integrins in flavivirus internalization, 
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3) Materials and Methods 
3.1) Materials 
 
All materials, reagents, solution protocols, equipments, softwares and databases are listed in Appendices 
I, II, III, VII, IX. 
3.2.) Cell culture methods 
3.2.1.) Cell lines and cultivation methods  
 
All cell lines used in this study are described in Table 1 and Appendix VIII. Generally, cells were maintained 
in medium containing 10 % fetal bovine serum (FBS). Cells were cultivated under standard conditions in a 
37°C incubator with 5% carbon dioxide. Prior to experiments, cells were cultivated with 5% FBS. For 
splitting, cells were washed twice with 1X phospate buffered saline (PBS) followed by adding 5ml of 0.25% 
trypsin solution into the flasks and incubation at 37°C for 5 minutes. Trypsin inactivation was performed 
by adding 5 ml of the usual cell culture medium supplied with FBS. 
 
Table 1: Cell lines used in this study 
Designation Species Background Organ/Tissue Reference/Source 
MEF-WT Mus musculus C57/BL6 Embryonal Dr. Markus Keller, INNT, 
Friedrich-Loeffler Institut, 
Insel Riems MEF-αVβ3-/- Mus musculus C57/BL6 Embryonal 
MEF-β3+/+R Mus musculus C57/BL6 Embryonal 
Hodivala-Dilke et al.,(1999); 
Schmidt et al.,(2013a) 
MEF-β3-/- Mus musculus C57/BL6 Embryonal 
MKF-β1Flox Mus musculus C57/BL6X 129SV Kidney 
Fassler et al.,(1995a) 
MKF-β1-/- Mus musculus C57/BL6X 129SV Kidney 
CHO-K1 Cricetulu. griseus - Ovary Puck et al.,(1958) 
Vero Chlorocebus aethiops - Kidney 
see references 1 and 2 in 
Osada et al.,(2014)  
Vero B4 Chlorocebus sabaeus - Kidney 
German Collection of 
microorganisms and cel 
culture - DSMZ 
Vero E6 Chlorocebus aethiops - Kidney 
see reference 13 in  
Osada et al.,(2014)  
Vero 76  Chlorocebus aethiops - Kidney 
   MEF: mouse embryonic fibroblasts; MKF: mouse kidney fibroblasts; CHO: Chinese Hamster Ovary cells; R: rescue 
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3.2.2) Mouse embryonic fibroblasts (MEFs) 
 
Wild type mouse embryonic fibroblasts (MEF-WT) and MEFs lacking the expression of either β3 integrin 
subunit (MEF-β3-/-) or αVβ3 integrin (MEF-αVβ3-/-) as well as MEFs rescued (R= rescue) for the expression 
of β3 integrin subunit (MEF-β3+/+R) were cultivated in Dulbecco’s Modified Essential Medium (DMEM) 
supplied with 10% FBS and 1% antibiotic-antimycotic mix composed of penicillin (10,000 U /ml), 
streptomycin (10 mg/ml) and amphotericin B (25 µg/ ml). Cells were cultivated until confluence of 
approximately 80% (MEF-WT) and 90% (MEF-αVβ3-/-) was reached. Cultures were routinely split at ratios 
of 1:10 for MEF-WT and MEF-αVβ3-/- and 1:3 for MEF-β3-/- and MEF-β3+/+R. For the MEF-β3+/+R transfected 
cells, the zeocin antibiotic was added into the medium at a final concentration of 10 µg per ml.  
 
3.2.3) Mouse kidney fibroblasts (MKFs) 
 
Wild type mouse kidney fibroblasts (MKF-β1flox) and mouse kidney fibroblasts lacking the expression of β1 
integrin subunit (MKF-β1-/-) were cultivated in DMEM supplied with 5% FBS and 1% antibiotic-antimycotic 
mix composed of penicillin (10,000 U/ml), streptomycin (10 mg/ml) and amphotericin B (25 µg/ml). Cells 
were cultivated until confluence of approximately 80% was reached. Cultures were routinely split at a ratio 
of 1:10.  
 
3.2.4) Chinese hamster ovary cells 
 
Chinese Hamster Ovary cells clone K1 (CHO-K1) were cultivated in Eagle’s Modified Essential Medium (E-
MEM) supplied with 10% FBS and 1% antibiotics-antimycotic mix composed of penicillin (10,000 U/ml), 
streptomycin (10 mg/ml) and amphotericin B (25 µg/ml). Cells were cultivated until confluence of 
approximately 80% was reached. Cultures were routinely split at a ratio of 1:5. For CHO-β3+/+R and CHO-
αV+/+R transfected cells, the selection antibiotics zeocin or hygromycin were added into the medium at a 
final concentration of 50 µg per ml and 5 µg per ml, respectively. 
 
3.2.5) Vero cells 
 
Vero cells from different lineages referred to as Vero-76, Vero-B4, Vero-E6 and Vero were cultivated in E-
MEM supplied with 10% FBS and 1% antibiotic-antimycotic mix (100 µg/ml). Cells were cultivated until 
confluence of approximately 80% was reached. Cultures were routinely split at a ratio of 1:5. 
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3.2.6) Cryopreservation methods 
 
For long-lasting storage of eukaryotic cells in liquid nitrogen, cells were detached from the flasks by trypsin 
as described above. The detached monolayers were resuspended in fresh medium and centrifuged at 900 
rotations per minute (RPM) for 10 minutes. Then, supernatants were discarded and the cell pellet was 
gently resuspended in fresh cold medium containing 10% of cell culture grade dimethylsulfoxide (DMSO) 
prepared shortly before the freezing procedure. Cell suspension was aliquoted in cryogenic storage vials 
and placed into Mr Frosty™ cell freezing container filled with isopropanol and stored overnight at -80°C. 
Finally, cells were transferred into liquid nitrogen tanks for long-term storage. 
For thawing cryopreserved cells, cryogenic storage vials were removed from liquid nitrogen tanks and 
placed into a portable small liquid nitrogen container. Cryogenic tubes were quickly thawed in a pre-
warmed water bath (37°C). Afterwards, cell suspension was gently resuspended and cells were seeded in 
fresh cell culture medium (10 ml) in T25 cm² flasks and incubated at 37°C. The day after, cells were washed 
with 1X PBS to remove cell debris and DMSO remains and fresh medium was added. 
 
3.2.7) Determination of cell number  
 
Determination of total cell number was achieved by counting the cells in a Neubauer chamber. All the four 
quadrants (16 squares) were counted and the average number of cells was calculated. The number of cells 
per ml was calculated using the formula 
 
N° of cells/ml =
A
B
 x C x 10000     
   
where A is the average of cells counted in each quadrant; B is the number of quadrants counted and C is 
the dilution factor. 
 
 
3.2.8) Determination of cell viability 
 
Routinely, prior to cell plating and all cell infection assays, cell viability was determined using the trypan 
blue exclusion method. In order to evaluate cell metabolism and consequently cell viability, the MTS-
tetrazolium colorimetric assay was applied. While the first method measures cell membrane selectiveness, 
the second method measures the ability of cells to metabolize tetrazolium metabolites.  
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Determination of cell viability by trypan blue exclusion method was performed as described by 
Strober,(2015). Briefly, cells were detached as described above and resuspended in a total volume of 10 
ml fresh medium. An aliquot of 100 µl of cell suspension was transferred into a microtube containing 0.4% 
trypan blue dye solution diluted in 1X PBS (1:10 dilution) to a final volume of 1 ml. After two minutes at 
room temperature, 10 µl of cell suspension was loaded into a Neubauer chamber and counted using 
inverted light microscope. Blue stained cells (i.e.: no cell membrane selectiveness) were considered dead 
and cells that did not acquire blue staining (i.e.: cell membrane selectiveness) were considered vital. 
Determination of viability was calculated by the following formula: 
 
Viability (%)=
number of vital cells
total number of cells
 x 100% 
 
 
Determination of cell viability was also performed using the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (Promega) following instructions of the manufacturer. Briefly, cells were detached as 
described above and resuspended in a total volume of 10 ml of fresh medium. Cell number was 
determined by counting in a Neubauer chamber as described before. Different cell concentrations (ranging 
from 10³ to 106 cells per well) were seeded in duplicate into the 96-well cell culture plates to a final volume 
of 100 µl. After addition of 20 µl of MTS-tetrazolium reagent to each well, the plates were gently mixed 
and incubated at 37°C with 5% carbon dioxide atmosphere under light protection for 4 hours with gently 
mixing every hour. Thereafter, absorbance was measured at 490 nm by an Enzyme-linked immunosorbent 
assay (ELISA) plate reader. Vero cells and Vero cells treated with 10% sodium azide (100 µl per ml of cells) 
were used as positive and negative control, respectively. Background wells (only MTS-tetrazolium reagent) 
as well as blank wells (no reagent) were added into the plate as internal controls. Absorbance was plotted 
by mean value of respective cell amount subtracted by the background absorbance. Two independent 
experiments were performed in duplicate (n=2). 
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3.3) Viruses and virological techniques 
 
All viruses used in this study are described in Table 2.  
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Dr. Katja Schmidt, 
FLI,INNT 
Arroyo et al.,(2004) 
Usutu virus USUV Germany 
Dr. Ute Ziegler, 
FLI,INNT 
Jöst et al.,(2011) 
Langat virus LGTV TP-21 
Dr. Ute Ziegler, 
FLI,INNT 
Smith,(1956) 
Zika virus ZIKV MR-766 
Dr. Ute Ziegler, 
FLI,INNT 
Dick et al.,(1952) 
  
3.3.1) Preparation of viral stocks 
 
For flavivirus propagation, confluent monolayers of Vero-76 cells were seeded in T75 cm2 flasks. Virus 
stocks were thawed on ice and diluted in E-MEM without FBS at a ratio of 1:10. Prior to inoculation, cell 
monolayers were washed once with 1X PBS and virus inoculum was added to the cell monolayers and 
incubated for 1 hour at 37°C with constant agitation every 20 minutes. After this period, the inoculum was 
removed and replaced with E-MEM 2% FBS. Inoculated monolayers were incubated at a 37°C incubator 
with 5% carbon dioxide for a period of 5 to 7 days until the cytopathic effects (syncytia formation, cell 
death and total or focal degeneration of cell monolayers) were clearly observed. Cell supernatants were 
harvested and centrifuged at 5,000 RPM for 10 minutes to remove cell debris. Virus stocks were aliquoted 
and stored at -80°C. 
 
3.3.2) Virus purification and concentration 
 
For the binding studies, viruses were purified by sucrose gradient density centrifugation. Briefly, virus 
stocks were propagated in Vero cells as described above. For virus purification, cells were cultivated in 
T162 cm² flasks. Supernatants from infected Vero cells were clarified by centrifugation at 5,000 RPM for 
10 minutes at 4°C. Cell debris was removed and the supernatant was mixed with 50% polyethylene glycol 
(PEG) 6000 and incubated for 30 minutes on ice. Afterwards, flasks were incubated overnight at 4 °C for 
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virus precipitation. In parallel, sucrose gradient was prepared with two densities: 30% and 60% of sucrose 
(30 g of sucrose per 100 ml of TNE buffer and 60 g of sucrose per 100 ml of TNE buffer). Then, 4 ml of 60% 
solution and 6 ml of 30% solution were added into ultracentrifugation tubes and incubated overnight at 
4°C. The day after, the virus/PEG 6000 mixture was centrifuged at 5,000 RPM for 30 minutes at 4°C. The 
pellet containing the precipitated virus particle was resuspended in TNE buffer, carefully added into the 
centrifugation tube containing the sucrose gradient and centrifuged at 28,000 RPM for 2 hours at 4°C. 
Afterwards, a visible band containing the precipitated virus was collected and centrifuged again using the 
same conditions described above. Finally, purified virus was resuspended in 500 µl of TNE buffer, aliquoted 
and stored at -80°C until use.  
 
3.3.3) Plaque assay  
 
The plaque assay was performed as previously described by Dulbecco et al.,(1953) with some 
modifications. For the plaque assay, specific Vero cells for each flavivirus were seeded into 6-well plates 
at a confluence of 1x105 cells per well in E-MEM 10% FBS, 24 hours prior to inoculation. On the day of 
inoculation, virus stocks were 10-fold serially diluted ranging from 1:10 to 1:108 in E-MEM without FBS and 
inoculated into the wells in duplicate. A negative control well (no virus) was also included in the assay. 
Infected monolayers were incubated for 1 hour at 37°C with constant agitation every 20 minutes. After 
this period, the inoculum was removed and monolayers were covered with an overlay medium composed 
of E-MEM 2% FBS supplied with 1.8% bacteriological agar.Plates were incubated at 37°C for a period of 5 
to 7 days. After this period, monolayers were fixed with buffered 10% formalin for 1 hour and stained with 
1% crystal violet solution overnight. The day after, monolayers were washed to remove excess of dye and 
agarose clumps, dried and plaques were counted. The plaque forming units (PFU) were calculated 
following the formula: 
 
PFU/ml= n° of plaques x 2 x inverse of dilution 
 
3.3.4) Tissue culture infectious dose determination 
 
The tissue culture infectious dose (TCID50) assay was performed as previously described by Reed,(1938) 
with modifications. For the assay, Vero cells were seeded in E-MEM 10% FBS at a confluence of 1x104 cells 
per well in 96-well plates at 24 hours prior to inoculation. Virus stocks were 10-fold serially diluted ranging 
from 1:10 to 1:1010 in E-MEM without FBS and incubated on ice until inoculation. Medium was removed 
from the wells and 100 µl of inoculum was added into the wells in quadruplicate. Inoculated monolayers 
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were incubated at 37°C for 1 hour for virus adsorption and infection. After this period, the inoculum was 
removed, the wells washed once with 1X PBS and the wells were replaced with fresh E-MEM 2% FBS. Plates 
were checked daily for the presence of cytopathic effect (i.e.: monolayer devastation) with an estimated 
time of 4 to 6 days post inoculation. Once the cytopathic effects were visualized, monolayers were fixed 
with buffered 10% formalin for 1 hour, washed twice with distilled water and stained with 1% crystal violet 
solution overnight. The following day, plates were washed and the end-point titer was calculated 
according to the Spearman-Kaerber method (Kärber, 1931; Spearman, 1908). The following formula was 




+ d/2 - ΣP
i 
Where, 
               M = Logarithm of titer in relation to the testing volume  
               X
k 
= Negative common logarithm of the highest dilution level where all wells are positive           
               d = Negative common logarithm of the dilution factor  
 P
i 
= Positive wells/well rate in a row starting with the dilution X 
 
3.4) Cloning of heterologous DNA in expression vectors 
 
All vectors, sequences, reagents and buffers are listed in Appendices I, II, IV and V. The Escherichia coli (E. 
coli) strain DH5α was used as standard strain for all cloning procedures. Further information concerning 
its genetic background and the manufacturer is displayed in Appendix VIII. 
 
3.4.1) Preparation of competent bacterial cells 
 
Preparation of competent E. coli cells was performed using the calcium-magnesium method (Hanahan et 
al., 1991). Frozen bacteria glycerol stocks were scraped and inoculated into Luria Bertani (LB) medium 
without antibiotics and incubated overnight at 37°C in a bacterial shaker at 200 RPM. The day after, 1 ml 
of the overnight bacterial culture suspension was added into 40 ml of LB medium without antibiotics. 
Cultures were incubated at 37°C with continuous agitation (200 RPM) and the optical density of 600 nm 
(OD600) was measured systematically. When the culture reached the OD600 value of 0.5, the bacterial 
suspension was transferred to a 50 ml centrifuge tube, incubated on ice for 10 minutes and centrifuged at 
2,000 RPM for 10 minutes at 4°C. After centrifugation, supernatants were discarded and the pellet was 
gently resuspended in 2 ml of ice-cold calcium-magnesium buffer, filled with 18 ml of the same buffer 
(final volume of 20 ml) and incubated on ice for 30 minutes. Afterwards, bacterial suspension was 
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centrifuged at 1,800 RPM for 10 minutes at 4°C. The supernatant was discarded and the pellet 
resusupended in 3 ml of ice-cold calcium-magnesium buffer plus 500 µl of glycerol. After gentle mixing 
suspension was aliquoted (100 µl) into microtubes and quickly frozen by liquid nitrogen. Stocks of 
competent bacteria were then transferred to -80°C and stored until use.  
 
3.4.2) Transformation of bacterial cells 
 
Bacteria were transformed by heat shock method as described by Froger et al.,(2007) with modifications. 
For this, competent E. coli (strain DH5α) cells were thawed on ice and 100-500 ng of vector or constructs 
were added, gently mixed and incubated for 30 minutes on ice. Following this incubation, bacterial cells 
were incubated at 42°C for 2 minutes followed by 5 minutes incubation on ice. After this, 1 ml of LB 
medium without antibiotics was added and bacterial cells were incubated for 1 hour and 30 minutes at 
37°C with constant shaking (300 RPM). Then, cells were centrifuged at 8,000 RPM for 3 minutes and 
resuspended in 100 µl of LB medium and gently mixed by pipetting. Bacteria were then seeded on LB agar 
plates containing either ampicillin (100 µg/ml) or kanamycin (50 µg/ml) according to the resistance gene 
assigned to the vector and incubated at 37°C for 12-16 hours in incubator. 
 
3.4.3) Selection of bacterial transformants 
 
Bacterial cells grown on the LB agar plate containing the selection antibiotic were considered to be 
transformed (containing the vector) and were selected for cultivation in LB medium. For this, 5-10 colonies 
were picked from each plate and inoculated individually in LB medium containing the antibiotics 
mentioned above. Cultures were incubated for 12-16 hours at 37°C with constant agitation at 200 RPM in 
a bacteriological shaker. The next day, cultures were centrifuged at 5,000 RPM for 30 minutes, supernatant 
discarded and the bacterial pellet lysed for DNA plasmid isolation or frozen at -20°C for further use.  
3.4.4) Purification of plasmid DNA 
 
For purification of plasmid DNA at small and medium scale, the QIAprep Spin Miniprep Kit (Qiagen) and 
QIAprep Plasmid Midi Kit (Qiagen) were used respectively, following manufacturer’s instructions. Bacterial 
pellets were resuspended in P1 buffer and subsequently lysed with P2 buffer and mixed by inversion 4 to 
6 times. Suspension was neutralized by addition of P3 buffer and centrifuged at 5,000 RPM for 30 minutes. 
After this, the supernatant was loaded into filter cartridges for filtration and loaded into gravity flow 
columns. After flow through of the supernatant, columns were washed twice with QC buffer and DNA was 
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eluted in QF buffer. DNA was precipitated by addition of absolute isopropanol at room temperature. The 
mixture was mixed and centrifuged at 5,000 RPM for one hour at 4°C. After this, the pellet was washed 
with 70% isopropanol and centrifuged again at 5,000 RPM for 30 minutes at 4°C. Pellets were dried and 
resuspended in 100-200 µl of TE buffer. Plasmid DNA concentrations were determined by micro-volume 
spectrophotometer (NanoDrop®). 
 
3.4.5) Agarose gel electrophoresis  
 
Separation of plasmid DNA and restriction fragments was achieved by agarose gel electrophoresis using 
gels with different agarose concentrations (0.8%, 1.0% and 1.8%) according to the DNA fragment size. For 
separation of large DNA fragments, lower agarose concentrations were used and for small DNA fragment 
size higher agarose concentrations instead. The 50x Tris-acetate-EDTA buffer concentrate (50x TAE) was 
used as standard electrophoresis buffer in a working concentration of 1X (1X TAE). The same fresh-
prepared 1X TAE buffer was used to dissolve the agarose powder. Agarose powder was weighed and 
dissolved in 100 ml of 1X TAE buffer and melted by heating the mixture under constant agitation. After, 
the homogeneous agarose mixture was added into an electrophoresis tray coupled with a 1.5 mm comb. 
Thereafter, the gels were transferred to an electrophoresis chamber and the chamber loaded with 1X TAE. 
In parallel, samples were diluted in 5 µl of 6x loading buffer dye and loaded into the gel slots. Alongside, a 
molecular size marker was loaded in the first slot to estimate the size of fragments. The separation took 
place at 110 volts for 1 hour. After electrophoresis, the gels were stained with ethidium bromide (1 
mg/liter). DNA fragments were visualized by ultraviolet (UV) light excitation using a transilluminator and 
documented with an integrated camera system and thermal printer. If necessary, the desired bands were 
excised and subjected to purification. 
 
3.4.6) Enzymatic digestion of plasmid DNA 
 
Vectors as well as constructs were digested by restriction endonucleases. High fidelity (HF) restriction 
enzymes from New England Biolabs were used for all experiments according to the manufacturer’s 
guidelines. Shortly, 20 units of restriction endonucleases (1 µl of each enzyme) were added to digest 1-2 
µg of DNA together with the 5X Cutsmart buffer (New England Biolabs). Water was added to complete the 
final volume to 50 µl. Reactions were run in a thermocycler for 2 hours at 37°C, followed by endonucleases 
heat inactivation at 65°C for 10 minutes. After digestion, DNA fragments were visualized by agarose gel 
electrophoresis as mentioned in the section above. 
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3.4.7) Vector DNA dephosphorylation  
 
To avoid spontaneous vector re-circularization, vector DNA was subjected to dephosphorylation to remove 
the phosphate groups from the 5’ ends soon after digestion. The New England Biolabs Antartic 
Phosphatase system was used since it allows high compatibility with the buffer used for previous digestion. 
For this, 1 μl of 10Χ Antarctic Phosphatase reaction buffer and 1 unit of Antarctic Phosphatase were 
added.per 10 μl of digestion reaction mixture. The reaction mix was incubated for 1 hour at 37 °C before 
inactivation of the enzyme for five minutes at 65 °C. 
 
3.4.8) Gel extraction of plasmid DNA  
 
For isolation of plasmid DNA from agarose gels, the QIAquick gel extraction kit (Qiagen) was used according 
to the manufacturer’s guidelines. Shortly, after electrophoresis and staining with ethidium bromide, 
fragments were excised from the agarose gels with a clean-sterile scalpel and added into 2.0 ml 
microtubes. The fragments were weighed and 100 µl of QG buffer per 100 mg of gel was added. The 
mixture was incubated at 50°C for approximately 10 minutes until complete gel dissolution. Then 1 volume 
of isopropanol was added to the mixture, mixed and loaded into QIAquick spin column and centrifuged at 
13,000 RPM for 1 minute. Subsequently, columns were washed with 750 µl PE buffer and centrifuged again 
at 13,000 for 1 minute. Finally, 50 µl of RNAse/DNAse free water was added onto the column, incubated 
for 5 minutes and transferred to a sterile 1.5 ml microtube for centrifugation at 13,000 RPM for 1 minute. 
The plasmid DNA concentration was measured by micro-volume spectrophotometer (Nanodrop®) and 
stored at -20° C until use. 
 
3.4.9) DNA clean-up and nucleotide removal 
 
In order to remove excess of salts, enzymes and nucleotides from the digestion reaction, vector DNA clean-
up was performed upon digestion and/or dephosphorylation using the QIAquick Nucleotide Removal Kit 
(Qiagen). Shortly, the digestion reaction was mixed with 10 volumes of PNI buffer, applied to a spin column 
and centrifuged at 6,000 RPM for 1 minute. The flow-through was discarded and the column washed with 
750 µl PE buffer and centrifuged again for 1 minute at 6,000 RPM. The flow-through was discarded and 
the column centrifuged again to remove excess of buffers. The DNA was eluted by adding 50 µl of water 
to the column, incubation for 5 minutes at room temperature and centrifugation at 13,000 RPM for 1 
minute. The plasmid DNA concentration was measured by micro-volume spectrophotometer (Nanodrop®) 
and stored at -20° C until use.  




Ligation reaction was performed using the Rapid DNA Ligation kit (ThermoFisher) following manufacturer’s 
instructions. Based on the plasmid (vector) DNA and insert concentration ratios were calculated as 1:1, 
1:3, 1:5. Then, the vector, insert, buffer and the T4 ligase were mixed and a final volume of 20 µl was 
completed with water. Reaction was incubated at room temperature for 1 hour and 5-10 µl of ligation 
reaction was used to transform competent bacteria as described above. For selection of recombinant 
bacteria, the procedure described in section 3.4.3 was applied. Constructs were confirmed by restriction 
endonuclease digestion (section 3.4.6) and sequencing (see below). 
 
3.4.11) DNA sequencing methods  
 
Plasmid DNA as well as PCR amplicons were submitted to sequencing to confirm their identities with the 
original sequences. The dideoxy chain-termination method according to Sanger et al.,(1977) was used to 
sequence all samples in this study.  Samples were prepared and shipped to Eurofins Genomics, Ebersberg, 
Germany, following instructions of the company. Shortly, samples containing 50-100 ng/µl of purified 
plasmid DNA or 2-5 ng/µl of purified PCR product were diluted in water to a total volume of 15 μl. If 
necessary, forward and reverse primers were shipped together with the samples in a separate mix 
containing a primer concentration of 10 pmol and final volume of 15 µl. 
 
3.4.12) Synthesis of integrin coding sequences  
 
The mouse αV and β3 integrin (ITG-αV and ITG-β3) subunit coding sequences (GenBank, accession no. 
KP296148.1 and NM016780.2) were commercially synthesized by GeneArt, Regensburg, Germany. The 
sequences were codon-optimized to enable maximal expression in murine cell lines. Additionally, to 
increase the expression of recombinant modified genes, the Kozak consensus sequence (5’-GCCACC-3’) 
was added at the 5’ region upstream of the integrin coding sequence. The cleavage sites for the restriction 
endonucleases BamHI and NotI were added at 5’ and 3’ regions, respectively. The integrin genes were 
cloned into a standard vector (pMK-RQ) harboring the kanamycin resistance gene. The final constructs 
named pMK-ITGαV and pMK-ITGβ3 were 5,450 base pairs and 4,678 base pairs, respectively. The genes 
corresponding to ITG-αV had 3,172 base pairs and ITG-β3 had 2,400 base pairs. These genes were used for 
subcloning into the pcDNA 3.1 vector system. 
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3.4.13) Cloning of integrin genes 
 
The respective pMK vectors harboring the ITG-αV and ITG-β3 genes were digested with HF BamHI and NotI 
restriction endonuclease enzymes as described in section 3.4.6. The integrin corresponding fragments, 
3,172 bp for the ITG-αV and 2,400 bp ITG-β3 were excised from the gels and subjected to gel extraction 
clean-up as described in section 3.4.8. Concentration of DNA fragments was measured by micro-volume 
spectrophotometer (Nanodrop®). 
The pcDNA 3.1 (+) Zeo and pcDNA 3.1 (+) Hygro plasmid DNA referred to as pcDNA 3.1 (Z) and pcDNA 3.1 
(H), respectively, were digested with HF-BamHI and HF-NotI as described in section 3.4.6. After digestion, 
the linearized vectors were immediately dephosphorylated as outlined in 3.4.7 and purified as mentioned 
in section 3.4.9. After purification, plasmid DNA and insert were subjected to ligation as described in 
section 3.4.10. After that, the procedures for bacterial transformation and selection of bacterial 
transformants were performed according to section 3.4.2 and 3.4.3. To confirm the successful subcloning 
of integrin genes, the putative recombinant plasmids were digested as described in 3.4.6. Selected 
recombinant plasmids were confirmed by DNA sequencing as mentioned in section 3.4.11. 
 
3.5) Transfection methods and antibiotic selection 
 
Transfection of plasmid DNA was performed using a cationic lipid based chemical, commercially known as 
Lipofectamine®. To deliver the respective foreign target genes into MEFs, Lipofectamine® LTX-Plus was 
used preferentially due to its low toxicity and high transfection efficiency. To create CHO-K1 cells 
expressing the αV or β3 integrin subunits, CHO-K1 cells were transfected with Lipofectamine® 3000. 
 
3.5.1) Transfection protocol optimization 
 
Transfection procedures were performed as recommended by the manufacturer’s (Invitrogen). The 
optimal DNA/Lipofectamine® ratios were evaluated in the cell lines to achieve the highest transfection 
efficiency with the lowest toxicity. Initially, cells were transfected with a vector harboring the green 
fluorescent protein (GFP) coding sequence. For the Lipofectamine® LTX, pcDNA-GFP was tested at ratios 
of 1:3, 1:5, 1:7 and 1:9 (DNA : Lipofectamine®). Best results were achieved with the ratio of 1:9. For the 
Lipofectamine® 3000, the ratios 2:3 and 2:5 (DNA : Lipofectamine®) were tested. Best results were 
achieved with the ratio 2:3. 
  
   
39 
3.5.2) Transfection of mouse embryonic fibroblasts 
 
MEF-β3-/- and MEF-αVβ3-/- cells were seeded into 12-well plates 12-16 hours prior to transfection with 
DMEM 10% FBS without antibiotics. The next day, the medium was replaced with fresh cell culture 
medium (500 µl per well) and incubated at 37°C until transfection. A mix containing the Lipofectamine® 
LTX reagent (18 µl), the Plus reagent (5 µl), the plasmid DNA (2 µg) and Opti-MEM® medium (to a final 
volume of 500 µl) were prepared in duplicate. The mixture was incubated for 10 minutes at room 
temperature and then added dropwise to the cells. Plates were gently rocked and incubated at 37°C with 
5% carbon dioxide for 24 hours. The medium was then replaced with fresh cell culture medium and cells 
were incubated for additional 24 hours before they were split and subjected to antibiotic selection. 
 
3.5.3) Transfection of CHO-K1 cells 
 
The CHO-K1 cells were seeded into 12-well plates 12-16 hours prior to transfection with E-MEM 5% FBS 
without antibiotics. The next day, the medium was replaced with fresh cell culture medium (500 µl per 
well) and incubated at 37°C until transfection. A mix containing the Lipofectamine® 3000 (6 µl), the P3000 
reagent (4 µl), the plasmid DNA (2 µg) and Opti-MEM® medium (to a final volume of 500 µl) was prepared 
in duplicate. The mixture was incubated for 10 minutes at room temperature and then added dropwise to 
the cells. Plates were gently rocked and incubated at 37°C with 5% carbon dioxide for 24 hours. The 
medium was then replaced with fresh cell culture medium and cells were incubated for additional 24 hours 
before they were split and subjected to antibiotic selection. 
 
3.5.4) Antibiotic selection  
 
Cells were split and subjected to antibiotic selection 48 hours after transfection. Cells were detached from 
the 12-well plates as described in 3.2.1. and seeded into 6-well plates. The MEFs transfected with pcDNA 
3.1 (H)-ITG-αV and pcDNA 3.1 (Z)-ITG-β3 were resuspended in DMEM 10% FBS supplied with hygromycin 
(100 µg/ml) and zeocin (500 µg/ml). For the CHO-K1 cells transfected with the pcDNA3.1(H)-ITG-αV and 
pcDNA3.1(Z)-ITG-β3, cells were resuspended in E-MEM 10% FBS containing the hygromycin (200 µg/ml)  
and zeocin (1000 µg/ml). Cells were kept under antibiotic selection for several (approximately 15) passages 




3.6) Cell sorting  
 
In order to obtain a homogenous cell population of integrin expressing cells, transfected cells were sorted 
magnetically using the MACS system following the instructions of the manufacturer. A positive selection, 
i.e. the selection of integrin expressing cells, was chosen. The system is composed of the MS magnetic 
columns, the MACS multiStand and the anti-biotin Microbeads. The procedure was performed under 
sterile conditions. Cells were detached from the flasks and resuspended in 1X MACSQuant Running buffer 
and the cell number was determined (1x107 cells per column). Cells were then incubated with biotinylated 
anti-αV and anti-β3 integrin subunit specific antibodies (1 µg per 1x107 cells) for one hour and 30 minutes 
at 4°C with slight rotation (20 RPM). After this, cells were centrifuged at 1,000 RPM at 4°C for 10 minutes 
and the pellet washed twice with 1X MACSQuant Washing buffer. The cell pellet was resuspended in 100 
µl of 1X MACSQuant Running buffer. Thereafter, 50 µl of anti-biotin Microbeads were added, mixed 
carefully and incubated at 4°C with constant agitation (20 RPM) for 1 hour at 4°C. Then, cells were washed 
twice with washing buffer and centrifuged at 1,000 RPM for 10 minutes at 4°C and resuspended in 500 µl 
of MACSQuant Running buffer. MS columns were placed in the MACS multiStand and equilibrated with 
MACSQuant Washing buffer followed by careful loading of cells into MS columns. The first fraction 
containing the unlabeled cells (flow-through) was collected and placed at 4°C. Subsequently, columns were 
washed three times with MACSQuant Washing buffer. Finally, columns were removed from the magnetic 
stand, loaded with 500 µl of MACSQuant Running buffer and cells were eluted by pressure with a plunger. 
This elution procedure was repeated twice. The positively selected cells were again centrifuged at 1,000 
RPM for 10 minutes and seeded into T25 cm² cell culture flasks with medium containing the selection 
antibiotics. To analyze the percentage of integrin expressing cells and separation efficiency, flow cytometry 
analysis was performed 
 
3.7) Flow cytometry analysis 
 
Further details about the antibodies used in this experiment are shown in Appendix III. Flow cytometry 
analysis was performed to measure the integrin expression on the cell surface. Briefly, cells were detached 
from flasks and passed through a 0.22 µm cell strainer. Cell number was determined and a concentration 
of 1x106 cells per tube was used. Tubes were incubated on ice for 30 minutes, centrifuged and incubated 
with anti mouse αV, β1 and β3 integrin-subunit specific antibodies for 1 hour at 4°C. After this incubation, 
cells were washed twice with ice-cold 1X PBS and centrifuged at 2,000 RPM for 5 minutes. Secondary 
antibodies labelled with Alexa 488 and Alexa 647 fluorescent dyes were added into the tubes and 
incubated for 1 hour at 4°C. Subsequently, cells were washed twice with ice-cold 1X PBS and centrifuged 
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at 2,000 RPM for 5 minutes. Cell pellets were resupended in 300 µl of ice-cold 1X PBS and analyzed by BD 
FACSCanto II flow cytometer with BD FACSDiva Software. A number of 10,000 events was determined. 
Data were processed and post-analyzed by Flowing software (Perttu Terho – Turku Centre for 
Biotechnology, University of Turku, Finland). 
  
3.8) Indirect Immunofluorescence 
 
Further details about the antibodies used in this experiment are shown in Appendix III. Cells were grown 
on glass coverslips 12-16 hours prior to the experiment. Thereafter, cells were fixed with 3 % 
paraformaldehyde for 15 minutes, followed by incubation with 50 mM ammonium chloride for 30 minutes. 
After this, cells were permeabilized with 0.5 % TritonX-100, washed twice with 1X PBS and subsequently 
blocked with 0.5 % skim milk. Antibodies were diluted in blocking buffer and cells were incubated with 
anti mouse αV, β1 and β3 integrin-subunit specific antibodies for 1 h at room temperature followed by 
three washes with 1X PBS and subsequent incubation with Alexa-488 and Alexa-647 labelled secondary 
antibodies for 1 hour at 4°C. For nucleus staining, the glass cover slips were quickly rinsed with 2 mg/ml 
4',6-Diamidino-2-Phenylindole (DAPI) solution diluted at 1:5,000 in 1X PBS followed by a final wash with 
1X PBS and a quick wash with distilled water. Finally, coverslips were dried and fixed upside down on 
microscopy slides with VectaShield® anti-fade mounting medium. Cells were visualized in the laser 
Confocal Leica DMI600 CS microscope and using the LAS AF Leica Application Suite software. Images were 
processed with ImageJ software (National Institutes of Health, NIH, USA). 
 
3.9) Cell adhesion assay 
 
In order to verify the presence of other RGD binding integrins and confirm the functionality of these 
integrins, a cell adhesion assay was performed as described by Miao et al.,(2000) with modifications. 
Enzyme-linked mmunosorbent assay (ELISA) Maxisorp® plates were coated overnight at 4°C with 1 µg/ml 
of recombinant mouse vitronectin or Poly-L-Lysin (Poly-L-Lsy) diluted in carbonate buffer (pH 8.0). The 
next day, plates were washed once with 1X PBS and blocked with 2% bovine serum albumin (BSA) prepared 
in 1X PBS  and incubated for 1 hour at 37°C. Cell monolayers were detached from the flasks using 5 mM 
EDTA, counted and added at a concentration of 1x105 cells per well in serum free E-MEM with 0.1% BSA 
fraction V. Cells were incubated for 30 minutes (MKF-β1Flox and MKF-β1-/-) or 45 minutes (all other cells) at 
37°C to allow for cell adhesion. Vero cells were used as control for the assay. After this incubation, plates 
were washed to remove non-adherent cells and adherent cells were fixed with 3% paraformaldehyde for 
1 hour at room temperature. After fixation, plates were washed and cells were stained with 1% crystal 
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violet prepared in 20% methanol for 1 hour. After extensive washing, plates were dried and the dye was 
extracted from the adhered cells with a dye removal solution (50% ethanol in 50 mM sodium citrate buffer, 
pH 4.5). Absorbances (OD 550 nm) were measured using ELISA plate reader. 
 
3.10) Development of synthetic RNA and production of standard curves for RT-qPCR 
 
Synthetic in vitro transcribed RNAs were produced to enable quantification of viral RNA load in the 
infection experiments. All sequences, their respective accession numbers as well as a schematic 
organization of these constructs are displayed in Appendix X. Sequences were collected from the online 
database GenBank® provided by the National Center for Biotechnology Information (NCBI). Geneious® 
software was used to process and modify the sequences. The in vitro transcription reactions were 
perfomed using the Riboprobe System SP6/T7 kit (Promega). 
 
3.10.1) Sequence design and synthesis 
 
Sequences from YFV-17D (NS5 gene), USUV (NS1 gene), WNV (E gene), LGTV (NS5 gene) and ZIKV (NS1 
gene) were collected from the GenBank database and the primer/probe binding regions from the virus 
sequences were tested in silico to certify the correct primer/probe annealing. In the 5’ extremity, the 
bacteriophage SP6 RNA polymerase promoter sequence was added upstream to the specific virus 
primer/probe binding regions. Between the SP6 promoter sequence and the virus primer/probe binding 
region a “spacer” region containing 8 nucleotides was added. Finally the specific virus primer/probe 
binding region was added. In addition to that, if the sequence length allowed modifications, an 
“identification” region was introduced to certify sequence authenticity and avoid and rapidly identify 
cross-contamination. Sequences were then commercially synthesized by Eurofins Genomics and cloned 
into pEX-A2 vector (Eurofins Genomics). 
 
3.10.2) Vector linearization and clean-up 
 
Four micrograms of each construct were linearized by restriction endonuclease cleavage using the HF-NotI 
as described in 3.4.6. Afterwards, linearization was confirmed by agarose gel electrophoresis and the 
linearized construct was purified using the QIAquick PCR Purification Kit following manufacturer’s 
instructions. Linearized vectors were eluted in 50 µl of DNAse/RNAse free water and stored at -20°C until 
use. 
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3.10.3) Production of synthetic RNAs 
 
Linearized vectors were in vitro transcribed using the Riboprobe system SP6/T7 kit (Promega) following 
manufacturer’s guidelines. Briefly, the reaction was scaled-up to a final volume of 40 µl. Then, a mix was 
prepared containing the transcription buffer, DTT, RNase inhibitors, the ribonucleotides (rATP, rGTP, rCTP 
and rUTP), the SP6 polymerase, the linearized vector and water to a final volume of 40 µl (Table 3) and the 
reactions were incubated at 37°C for 2 hours. 
 
 




            
3.10.4) Removal of DNA template 
 
To completely remove remaining template DNA, reactions were digested with 2 units (2 µl) of DNAse turbo 
per µg of DNA template and incubated at 37°C for 1 hour. 
  
Reagent Volume 
Transcription Optimized 5X Buffer 8.0 µl 
DTT (100mM) 4.0 µl 
Recombinant RNasin  Ribonuclease Inhibitor (20–40 units) 1.0 µl 
rATP, rGTP and rUTP (2.5 mM each) 8.0 µl 
100 µM rCTP (diluted from stock) 4.8 µl 
Linearized template DNA  (0.2–1.0 mg/ml in water or TE buffer) X 
SP6, T3 or T7 RNA Polymerase (15–20 units) 4.0 µl 
Water X 
 Final Volume 40 µl 
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3.10.5) RNA purification 
 
The in vitro transcribed RNAs were cleaned up using the RNeasy Mini Kit (Qiagen) following manufacturer’s 
instructions. Briefly, the in vitro transcription reaction was resuspended in 350 µl of RLT buffer and 250 µl 
of absolute ethanol. Samples were loaded into spin columns and centrifuged at 8,000 RPM for 1 minute. 
The flow-through was discarded and the columns were washed twice with 500 µl RPE buffer. To remove 
remaining buffer, the columns were centrifuged at 13,000 RPM for 1 minute. Then, columns were loaded 
with 50 µl of DNase/RNase free water and incubated for 5 minutes and then centrifuged again at 13,000 
RPM for 1 minute. Synthetic RNAs were quantified by micro-volume spectrophotometer (Nanodrop®) and 
stored at -80°C until use. 
 
3.10.6) Determination of RNA copy numbers  
 
RNA copy numbers were determined as described by Hoffmann et al.,(2005). The following formula was 
applied for this calculation: 
 
Copy numbers =
conc of RNA (g)/(µl)
transcript length in nucleotides x 340 
x 6.022x1023 
 
3.10.7) Preparation of standard curve 
 
To quantify the absolute viral RNA copy numbers, a standard curve was developed based on serial dilutions 
of the respective synthetic RNAs. Shortly, samples were diluted serially in RNA-safe-buffer (RSB) ranging 
from 1:10 to 1:108 to a final volume of 250 µl. After dilution, samples were stored at -80°C and once 
thawed, stored at -20°C with a maximum of 5 freeze- and thaw-cycles.  
 
3.11) Isolation of nucleic acids 
3.11.1) Isolation of viral RNA from cell culture supernatant 
 
Virus RNA was isolated using the QIAamp Viral RNA Mini Kit (Qiagen) following manufacturer’s protocol. 
Briefly, 140 µl of cell culture supernatant were collected and mixed with 560 µl AVL buffer. Afterwards, 
suspensions were spin-centrifuged to remove droplets from the lid and 560 µl of absolute ethanol were 
added to the mixture, mixed and shortly spun-down to remove lid droplets. Then 630 µl were loaded to a 
spin column and centrifuged at 8,000 RPM for 1 minute, the flow-through was discarded and the step 
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repeated again. Columns were first washed with 500 µl of AW1 and subsequently with 500 µl of AW2 
buffer, centrifuged at 8,000 RPM for 1 minute and 3 minutes, respectively. Finally, the spin columns were 
transferred to a sterile 1.5 ml microtube, 50 µl of AVE buffer were added to the columns, incubated for 5 
minutes and then centrifuged at 13,000 RPM for 1 minute. The eluted RNA was stored at -80°C until use. 
 
3.11.2) Isolation of total RNA from cell monolayers  
 
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) following manufacturer’s instructions.  Cell 
culture monolayers were resusupended in 350 µl of RLT buffer and frozen overnight at -80°C. Suspensions 
were spun-down to remove droplets from the lid and 350 µl of 70% ethanol were added, mixed and shortly 
spun-down again. Then 700 µl of the mixture were loaded to a spin column and centrifuged at 8,000 RPM 
for 1 minute, the flow-through discarded and the step repeated, if necessary. Columns were washed with 
700 µl of RW1 buffer and subsequently with 500 µl of RPE buffer before centrifugation at 10,000 RPM for 
1 minute (RW1 buffer) and 2 minutes (RPE buffer). Finally, the spin columns were transferred to a sterile 
1.5 ml microtube, 50 µl of AVE buffer was added to the columns, incubated for 5 minutes and then 
centrifuged at 13,000 RPM for 1 minute. The eluted RNA was stored at -80°C until use. 
 
3.12) Polymerase chain reaction 
 
Primer sequences and reagents are all listed in Appendices VI, IV.  
 
3.12.1) One-step reverse transcription-polymerase chain reaction (RT-PCR) 
 
To detect the gene expression by reverse transcription (RT) followed by polymerase chain reaction (PCR) 
two systems are available: one-step and two-step RT-PCR. Basically, the first system performs both, the 
RT and PCR reaction in a single reaction while in the second system, each reaction must be performed 
separately. For detection of integrin mRNA expression, we chose the one-step RT-PCR method using the 
Superscript III™ One-Step RT-PCR kit. Total RNA was isolated as described in section 3.11.2. A master mix 
containing 1.0 µl of each forward and reverse primers (at a concentration of 10 pmol), 25 µl of the PCR 
buffer (containing dNTPs, magnesium and DTT) and 2.0 µl of the enzyme mix containing both RT (Moloney 
murine leukemia virus RT) and Thermus aquaticus (Taq) DNA polymerase enzymes were added into a 1.5 
ml microcentrifuge tube. Sterile RNase/DNase free water was added into the tube to complete the 
reaction to a final volume of 45 µl. The master mix was then gently homogenized and aliquoted into a 0.2 
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ml PCR reaction tube. After this, the total RNA (5 µl) was added into each tube separately and reactions 
were mixed and submitted to thermal cycling as shown in Tables 4, 5 and 6. 
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Stage Temperature Time Cycles 
Reverse Transcription 55° C 60 min 1x 
PCR 
94° C 2 min 
40 x 
94°C 15 sec 
56°C 30 sec 
68°C 60 sec 
Final Elongation 68°C 10 min  
Stage Temperature Time Cycles 
Reverse Transcription 60° C 60 min 1x 
PCR 
94° C 2 min 
40 x 
94°C 15 sec 
62°C 30 sec 
68°C 60 sec 
Final Elongation 68°C 10 min  
Stage Temperature Time Cycles 
Reverse Transcription 55° C 60 min 1x 
PCR 
94° C 2 min 
40 x 
94°C 15 sec 
60°C 30 sec 
68°C 60 sec 
Final Elongation 68°C 10 min  
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3.12.2) Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) 
 
Quantification of viral genome by quantitative reverse transcription-polymerase chain reaction (RT-qPCR) 
was performed in a one-step system. The detection method used in this study was based on DNA probes 
labelled with fluorescent dyes (commonly known as Taqman system). Primers and probes were diluted to 
a final concentration of 10 pmol in 0.1X TE buffer. The primer/probe mix was stored at -20°C under light 
protection. The RT-qPCR reactions were set using the QuantiTec Probe RT-PCR kit (Qiagen). The standard 
protocol was used for all RT-qPCR reactions. Viral RNA was isolated from supernatants or cell culture 
monolayers as outlined in 3.11. A mastermix containing 12.5 µl of the PCR buffer (supplied with dNTPs, 
magnesium and the Taq DNA polymerase), 2.0 µl of the primers/probe mix, 0.25µl of the RT enzyme mix 
(Omniscript® Reverse Transcriptase and Sensiscript® Reverse Transcriptase) and water was added up to a 
final volume of 20 µl. The mastermix was homogenized by agitation and a quick spin-centrifugation was 
done to collect droplets from the lid. Then, the mastermix was aliquoted into 96-well PCR plates. Finally, 
5 µl of RNA template were added into the respective wells, plates were sealed with adhesive optical PCR 
sealing film, centrifuged and submitted to thermal cycling as shown in Table 7. A standard curve based on 
in vitro transcribed RNA was used to quantify the absolute copy number. Positive controls as well as 
negative and blank controls were also added in every RT-qPCR experimental run. All RT-qPCR reactions 
were run in the CFX96™ Real-Time PCR Detection System (Biorad). 
 









3.12.3) Detection of flavivirus RNA by RT-qPCR 
 
The pan-flavivirus detection and identification assay was used for the detection and quantification of YFV 
and LGTV genomes (Vina-Rodriguez et al., 2017). In this assay, a primer pair was designed targeting the 
NS5 region of different flaviviruses, enabling the detection of almost all flavivirus species. Aside in this 
study, a DNA-based probe labelled with fluorescence dye was designed separately targeting the inter-
Stage Temperature Time Cycles 
Reverse Transcription 
50° C 30 min 
1x 
95° C 15 min 
PCR 
95°C 15 sec 
45 x 55°C 30 sec 
72°C 15 sec 
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regions between forward and reverse primers. The YFV and LGTV DNA-probes were labelled with 
6’carboxyfluorescein (FAM) reporter at the 5’ region and with a tetramethylrhodamine (TAMRA) quencher 
at the 3’ region. FAM-specific fluorescences were excited at 450-490 nm and detected at 515-530 nm. 
Detection of USUV genome was performed as described by Jöst et al.,(2011) with modifications. The DNA-
based probe was labelled with a Hexachlorofluorescein (HEX) at the 5’ region and Black Hole Quencher 1 
(BHQ-1) as quencher at the 3’ region. HEX specific fluorescences were excited at 515-535 nm and detected 
at 560-580 nm. The WNV genome detection was performed as described by Lanciotti et al.,(2000) with 
modifications. The DNA-based probe was labelled with FAM reporter at the 5’ region and with TAMRA 
quencher at the 3’ region. FAM specific fluorescences were excited at 450-490 nm and detected at 515-
530 nm. ZIKV genome was detected using primers and probe described by Lanciotti et al.,(2008) with 
modifications. The DNA-based probe was labelled with FAM reporter at the 5’ region and TAMRA quencher 
at the 3’ region. FAM specific fluorescences were excited at 450-490 nm and detected at 515-530 nm. 
 
3.13) Cell infection assays 
 
Generally, all cell infection assays were performed in 12-well plates except the binding inhibition assay 
that was performed in 24-well plates. Unless specified, all integrin deficient MEFs and MKFs, their 
respective wild-type cells and the CHO cells expressing the αV and β3 integrin subunits were seeded at a 
concentration of 1x105 cells per well. Cells were cultivated in DMEM or E-MEM supplied with 2% FBS unless 
further specified. Prior to inoculation, cell concentrations as well as cell viability (Trypan Blue method) 
were determined to ensure correct multiplicity of infection (MOI) calculation. For virus inoculation, serum 
and antibiotic free DMEM or E-MEM were used. 
 
3.13.1) Virus binding assay 
 
For the binding assay, cell culture medium was replaced with serum-free DMEM or E-MEM medium and 
cells were pre-incubated at 4°C for 30 minutes prior to inoculation. After this, plates were placed on ice 
and cells inoculated with sucrose gradient purified flaviviruses at an MOI of 10. Then, cells were incubated 
for one hour on ice with agitation every 15 minutes. After this period, the inoculum was removed and the 
wells were washed four times with ice-cold 1X PBS to remove unbound virus particles. Cell monolayers 




3.13.2) Replication Assay 
 
For the replication assay, cells were inoculated at an MOI of 10 and incubated at 37°C for virus adsorption 
for one hour. After this period, the inoculum was removed and monolayers were washed four times with 
1X PBS to remove unbound virus particles. Finally, either fresh E-MEM or DMEM 2% FBS medium was 
added into the wells and plates were incubated at 37°C with 5% carbon dioxide. Supernatants were 
harvested 48 hours after inoculation and stored at -80°C until use. Three independent experiments were 
performed in triplicate. 
 
3.13.3) Virus internalization assay 
 
For the internalization assay, cell culture medium was replaced with serum-free DMEM and cells were pre-
incubated at 4°C for 30 minutes prior to inoculation. After this, plates were placed on ice and cells 
inoculated with different flaviviruses at an MOI of 10. Cells were incubated for one hour on ice with 
agitation every 15 minutes. After this period, inoculum was removed and cells washed four times with ice-
cold 1X PBS to removed unbound virus particles and serum-free DMEM was added into the wells. Cells 
were shifted to 37°C for 40 minutes to allow virus internalization. After this period, medium was removed 
and cell monolayers were washed once with 1X PBS and treated with acidic glycine (pH 2.5) for 2 minutes 
to inactivate non-internalized virions as described elsewhere (Hung et al., 1999; Suksanpaisan et al., 2009; 
Thepparit et al., 2004a). Following this treatment, monolayers were washed twice with 1X PBS and cell 
monolayers were resuspended in RLT buffer and stored at -80°C. Three independent experiments were 
performed in triplicate. 
 
3.13.4) Detection of flavivirus negative-strand RNA 
 
For the detection of flavivirus negative-strand RNA, cells were inoculated as detailed in 3.13.2. 
Supernatants were removed and cell monolayers were extensively washed with 1x PBS to remove excess 
of virus. Cell monolayers were resuspended in RLT buffer and stored at -80°C. Three independent 
experiments were performed in triplicate. Levels of flavivirus negative-strand RNA were calculated using 
the 2^ddCT method as described by Pfaffl,(2001).  
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3.13.5) Binding inhibition assay 
 
For the binding inhibition assay, cells were seeded in 24-well plates with DMEM supplied with 2% FBS at a 
concentration of 1x104 cells per well, 12-16 hours prior to inoculation. Medium was replaced with serum-
free DMEM and cells were pre-incubated at 4°C for 15 minutes prior to inoculation. Subsequently, type I 
collagen (0-500 µg/ml), synthetic RGD motif peptide (0-250 µg/ml) and recombinant mouse vitronectin (0-
50 µg/ml) were added into the wells in serum-free DMEM supplied with 1 mM MnCl2 and 1 mM MgCl2 and 
incubated at 4°C for 30 minutes to allow ligand binding. After this, plates were placed on ice, washed twice 
and cells inoculated at an MOI of 10. Cells were incubated for 1 hour on ice with constant agitation every 
15 minutes. After this period, the inoculum was removed and the wells were washed four times with ice-
cold 1X PBS to remove unbound virus particles. Cell monolayers were resuspended in RLT buffer and stored 
at -80°C. Experiments were performed in duplicate. Percentage of binding inhibition was calculated using 
the following formula: 
 
Percentage of binding inhibition =
Ct value of infected cell − Ct value of treated control cells
Ct value of  infected cell
 𝑥 100 
 
3.14) Graphical design and statistical analysis 
 
Graphics were designed using Graphpad Prism software version 6. Statistical analysis was also performed 
using Graphpad Prism software version 6. if necessary, prior to statistical analysis, the D’Agostino & 
Pearson and Shapiro-Wilk normality tests were performed in order to assure normal distribution. The non-
parametric Mann-Whitney test was used to evaluate statistical significance between the two groups (Wild-
type vs.Knock-out cells) in the binding experiments. The parametric Student’s t-test was used to evaluate 
statistical significance between the two groups (Wild-type vs.Knock-out cells) in the internalization and 
replication experiments. The parametric One-way ANOVA with Bonferroni’s correction was used to 
compare three or more groups. Indication of statistical significance is represented by asterisks (*) as 
follows: * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001; **** = p = ≤ 0.0001. The abbreviation “ns” stands for 




4.1) Generation of integrin expressing cells 
4.1.1) Cloning of integrin genes into mammalian expression vectors 
 
The constructs pMK-ITGαV and pMK-ITGβ3 were digested separately with the HF-BamHI and HF-NotI 
restriction endonucleases. In a subsequent step, the mouse ITG-αV and ITG-β3 genes were inserted into 
pcDNA 3.1 (H) (5,600 bp) and pcDNA 3.1 (Z) (5,000 bp) vectors, respectively, and transformed into E. coli 
strain DH5α. Constructs containing the correct insert were subjected to DNA sequencing. Sequence 
analysis showed the absence of mutations and confirmed in-frame orientation of the inserted sequences 
(data not shown).  
As demonstrated in Figure 7, gel electrophoresis showed fragments of 5,600 bp and 3,172 bp (lane 2) 
corresponding to the pcDNA 3.1 (H) vector and mouse ITG-αV gene, respectively, and fragments of 5,000 




Figure 7: Restriction digestion analysis of pcDNA 3.1 (H) and pcDNA 3.1 (Z) derived integrin gene constructs. The 
constructs were digested by restriction endonucleases HF-BamHI and HF-NotI. Agarose electrophoresis showing 
fragments of 5,600 and 3,172 bps (lane 2; L2) corresponding to the pcDNA 3.1 (H) and the mouse ITG-αV gene; 
fragments of 5,000 and 2,400 bps corresponding to the pcDNA 3.1 (Z) vector and the mouse ITG-β3 gene (lane 3; L3). 
Agarose concentration: 0.8%; electrophoresis conditions: 110V, 70 minutes; ethidium bromide staining; L1: 
GeneRuler 1 Kb DNA ladder (Fermentas). Abbreviation: bp: base pairs. 
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4.1.2) Recovery of αVβ3 integrin expression in MEF-αVβ3-/- cells 
 
To recover the expression of αVβ3 in MEF-αVβ3-/-cells, both vectors harboring the mouse αV and β3 
integrin subunit genes were transfected simultaneously into MEF-αVβ3-/- cells. Forty-eight hours after 
transfection with the vectors harboring the mouse ITG-αV and mouse ITG-β3 integrin subunit genes, 
antibiotic selection using hygromycin B and zeocin was initiated. Within the first 3 days, more than 80% of 
the cells died due to the antibiotic selection. Resistant cell populations were kept under antibiotic selection 
for approximately 6-12 weeks or until a confluent cell monolayer was achieved that allowed splitting to 
T25 cm² flasks. Several clones showed the presence of both αV and β3 integrin subunit genes at the cellular 
DNA level (data not shown). However, the expression levels of αV and β3 integrin subunits at the cell 
surface measured by FACS were less than 10% (data not shown). Positive selection by magnetic cell sorting 
was performed in order to obtain a homogeneous cell population expressing the respective integrin 
subunits. The cell sorting resulted in a cell population of very low density that was further maintained 
under cultivation. After reaching the confluence, cells were tested again by PCR and FACS. Most cells of 
the population lost the expression of one or both integrin subunits but still grew under antibiotic selection. 
Several modifications and different strategies were applied in order to recover the αVβ3 integrin 
expression in MEF-αVβ3-/- cells such as i) decrease of antibiotic concentration; ii) removal of antibiotics 
after cell sorting until the sorted cells reach confluence of more than 60% and iii) use of other transfection 
reagents and transfection techniques such as electroporation. Indeed, all these modifications resulted in 
cell populations with low or absent αVβ3 integrin expression. In turn, the recovery of αVβ3 integrin 
expression in the MEF-αVβ3-/- cells was not achieved (data not shown). Thus, the MEF-WT cells were used 
as the respective wild-type cells. 
 
4.1.4) Establishment of CHO cells expressing the integrin subunits 
 
Transfection efficiency in CHO cells reached more than 80% as determined by the GFP-encoding vector 
control. Forty-eight hours after transfection with the vectors harboring the mouse ITG-αV and mouse ITG-
β3 integrin subunit genes, CHO cells were split into T25 cm² flasks and set under antibiotic selection with 
either zeocin or hygromycin. Hygromycin resistant cell populations were observed after three days of 
antibiotic selection. Zeocin resistant cell populations were observed after one week. Cells were 
successively passed for up to 20 passages. These cell populations were then subjected to positive selection 
by magnetic cell sorting and further characterized for expression of ectopic integrins 
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4.2) Characterization of integrin expressing cells  
4.2.1) Cell morphology and growth 
4.2.1.1) Cell morphology and growth of MEF and MKF cells 
 
Integrin deficient cells as well as their respective wild-type cells were characterized by indirect 
immunofluorescence, FACS and RT-PCR. Initial morphological analyses of the integrin deficient cells as well 
as their respective wild-type cells revealed slight differences in cell morphology (Figure 8). The MKF-β1-/- 
cells showed to be more round-shaped than the parental wild-type cells, the MKF-β1Flox. Both cell lines 
showed similar growth rates and were split more often than MEFs. Interestingly, the MEF-αVβ3-/- cells 
showed morphological changes by forming more cell aggregations than their respective wild-type cells. 
MEF-αVβ3-/- cells showed to be more round-shaped and the cell density was much lower than for the MEF-
WT and MKF cells (Figure 8). The MEF-β3+/+R cells showed a discrete decrease in the growth rate when 
compared to MEF-β3-/- cells. No substantial differences on cell morphology were observed between MEF-
β3+/+R and MEF-β3-/- cells. 
 
Figure 8: Morphology of integrin deficient MEFs and MKFs and their respective wild-type cells. Cells were visualized 
by inverted light microscopy 72 hours after seeding in T25 cm² cell culture flasks. Magnification: 20X. Abbreviations: 
MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 
integrin; MKF-β1Flox: mouse kidney fibroblasts expressing the β1 integrin subunit; MKF-β1-/-: mouse kidney fibroblasts 
deficient for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R 
= rescue; rescued by ITG-β3 gene transfection) and MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 
integrin subunit. 
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4.2.1.2) Cell morphology and growth of CHO cells 
 
CHO-K1 cells were transfected with pcDNA plasmids harboring the mouse αV or mouse β3 integrin subunit 
genes. Upon transfection and establishment of CHO cells expressing the mouse αV or β3 integrin subunits, 
referred to as CHO-αV+/+ and CHO-β3+/+, cells were characterized for their morphology and growth. As 
demonstrated in Figure 9, expression of mouse αV and β3 integrin subunits in CHO cells did not alter cell 
morphology in comparison with the CHO-K1 cells. The cell growth of CHO-αV+/+ and CHO-β3+/+ cells was 
substantially slower than that of CHO-K1 cells as observed by different split rates during the maintenance 
of the cell cultures (data not shown).  
 
 
Figure 9: Morphology of wild-type CHO-K1 cells and CHO cells expressing mouse αV or mouse β3 integrin subunits. 
Cells were visualized by inverted light microscopy 72 hours after seeding in T25 cm² cell culture flasks. Magnification: 
10X. Abbreviations: CHO-K1: Chinese hamster ovary cell clone K1; CHO-αV+/+: Chinese hamster ovary cells expressing 
the mouse αV integrin subunit; CHO-β3+/+: Chinese hamster ovary cells expressing the mouse β3 integrin subunit. 
αV: alpha V integrin subunit; β3: beta 3 integrin subunit. 
 
4.2.2) Detection of integrin mRNA by RT-PCR  
4.2.2.1) Detection of integrin mRNA by RT-PCR in MEFs and MKFs 
 
RT-PCR was performed to test for the mRNA expression of αV, β1 and/or β3 integrin subunits in the 
integrin deficient, rescued and WT cells. As shown in Figure 10 A (right panel), the detection of αV, β1 and 
β3 integrin subunit mRNA in MEF-WT cells was confirmed by amplification of fragments of 300 bp, 500 bp 
and 200 bp corresponding to the αV, β1 and β3 integrin subunit mRNAs, respectively. In contrast to that, 
MEF-αVβ3-/- cells only expressed the β1 integrin subunit mRNA (Figure 10 A, left panel).  
The MKF-β1Flox and MEF-β3+/+R cells showed an expression pattern of αV, β1 and β3 integrin subunit mRNA 
identical to the MEF-WT cells (Figure 10 B, right panel and Figure 10 C, right panel). The MKF-β1-/-  cells 
were demonstrated to express αV and β3 integrin subunit mRNA while lacking β1 integrin subunit mRNA 
(Figure 10 B, left panel). Last, the analysis of MEF-β3-/- cells revealed the expression of αV and β1 integrin 




Figure 10: Expression of integrin mRNA in MEF-WT and MEF-αVβ3-/- (A); MKF-β1Flox and MKF-β1-/- (B) and MEF-β3+/+R 
and MEF-β3-/- (C) cells. The RT-PCR resulted in amplification of 300 bp (αV integrin), 500 bp (β1 integrin) and 200 bp 
(β3 integrin) products. Agarose concentration: 2.5%; electrophoresis conditions: 110 V, 70 minutes; ethidium 
bromide staining; Ladder: GeneRuler 100 bp DNA ladder (Fermentas). Abbreviations: MEF-WT: mouse embryonic 
fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblast deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney 
fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 
integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); MEF-β3-/-
: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin 




4.2.2.1) Detection of integrin mRNA by RT-PCR in CHO cells 
 
To confirm the expression of αV and β3 integrin subunit mRNAs in transfected CHO cells, RT-PCR was 
performed. As shown in Figure 11, the CHO-K1 cells express only the β1 integrin subunit. Obviously, the 
endogenous hamster β1 integrin subunit was also expressed in the CHO cells transfected with either the 
mouse αV or the mouse β3 integrin subunit genes (Figure 11). CHO-αV+/+ cells that were transfected with 
a DNA plasmid harboring the mouse αV integrin gene expressed the respective αV integrin subunit mRNA 
(Figure 11). Finally, the CHO-β3+/+ cells expressed the β3 integrin subunit mRNA (Figure 11). In conclusion, 
the CHO cells transfected with the mouse αV and β3 integrin subunits genes expressed the respective 
mRNAs. 
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Figure 11: Expression of integrin mRNA in CHO-K1, CHO-αV+/+ and CHO-β3+/+ cells. The RT-PCR resulted in 
amplification of 300 bp (αV integrin), 500 bp (β1 integrin) and 200 bp (β3 integrin) products. Agarose concentration: 
2.5%; electrophoresis conditions: 110 V, 70 minutes; ethidium bromide staining; Ladder: GeneRuler 100 bp DNA 
ladder (Fermentas). Abbreviations: CHO-K1: Chinese hamster ovary cell clone K1; CHO-αV+/+: Chinese hamster ovary 
cells expressing the mouse αV integrin subunit; CHO-β3+/+: Chinese hamster ovary cells expressing the mouse β3 
integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin subunit; β3:  beta 3 integrin subunit; Ctrl-: negative 
control; bp: base pairs. 
 
4.2.3) Characterization of integrin expressing cells by indirect immunofluorescence assay 
4.2.3.1) Characterization of MEFs and MKFs  
 
In order to visualize the integrin expression pattern and to determine its sub-cellular localization, indirect 
immunofluorescence assays were performed using antibodies raised against the αV, β1 and β3 integrin 
subunits.  
Images analyzed by confocal laser microscopy revealed that all of the expressed integrin subunits are 
globally distributed along the cell membrane with the formation of focal adhesion sites intensively stained 
at the cell surface (Figure 12). As expected, MEF-WT, MEF-β3+/+R and MKF-β1Flox cells expressed the αV 
(shown in red, left panel, Figure 12), β1 and β3 integrin subunits (shown in green, middle and right panel, 
Figure 12). When analyzing the integrin deficient cells, the MEF-αVβ3-/- cells expressed only the β1 integrin 
subunit (Figure 12) while the MEF-β3-/- cells expressed the αV and β1 (Figure 12). The MKF-β1-/- cells 
showed no expression of β1 but readily expressed the αV and β3 integrin subunits (Figure 12). 
Interestingly, the formation of focal adhesion sites was also observed in the MEF-αVβ3-/- , the MEF-β3-/- 
and the MKF-β1-/- cells indicating that the absence of a certain integrin subunit had no impact on the 
functional expression of other integrin heterodimers. In summary, these results further confirm the results 




Figure 12: Immunofluorescence-based detection of αV, β1 and β3 integrin subunits in MEF and MKF cells. Antibodies 
raised against mouse αV (red), β1 and β3 (green) integrin subunits were used to detect the integrin expression on 
the cell surface. Nuclei were stained using DAPI (blue). Images were captured by Leica laser scanning confocal 
microscope and processed with LAS AF, Leica. Images were edited using ImageJ software. Scale bar: 20 µm (αV 
staining) and 13 µm (β3 and β1 staining). Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-
/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts expressing the β1 
integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-β3+/+R: 
mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts 
deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin subunit; β3: beta 3 integrin 
subunit. 
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4.2.3.1) Characterization of CHO cells 
 
To confirm the expression of mouse αV and β3 integrin subunits in CHO cells at the cell membrane, the 
same immunofluorescence protocol as described for MEF/MKF cells was applied here. As shown in Figure 
13, the respective mouse integrin subunits were detected at the cell surface forming characteristic focal 
adhesion sites in both CHO-αV+/+ and CHO-β3+/+ cells indicating the formation of chimeric integrin 
heterodimers in CHO-αV+/+ as well as in CHO-β3+/+ cells.  
 
 
Figure 13: Immunofluorescence-based analysis of CHO-αV+/+ and CHO-β3+/+ cells for the expression of αV and β3 
integrin subunits on the cell surface. Antibodies raised against mouse αV (red) or β3 (green) integrin subunits were 
used to detect the respective integrin subunits. Nuclei were stained using DAPI (blue). Images were captured by Leica 
laser scanning confocal microscope and processed with LAS AF, Leica. Images were edited using ImageJ software. 
Scale bar: 13 µm. Abbreviations: CHO-αV+/+: Chinese hamster ovary cells expressing the mouse αV integrin subunit; 
CHO-β3+/+: Chinese hamster ovary cells expressing the mouse β3 integrin subunit; αV: alpha V integrin subunit; β3: 
beta 3 integrin subunit. 
 
 
4.2.4) Characterization of integrin expressing cells by flow cytometry 
4.2.4.1) Characterization of MEFS and MKFs by flow cytometry 
 
In order to verify the indirect immunofluorescence results as well as to quantify integrin expression on the 
cell surface, flow cytometry was applied. As shown in Figure 14, all wild-type MEFs and MKFs expressed 
high levels of αV, β1 and β3 integrin subunit on the cell surface. The expression levels ranged from 98% to 
100% for all integrin subunits (Table 8). MEF-αVβ3-/- cells showed no expression of both αV and β3 integrin 
subunits but expressed considerable amounts of β1 integrin subunits (Figure 14 and Table 8). MEF-β3-/- 
cells showed high expression of αV and β1 integrin subunits but complete absence of β3 integrin subunit 
expression (Figure 14). MKF-β1-/- cells expressed high levels of αV and β3 integrin subunits but no 
detectable levels of β1 integrin subunits (Figure 14). In summary, the results achieved by flow cytometry 




Figure 14: Flow cytometry analysis of MEF and MKF cells for αV, β1 and β3 integrin subunit expression. The figure shows 
the flow cytometry histograms based on the mean fluorescence intensity (MFI). Cells were incubated with anti-integrin 
subunit specific antibodies followed by isotype specific secondary antibodies labelled with Alexa-647 (αV integrin) or Alexa-
488 (β3 and β1 integrin). Unlabelled cells as well as mouse IgG isotype (not shown) were used as controls. MFI is 
represented in log scale. Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic 
fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts expressing the β1 integrin subunit (wild-type); 
MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts 
expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; 
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Table 8: Percentage of integrin expression in MEFs and MKFs measured by flow cytometry  
 
 
Percentage of cells expressing respective 
integrin subunits 
Cell Line αV β3 β1 
MEF-WT 99.2 99 99.8 
MEF-αVβ3-/- nd nd 99.4 
MEF-β3+/+R 99.9 100 99.9 
MEF-β3-/- 99.9 nd 99.9 
MKF-β1Flox 99.7 99 99 
MKF-β1-/- 99.9 98.7 nd 










Abbreviations: nd: not detected; MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: 
mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts 
expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the 
β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit; 
MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin 
subunit; β1: beta 1 integrin subunit; β3: beta 3 integrin subunit. 
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4.2.4.1) Characterization of CHO cells by flow cytometry 
 
The levels of integrin expression were measured by flow cytometry using the same antibodies raised 
against the mouse αV and β3 integrin subunit. As seen in Figure 15, CHO-αV+/+ and CHO-β3+/+ cells 
expressed high amounts of mouse αV and β3 integrin subunits while the respective wild-type CHO-K1 cells 
showed no expression of these integrin subunits. The percentage of αV or β3 integrin expressing cells 




Figure 15: Flow cytometry analysis of CHO-K1, CHO-αV+/+ and CHO-β3+/+.cells for αV and β3 integrin subunit 
expression. Flow cytometry histograms are based on the mean fluorescence intensity (MFI). Cells were incubated 
with αV (red) and β3 (green) anti-integrin subunit specific antibodies followed by incubation with isotype specific 
secondary antibody labelled with Alexa-647 (αV integrin) or Alexa-488 (β3 integrin). Abbreviations: CHO-αV+/+: 
Chinese hamster ovary cells expressing the mouse αV integrin subunit; CHO-β3+/+: Chinese hamster ovary cells 
expressing the mouse β3 integrin subunit; αV: alpha V integrin subunit; β3: beta 3 integrin subunit.  
 
Table 9: Percentage of integrin expression in CHO-K1, CHO-αV+/+ and CHO-β3+/+ cells measured by flow 
cytometry 
 
Percentage of cells expressing 
respective integrin subunits 
Cell Line αV β3 
CHO-K1 nd nd 
CHO-αV
+/+
 99.7 nt 
CHO-β3
+/+
 nt 99.9 
                    
  
Abbreviations: nd: not detected; nt: not tested; CHO-αV+/+: Chinese hamster ovary cells 
expressing the mouse αV integrin subunit; CHO-β3+/+: Chinese hamster ovary cells 
expressing the mouse β3 integrin subunit; αV: alpha V integrin subunit; β3:  beta 3 
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4.3) Effect of integrin ablation on cell viability 
 
Loss of integrin expression might lead to the inability of the cell to attach to the ECM and potentially 
triggering anoikis, a type of apoptosis triggered by the inability of cells to bind to the ECM (Gilmore, 2005). 
In order to determine whether the deletion of αVβ3 integrin and the β1 and β3 integrin subunits affects 
viability of MEFs and MKFs, a colorimetric cell viability assay based on MTS-tetrazolium was applied. There 
was no difference in cell viability detected for MEF-αVβ3-/- and MEF-β3-/- cells when compared to their 
respective wild-type, MEF-WT and MEF-β3+/+R cells (Figure 16 A and C). Similarly, the loss of β1 integrin 
subunit expression in MKF-β1-/- cells did not influence cell viability in comparison to MKF-β1Flox as their 
respective wild-type cells (Figure 16 B). 
 
 
Figure 16: Tetrazolium cell viability assay for MEF-αVβ3-/- and MEF-WT (A); MKF-β1-/- and MKF-β1Flox (B) and MEF-β3-
/- and MEF-β3+/+R (C) cells. Cells were seeded at different concentrations (103 to 106 cells per well) and incubated with 
the tetrazolium reagent for 4 hours at 37°C with 5% carbon dioxide. Optical density was measured at 490 nm. Two 
independent experiments were each performed in duplicate (n=2). Square and circle represent the mean values, bars 
represent the standard deviation (means ± standard deviation). Dashed lines indicate the detection limit of the test. 
Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient 
for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: 
mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing 
the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: 
alpha V integrin subunit; β1: beta 1 integrin subunit; β3: beta 3 integrin subunit.  
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In addition to that, routine observation of MEF and MKF cells by light microscopy did not show any signs 
of cell viability reduction such as nuclear retraction, loss of nucleus/cytoplasm ratio, loss of cell adherence 
or excessive number of dead cells (data not shown). In conclusion, the ablation of αVβ3 integrin and β1 
and β3 integrin subunits did not interfere with cell viability. 
 
4.4) Functional characterization of integrin deficient and corresponding wild-type cells 
 
In order to analyze whether the deletion of integrins affects the ability of the integrin deficient cells to 
bind to their ligands, a cell adhesion assay was performed. Poly-L-Lsy, a positively charged polymer, served 
as positive control for cell adhesion since it facilitates binding via electrostatic interactions and is 
independent of integrins (Salmela et al., 2017). All tested cell lines bound to the Poly-L-Lsy (Figure 17 A - 
C). Interestingly, integrin deficient cells bound less efficiently to Poly-L-Lsy coated wells. BSA coated wells, 
used as a control to prove sufficient blocking of the wells showed no cell adhesion for any of the tested 
cells (Figure 17 A - C). Vero cells, known to express a broad variety of different integrins, served as positive 
control and bound efficiently to the vitronectin (Figure 17 A – C). As demonstrated in Figure 17 A, MEF-
αVβ3-/- cells bound to a less extent to mouse vitronectin in comparison to the wild-type cells (MEF-WT). 
The binding activity of MEF-αVβ3-/- cells to vitronectin was reduced by approximately 37.6% (Figure 17 A). 
In a similar manner, the deletion of the β3 integrin subunit in the MEF-β3-/- cells reduced the binding to 
vitronectin to approximately 40.5% compared to the MEF-β3+/+R cells (Figure 17 C). The deletion of β1 
integrin subunit affected poorly the ability of MKF-β1-/- cells to bind to vitronectin (Figure 17 B). In this 
case, a reduction of approximately 8.0% on binding to mouse vitronectin compared to the MKF-β1Flox cells 
was observed (Figure 17 B). In turn, in both integrin deficient MEF and MKF cells, the deletion of one or 












Figure 17: Vitronectin cell adhesion assay with MEF-αVβ3-/- and MEF-WT (A); MKF-β1-/- and MEF-β1Flox (B) and MEF-
β3-/- and MEF-β3+/+R cells (C). Plates were coated overnight with 1 µg/ml of mouse vitronectin. Then, plates were 
blocked with 1% BSA and cells were seeded and incubated at 37°C with 5% carbon dioxide for 30 minutes. Plates 
were washed carefully, fixed with 3% PFA and cells were stained with 1% crystal violet. Dye was extracted and optical 
density was measured at 550 nm. Vero cells, Poly-L-Lsy and BSA were used as controls for the assay. The experiment 
was performed in triplicate. Bars represent the mean values and error bars represent the standard deviation (means 
± standard deviation). Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse 
embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts expressing the β1 integrin 
subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-β3+/+R: mouse 
embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts 
deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin subunit; β3: beta 3 integrin 







Next, it was evaluated whether the mouse αV and β3 integrin subunits expressed in CHO-αV+/+ and CHO-
β3+/+ cells are functional and able to recognize their ligands such as vitronectin. For this, CHO cells 
expressing either the αV or β3 integrin subunits were subjected to the same cell adhesion assay as applied 
to the integrin deficient MEF and MKF cells.  
As shown in Figure 18, the binding to mouse vitronectin was higher in CHO-αV+/+ and CHO-β3+/+ cells in 
comparison to the CHO-K1 cells. The increase in vitronectin binding was 41.9% and 44.5% for the CHO-
αV+/+ and CHO-β3+/+ cells, respectively. In conclusion, the chimeric integrins formed by the ectopic 
expression of mouse αV and β3 integrin subunits associated with the corresponding hamster integrin 





Figure 18: Vitronectin cell adhesion assay with CHO-K1, CHO-αV+/+ and CHO-β3+/+ cells. Plates were coated overnight 
with 1 µg/ml of mouse vitronectin. Plates were then blocked with 1% BSA and cells were seeded and incubated at 
37°C with 5% carbon dioxide for 30 minutes. Plates were washed carefully, fixed with 3% PFA and cells were stained 
with 1% crystal violet. Dye was extracted and optical density was measured at 550 nm. Vero cells, Poly-L-Lsy and BSA 
were used as controls for the assay. The experiment was performed in triplicate. Bars represent the mean values and 
error bars represent the standard deviation (means ± standard deviation). Abbreviations: CHO-αV+/+: Chinese 
hamster ovary cells expressing the mouse αV integrin subunit; CHO-β3+/+: Chinese hamster ovary cells expressing the 
mouse β3 integrin subunit; αV: alpha V integrin subunit; β3: beta 3 integrin subunit; Poly-L-Lsy: Poly-L-Lysine; BSA: 
bovine serum albumin; VTN: vitronectin; O.D.: optical density. 
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4.5) Cell infection assays 
 
In order to investigate whether integrins are involved in the early or late steps of flavivirus infection, 
experiments were designed to analyze these steps separately. Basically it was the aim of this study to 
assess: i) susceptibility and permissiveness of integrin deficient cells for different flaviviruses by analyzing 
the flavivirus replication kinetics; ii) flavivirus binding to integrin deficient cells; iii) virus internalization and 
iv) virus RNA replication.  
 
4.5.1) Flavivirus replication kinetics in MEFs, MKFs and CHO cells 
 
In order to evaluate if the absence of αV, β1 and β3 integrin subunits affects cell permissiveness and/or 
influences replication efficiency of different flaviviruses, all integrin deficient MEFs and MKFs as well as 
the respective wild-type cells were inoculated with YFV-17D, WNV, USUV and LGTV at an MOI of 0.1. Vero 
cells, known to be highly permissive and susceptible to flaviviruses, were used as control in all assays. 
Inoculation of CHO-K1 cells with the flaviviruses mentioned above resulted in no detectable virus titers 
(data not shown). 
As shown in Figure 19 A – D, all four cell lines were permissive for the four flaviviruses investigated. 
However, the replication kinetics of different flaviviruses differed distinctly among the cell lines. Flavivirus-
inoculated Vero cells, the most permissive cell line for flaviviruses, displayed the highest titers for all 
flaviviruses tested 96 hours post inoculation (Figures 19 A – D). Surprisingly, YFV-17D replication in MEF-
β3-/- cells reached similar titers as in Vero cells (6.0 vs. 6.25 log TCID50/ml; Figure 19 A). In addition, YFV-
17D showed to replicate more efficiently in MEF-WT than in Vero cells within the first 72 hours (Figures 
19 A). Among the MEFs, MEF-WT cells produced the highest titers for all flaviviruses tested in this study. 
In these cells, the highest titers were observed for USUV reaching a maximum of up to 9 log TCID50/ml 
after 96 hours (Figure 19 C) and LGTV (7 log TCID50/ml, Figure 19 D) followed by YFV-17D (6.50 TCID50/ml 
Figure 19 A) and WNV (4.5 TCID50/ml Figure 19 B).  
In contrast to that, MEF-αVβ3-/- cells displayed low viral titers for all flaviviruses tested (Figure 19 A – D). 
After 96 hours, titers reached 3.0 log TCID50/ml for YFV-17D, 3.75 log TCID50/ml for WNV, 5.0 log TCID50/ml 
for USUV and 3.25 log TCID50/ml for LGTV. In MEF-β3-/- cells, LGTV and USUV titers were even lower 
reaching only a maximum of 3.75 and 4.75 log TCID50/ml at 96 hours post inoculation, respectively (Figure 
19 C and D). As mentioned above, YFV-17D showed to moderately replicate in MEF-β3-/- cells in 
comparison to the MEF-WT cells (Figure 19 A). Finally, LGTV showed to replicate more efficiently in MKF-
β1-/- cells than the other flaviviruses tested, reaching titers comparable to MEF-WT cells after 96 hours 
post-infection (MKF-β1-/- 6.75 log TCID50/ml vs. MEF-WT 7.0 log TCID50/ml; Figure 19 D). In sum, the 
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deletion of one or two integrin subunits was not able to abrogate flavivirus infection, but substantially 
impaired replication of some flaviviruses.  
 
 
Figure 19: Replication kinetics of YFV-17D, WNV, USUV and LGTV in MEF-WT (red), MEF-αVβ3-/- (blue), MKF-β1-/- 
(black), MEF-β3-/- (green) and Vero (brown) cells. Cells were seeded into 24-well plates and infected with MOI of 0.1. 
Supernatants were harvested every 24 hours over a period of 4 days post inoculation. Virus titers were measured by 
TCID50 in Vero cells. Virus titers were expressed as log of TCID50 per ml of supernatant. Three independen experiments 
were performed. Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic 
fibroblasts deficient for αVβ3 integrin; MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-
β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 
integrin subunit; β3: beta 3 integrin subunit; YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: 
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4.5.2) Influence of integrins on flavivirus binding  
 
Several viruses such as FMDV, echovirus and hantaviruses bind to integrins mediating virus internalization 
into the host cell (Hussein et al., 2015). To investigate whether integrins are involved in flavivirus binding 
to MEFs and MKFs, a virus binding assay was performed.  
First, flavivirus binding to the Vero cells was evaluated by RT-qPCR. As expected, all flaviviruses bound to 
Vero cells but to a different extent (Figure 20). Among all the viruses tested, USUV bound to Vero cells to 
the highest amount displaying mean Ct values of 17.1 followed by WNV (mean Ct value of 21) and YFV-
17D with a mean Ct value of 25.5 (Figure 20). Unexpectedly, LGTV, a cell culture adapted TBEV strain bound 





Figure 20: Flavivirus binding to Vero cells measured by RT-qPCR. Cells were seeded into 12-well plates, placed on ice 
and inoculated with different flaviviruses at an MOI of 10. After one hour, monolayers were washed, harvested and 
lysed with RLT buffer. Total RNA was isolated and RT-qPCR was performed to indirectly measure virus binding to the 
cell surface by detection of viral RNA. Virus binding values are expressed in cycle threshold values (Ct values). Bars 
represent the mean of Ct values and error bars represent the standard deviation (means ± standard deviation). 
Abbreviations: YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; 








4.5.2.1) Influence of integrins on flavivirus binding to MEF and MKF cells 
 
Next, it was evaluated if the deficiency of one or two integrin subunits could affect flavivirus binding to 
MEFs and MKFs. As shown in Figure 21 A-C, the deletion of αVβ3 integrin, β1 or β3 integrin subunits did 
not affect the flavivirus binding to integrin deficient MEFs and MKFs in comparison to the respective wild-
type cells. Statistical analysis did not infer any statistical significance (p > 0.05) in all groups tested with 
different flaviviruses (Figure 21 A-C). Taken together, these results indicate that αVβ3 integrin, β1 or β3 
integrin subunits are not involved in flavivirus binding to the MEF and MKF cells. 
 
 
Figure 21: Flavivirus binding to MEF-WT and MEF-αVβ3-/- (A); MKF-β1Flox and MKF-β1-/-(B) and MEF-β3+/+R and MEF-
β3-/- (C) cells. Cells were seeded into 12-well plates, placed on ice and inoculated with different flaviviruses at an MOI 
of 10. After one hour, monolayers were washed, harvested and lysed with RLT buffer. Total RNA was isolated and 
RT-qPCR was performed to indirectly measure virus binding to the cell surface by detection of viral RNA. Virus binding 
values are expressed in cycle threshold values (Ct values). Three independent experiments were each performed in 
triplicate (n=3). Bars represent the mean Ct values and error bars represent the standard deviation (means ± standard 
deviation). Statistical analysis: Mann-Whitney test; ns: not significant (p> 0.05). Abbreviations: MEF-WT: mouse 
embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: 
mouse kidney fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient 
for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); 
MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 
integrin subunit; β3: beta 3 integrin subunit; YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: 
Usutu virus; LGTV: Langat virus; Ct: cycle threshold.  
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4.5.2.2) Influence of integrins on flavivirus binding to CHO cells 
 
To further investigate the influence of integrins on flavivirus infection, CHO cells expressing the mouse αV 
or mouse β3 integrin subunits, CHO-αV+/+ and CHO-β3+/+, and the respective wild-type cells, CHO-K1, were 
used. It was investigated whether the ectopic expression of mouse αV and β3 integrin subunits in CHO-
αV+/+ and CHO-β3+/+ cells influences flavivirus binding to the cell surface.  
As demonstrated in Figure 22, expression of both αV and β3 integrin subunits had no impact on flavivirus 
binding to CHO cells. The statistical analysis also failed to show any significant differences between CHO-
K1 and CHO cells expressing either the αV or the β3 integrin subunit (p > 0.05). 
Together, the expression of mouse αV and mouse β3 integrin subunits in CHO cells per se did not influence 




Figure 22. Flavivirus binding to CHO-K1, CHO-αV+/+ and CHO-β3+/+ cells. Cells were seeded into 12-well plates, placed 
on ice and inoculated with an MOI of 10. After one hour, monolayers were extensively washed, harvested and lysed 
with RLT buffer. Total RNA was isolated and RT-qPCR was performed to indirectly measure virus binding to the cell 
surface by detection of viral RNA. Virus binding values are expressed in cycle threshold (Ct) values. Three independent 
experiments were performed in triplicate (n=3). Bars represent the mean Ct values and error bars represent the 
standard deviation (means ± standard deviation). Statistical analysis: Mann-Whitney test; ns: not significant (p > 
0.05). Abbreviations: YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat 
virus; CHO-K1: Chinese hamster ovary cells clone K1; CHO-αV+/+: Chinese hamster ovary cells expressing the mouse 




4.5.3) Effect of integrin ligands on flavivirus binding to MEF and MKF cells 
 
For a functional blocking assay, MEF-αVβ3-/- and the respective MEF-WT cells were selected for treatment 
with different integrin ligands. For this assay, three integrin ligands were selected: i) the synthetic RGD 
peptide that represents the minimum residual sequence that integrins recognize; ii) the vitronectin that 
binds with high affinity to RGD binding integrins such as α5β5 and α8β1 and iii) the type I collagen that 
binds to collagen binding integrins such as α1β1, α2β1 and α10β1 integrins (Humphries et al., 2006). 
A pilot experiment was performed in Vero cells to evaluate whether the experimental conditions allowed 
efficient integrin ligand binding. Cells were first treated on ice with 50 µg of a recombinant his-tagged 
vitronectin that was subsequently detected on the cell surface using monoclonal anti-his-tag antibodies. 





Figure 23: Detection of recombinant his-tagged mouse vitronectin on the cell surface of Vero cells. Vero cells were 
treated with recombinant mouse vitronectin (50 µg/ml) for 30 minutes, and then washed and fixed with PFA for 15 
minutes. Then, monoclonal antibodies raised against the his-tag motif were used followed by an anti-mouse Alexa 
488 secondary antibody (green). Nuclei were stained using DAPI (blue). Images were visualized by laser scanning 
confocal microscopy and edited using ImageJ software. 
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The established protocol was then applied to MEF-WT and MEF-αVβ3-/- cells that, after treatment with the 
integrin ligands mentioned above, were inoculated with different flaviviruses. As demonstrated in Figure 
24 (panel A, B and C) none of the integrin ligands were able to disrupt flavivirus binding to the cell surface 
of MEF-WT or MEF-αVβ3-/- cells as determined by RT-qPCR. Treatment with recombinant mouse 
vitronectin had almost no impact on flavivirus binding (Figure 24, panel A). The maximum inhibitory effect 
of recombinant mouse vitronectin on virus binding observed for MEF-WT and MEF-αVβ3-/- cells was 6.3% 
for the YFV-17D, 7.6% for the WNV, 4.8% for the USUV and 4.9% for the LGTV compared to the untreated 
controls (Figure 24, panel A). The treatment of MEF-WT and MEF-αVβ3-/- cells with a synthetic cyclic RGD 
peptide equally resulting in no substantial binding inhibition of the investigated flaviviruses (Figure 24, 
panel B). Pre-treatment of the cells with type I collagen did not affect flavivirus binding in both, MEF-WT 
and MEF-αVβ3-/- cells (Figure 24, panel C). The maximum binding inhibition achieved was 5.1% for YFV-
17D, 7.8 % for WNV, 4.5% for USUV and 3.4% for LGTV when compared to the untreated control. Taken 
together, the results of these assays including the binding assay reinforce that integrins are not involved 





Figure 24: Binding inhibition assay with MEF-WT and MEF-αVβ3-/- cells. Cells were first treated with increasing 
concentrations of recombinant mouse vitronectin (0-50 µg/ml) (panel A); synthetic cyclic RGD peptide (0-250 µg/ml) 
(panel B) and type I collagen (0-500 µg/ml) (panel C) for 30 minutes prior to virus inoculation. Then, treated cells 
were shifted to 4°C and inoculated with different flaviviruses at an MOI of 10 for 1 hour. Monolayers were extensively 
washed and resuspended in RLT buffer. The total RNA was isolated and RT-qPCR was performed. Percentage of 
binding inhibition was calculated based on cycle threshold values. Two independent experiments were performed in 
duplicate. Dots represent the mean of individual values from each independent experiment. Dashes represent the 
median. Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts 
deficient for αVβ3 integrin; αV: alpha V integrin subunit; β3: beta 3 integrin subunit; YFV-17D: Yellow fever virus 
strain 17D; WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; RGD: Arginine-Glycine-Aspartic acid. 
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4.5.4) Effect of integrins on flavivirus internalization by MEF and MKF cells 
 
In order to investigate whether the lack of integrin expression influences flavivirus internalization, the 
integrin deficient MEF and MKF cells as well as their respective wild-type cells were inoculated with 
different flaviviruses. As shown in Figures 25, 26 and 27 A – D, the absence of integrin expression did not 
abrogate flavivirus internalization by MEF and MKF cells.  
Internalization of YFV-17D and LGTV was not affected by the loss of αVβ3 integrin expression in MEF-αVβ3-
/- cells when compared to MEF-WT cells (Figures 25 A and D). Statistical analysis using the Student’s t-test 
revealed no significant differences (p > 0.05) between the two cell lines with 4.3% and 6.3% of differences 
in internalization for YFV-17D and LGTV, respectively. On the other hand, statistical analysis using the 
unpaired Student’s t-test revealed a significant difference between MEF-WT and MEF-αVβ3-/- cells 
concerning the internalization of WNV (p = 0.0007) and USUV (p =  0.0001) (Figure 25 B and C). Data 
analysis demonstrated the differences in internalization of USUV and WNV to be rather low between the 
two cell lines. The differences in virus internalization between MEF-WT and MEF-αVβ3-/- cells for WNV and 
USUV were 3.6% and 7.6%, respectively. These results indicate that αVβ3 integrin might be involved in the 
internalization of some flaviviruses. 
Our findings for MKF-β1Flox and MKF-β1-/- cells demonstrated that deletion of β1 integrin subunit did not 
influence flavivirus internalization (Figure 26 A-D). The differences in virus internalization were 2.25% for 
YFV-17D, 0.59% for WNV, 1.16% for USUV and 7.16% for LGTV resulting in no statistical significance for all 
the viruses tested (p > 0.05) suggesting that β1 integrin subunit is not involved in flavivirus internalization. 
Internalization of YFV-17D (p = 0.2254), WNV (p = 0.9880) and USUV (p = 0.0779) by MEF-β3-/- and MEF-
β3+/+R cells was not affected by the deletion of the β3 integrin subunit (Figure 27 A-D). Statistical analysis 
showed only a small but significant difference in internalization of LGTV (p = 0.0318) between the two cell 
lines with a difference in virus internalization of 11.34%. The difference in virus internalization was 
extremely low for YFV-17D (p=0.2254) and USUV with 1.71% and 2.21%, respectively. These findings 
suggest that the β3 integrin subunit might be involved in the internalization of LGTV.  
Collectively, these results implicate that αVβ3 integrin and the β3 integrin subunit might have an effect on 












Figure 25: Internalization of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) by MEF-WT and MEF-αVβ3-/- cells. Cells 
were seeded into 12-well plates, placed on ice and inoculated with different flaviviruses at an MOI of 10. After one 
hour, monolayers were extensively washed and shifted to 37°C for 30 minutes. Cell monolayers were then washed 
once with acidic glycine (pH 2.5) and incubated for 2 minutes, washed twice with 1X PBS and monolayers harvested 
and lysed with RLT buffer. Total RNA was isolated and RT-qPCR was performed to measure internalized virus particles 
by detection of viral RNA. The amount of internalized virus is expressed as copy numbers per microliter (log 
transformed). Three independent experiments were performed in triplicate (n=3). Dot plots represent each 
individual replicate from the three independent experiments. Statistical analysis: Unpaired Student’s t-test with 
Welch’s correction; (***) p ≤ 0.001; (****) p ≤ 0.0001; ns: not significant (p > 0.05). Abbreviations: MEF-WT: mouse 
embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; αV: alpha V 
integrin subunit; β3: beta 3 integrin subunit; YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: 











Figure 26: Internalization of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) by MKF-β1Flox and MKF-β1-/- cells. Cells 
were seeded into 12-well plates, placed on ice and inoculated with different flaviviruses at an MOI of 10. After one 
hour, monolayers were extensively washed and shifted to 37°C for 30 minutes. Cell monolayers were then washed 
once with acidic glycine (pH 2.5) and incubated for 2 minutes, washed twice with 1X PBS and monolayers harvested 
and lysed with RLT buffer. Total RNA was isolated and RT-qPCR was performed to measure internalized virus particles 
by detection of viral RNA. The amount of internalized virus is expressed as copy numbers per microliter (log 
transformed). Three independent experiments were performed in triplicate (n=3). Dot plots represent each 
individual replicate from the three independent experiments. Statistical analysis: Unpaired Student’s t-test with 
Welch’s correction; ns: not significant (p > 0.05). Abbreviations: MKF-β1Flox: mouse kidney fibroblasts expressing the 
β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin subunit; MEF-β3+/+R: 
mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts 
deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin subunit; β3: beta 3 integrin 









Figure 27: Internalization of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) by MEF-β3+/+R and MEF-β3-/- cells. Cells 
were seeded into 12-well plates, placed on ice and inoculated with different flaviviruses at an MOI of 10. After one 
hour, monolayers were extensively washed and shifted to 37°C for 30 minutes. Cell monolayers were then washed 
once with acidic glycine (pH 2.5) and incubated for 2 minutes, washed twice with 1X PBS and monolayers harvested 
and lysed with RLT buffer. Total RNA was isolated and RT-qPCR was performed to measure internalized virus particles 
by detection of viral RNA. The amount of internalized virus is expressed as copy numbers per microliter (log 
transformed). Three independent experiments were performed in triplicate (n=3). Dot plots represent each 
individual replicate from the three independent experiments. Statistical analysis: Unpaired Student’s t-test with 
Welch’s correction; (*) p ≤ 0.05; ns: not significant (p > 0.05). Abbreviations: MEF-β3+/+R: mouse embryonic fibroblasts 
expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin 
subunit; β3: beta 3 integrin subunit; YFV-17D: Yellow fever virus strain 17D; WNV: West Nile virus; USUV: Usutu virus; 
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4.5.5) Influence of integrins on flavivirus replication in MEFs, MKFs and CHO cells 
 
So far, this study has shown that integrins are not involved in binding of flaviviruses to MEFs, MKFs and 
CHO cells. On the other hand, internalization of some flaviviruses was slightly affected by the loss of 
integrins. Next, it was evaluated whether the deletion of one or two integrin subunits affects flavivirus 
replication in MEF, MKF and CHO cells by RT-qPCR and virus titration.  
 
4.5.5.1) Effect of β1 integrin subunit deletion on flavivirus replication 
 
As seen in Figure 28 A and B, the deletion of β1 integrin subunit in MKF-β1-/- cells affected the replication 
of YFV-17D and WNV reducing viral loads by 65.1% and 45.5%, respectively, as determined by 
quantification of viral genome. On the other hand, replication of USUV was not affected by the deletion of 
β1 integrin subunit (Figure 28 C). Statistical analysis using the parametrical Student’s t-test showed a 
statistically significant reduction in the viral loads of YFV-17 (p = 0.0003), WNV (p = 0.0001) but not for 
USUV (p = 0.4086) in MKF-β1-/- cells (Figure 28 A – C). Virus titers measured by TCID50 were also decreased 
in MKF-β1-/- cells infected with YFV-17D (MKF-β1-/- vs MKF-β1flox: 4.55 vs 4.13 log TCID50/ml) and WNV 
(MKF-β1-/- vs MKF-β1flox: 5.58 vs 5.33 log TCID50/ml) (Figure 28 A and B). USUV titers were slightly increased 
in MKF-β1flox cells in comparison to MKF-β1-/- cells (MKF-β1-/- vs MKF-β1flox: 7.25 vs 6.33 log TCID50/ml) 
(Figure 28 C). Unexpectedly, the LGTV replication in MKF-β1-/- cells was increased up to 335% resulting in 
a higher viral load compared to wild-type MKF-β1Flox cells (Figure 28 D). This increase of viral load observed 
in MKF-β1-/- cells showed to be statistically significant (p = 0.0001).  LGTV titers were also substantially 
higher in MKF-β1-/- than in MKF-β1Flox cells (MKF-β1-/- vs MKF-β1flox: 5.91 vs 6.83 log TCID50/ml).  
Taken together, these results suggest that the deletion of β1 integrin subunit might impair the replication 





Figure 28: Replication analysis of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) in integrin deficient MKF-β1-/- and 
corresponding wild-type MKF-β1Flox cells. RNA yields and virus titers were measured 48 hours post inoculation. Cells 
were seeded into 12-well plates and inoculated with different flaviviruses at an MOI of 10. After one hour, 
monolayers were extensively washed and shifted to 37°C for 48 hours. Supernatants were harvested, total RNA was 
isolated and RT-qPCR was performed to determine the yield of viral RNA. The amount of virus genome is expressed 
as copy numbers per microliter (log transformed). Virus titers were determined by TCID50. End-point determinations 
of virus titers were calculated using the Spearman-Kaerber method. Titers are expressed in log values. Three 
independent experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent 
the standard deviation (mean ± standard deviation). Statistical analysis: Unpaired Student’s t-test with Welch’s 
correction; (***) p ≤ 0.001; (****) p ≤ 0.0001; ns: not significant (p > 0.05). Abbreviations: YFV-17D: Yellow fever 
virus strain 17D; WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; MKF-β1Flox: mouse kidney fibroblasts 
expressing the beta 1 integrin subunit; MKF-β1-/-: mouse kidney fibroblasts deficient for the beta 1 integrin subunit. 
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4.5.5.2) Effect of β3 integrin subunit deletion on flavivirus replication in MEFs 
 
Similar results were also found for MEF-β3+/+R and MEF-β3-/- cells (Figure 29 A – D). Quantification of viral 
RNA revealed decrease in flavivirus replication for WNV, USUV and LGTV in MEF-β3-/- cells in comparison 
to MEF-β3+/+R  cells (Figure 29 B, C and D). The reduction of viral RNA yields for WNV, USUV and LGTV were 
28.2%, 63.5% and 43.9%, respectively (Figure 29 B, C and D). Statistical analysis indicated that these 
differences are significant (WNV p = 0.0001; USUV p = 0.0001 and LGTV p = 0.0001). Viral titers measured 
by TCID50 also showed a decrease for WNV (MEF-β3+/+R vs MEF-β3-/-: 5.16 vs 4.25 log TCID50/ml), USUV 
(MEF-β3+/+R vs MEF-β3-/-: 6.33 vs 5.08 log TCID50/ml) and LGTV (MEF-β3+/+R vs MEF-β3-/-: 6.25 vs 6.33 log 
TCID50/ml) (Figure 29 B, C and D). 
On the other hand, viral load of YFV-17D showed to be lower in MEF-β3+/+R cells than in the integrin 
deficient MEF-β3-/- cells (Figure 29 A). The increase of YFV-17D replication in MEF-β3-/- cells was 116% 
compared to MEF-β3+/+R cells. Statistical analysis also demonstrated that the differences observed in YFV-
17D replication in the two cell lines were significant (p = 0.0001). YFV-17D titers were also higher in MEF-
β3-/- in comparison to MEF-β3+/+R cells (MEF-β3+/+R vs MEF-β3-/-: 4.66 vs 4.83 log TCID50/ml) (Figure 29 A). 
Together, these results indicate that the deletion of β3 integrin subunit might impair replication of USUV, 









Figure 29: Replication analysis of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) in integrin deficient MEF-β3-/- and 
corresponding wild-type MEF-β3+/+R cells. RNA yields and virus titers were measured 48 hours post inoculation. Cells 
were seeded into 12-well plates and inoculated with different flaviviruses at an MOI of 10. After one hour, 
monolayers were extensively washed and shifted to 37°C for 48 hours. Supernatants were harvested, total RNA was 
isolated and RT-qPCR was performed to determine the yield of viral RNA. The amount of virus genome is expressed 
as copy numbers per microliter (log transformed). Virus titers were determined by TCID50. End-point determinations 
of virus titers were calculated using the Spearman-Kaerber method. Titers were expressed in log values. Three 
independent experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent 
the standard deviation (mean ± standard deviation). Statistical analysis: Unpaired Student’s t-test with Welch’s 
correction; (****) p ≤ 0.0001; ns: not significant (p > 0.05). Abbreviations: YFV-17D: Yellow fever virus strain 17D; 
WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; MEF-β3+/+R:  mouse embryonic fibroblasts expressing 
the beta 3 integrin subunit (R = rescue); MEF-β3-/-: mouse embryonic fibroblasts deficient for the beta 3 integrin 
subunit. 
 
4.5.5.3) Effect of αVβ3 integrin deletion on flavivirus replication in MEFs 
 
As demonstrated in Figure 30 A – D, flavivirus replication in MEF-αVβ3-/- cells was strongly impaired by the 
lack of αVβ3 integrin expression when compared to MEF-WT cells (Figure 30 A – D). The reduction of viral 
RNA yields was 99.2% for YFV-17D, 99.9% for WNV, 99.5% for USUV and 99.0% for LGTV (Figure 30 A - D). 
The statistical analysis (Student’s t-test) evidenced that the differences observed in flavivirus replication 
between MEF-WT and MEF-αVβ3-/- cells were highly significant (p = 0.0001) for all the viruses analyzed. 
Virus titers were also strongly reduced in MEF-αVβ3-/- cells in comparison to MEF-WT cells (Figure 30 A - 
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D). The viral titers were 5.24-fold decreased for YFV-17D (MEF-WT vs MEF-αVβ3-/-: 6.08 vs 1.16 log 
TCID50/ml), 2.6-fold decreased for WNV (MEF-WT vs MEF-αVβ3-/-: 5.41 vs 2.08 vs log TCID50/ml), 1.82-fold 
decreased for USUV (MEF-WT vs MEF-αVβ3-/-: 8.66 vs 4.75 log TCID50/ml) and 1.68-fold decreased for LGTV 
(MEF-WT vs MEF-αVβ3-/-: 7.16 vs 4.25 log TCID50/ml). In sum, the deletion of αVβ3 integrin strongly 
affected flavivirus replication. 
 
 
Figure 30: Replication analysis of YFV-17D (A), WNV (B), USUV (C) and LGTV (D) in the integrin deficient MEF-αVβ3-/- 
and corresponding wild-type MEF-WT cells. RNA yields and virus titers were measured 48 hours post inoculation. 
Cells were seeded into 12-well plates and inoculated with different flaviviruses at an MOI of 10. After one hour, 
monolayers were extensively washed and shifted to 37°C for 48 hours. Supernatants were harvested, total RNA was 
isolated and RT-qPCR was performed to determine the yield of viral RNA. The amount of virus genome is expressed 
as copy numbers per microliter (log transformed). Virus titers were determined by TCID50. End-point determinations 
of virus titers were calculated using the Spearman-Kaerber method. Titers were expressed in log values. Three 
independent experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent 
the standard deviation (mean ± standard deviation). Statistical analysis: Unpaired Student’s t-test with Welch’s 
correction; (****) p ≤ 0.0001; ns: not significant (p > 0.05). Abbreviations: YFV-17D: Yellow fever virus strain 17D; 
WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; MEF-WT:  mouse embryonic fibroblasts wild-type; MEF-
αVβ3-/-: mouse embryonic fibroblasts deficient for the alpha V beta 3 integrin. 
  
84 
As demonstrated in Figure 30 A - D, the deletion of αVβ3 integrin strongly impairs flavivirus replication. In 
order to further investigate whether the deletion of αVβ3 integrin influences the flavivirus RNA replication, 
the level of flavivirus negative-strand RNA was measured. As shown in Figure 31, the level of negative-
strand RNA in MEF-αVβ3-/- cells was strongly reduced in comparison to MEF-WT cells. LGTV showed the 
strongest reduction of negative-strand RNA with 98.2% of reduction (Figure 31 D). The other flaviviruses 
showed reductions of 94% (YFV-17D), 65.7% (WNV) and 85% (USUV). Together, these results suggest that 
integrin expression might influence flavivirus RNA replication. 
 
 
Figure 31: Detection of flavivirus negative-strand RNA in MEF-WT and MEF-αVβ3+/+ cells. Cells were inoculated with 
YFV-17D (A), WNV (B), USUV (C) and LGTV (D) at an MOI of 10. After 48 hours post inoculation, monolayers were 
washed and then harvested, lysed and total RNA was extracted. RT-qPCR was performed to quantify the amount of 
negative-strand RNA. The levels of flavivirus negative-strand RNA were normalized against beta-actin, a 
housekeeping gene, and the relative gene expression was calculated by 2^ddCT method. Levels of flavivirus negative-
strand RNA were expressed as fold amplification in relation to the housekeeping gene. Three independent 
experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent the standard 
deviation (mean ± standard deviation). Abbreviations: YFV-17D: yellow fever virus strain 17D; WNV: West Nile virus; 
USUV: Usutu virus; LGTV: Langat virus; MEF-WT:  mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse 
embryonic fibroblasts deficient for the alpha V beta 3 integrin.  
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4.5.5.4) Effect of αV or β3 integrin expression on flavivivirus replication in CHO cells 
 
In order to analyze whether the expression of αV and β3 integrin subunits could influence flavivirus 
replication in CHO cells, the CHO-K1 as well as the CHO cells expressing the αV and β3 integrin subunits 
were inoculated with YFV-17D, WNV, USUV and LGTV at an MOI of 10. 
The Figures 32 A – D show the replication profile of different flaviviruses in CHO cells expressing the mouse 
αV or β3 integrin subunit as well as in the CHO-K1 cells. Despite the high MOI (10) used in this study, 
flaviviruses only replicated poorly in all CHO cell lines tested. However, replication was slightly increased 
in CHO cells expressing either αV or β3 integrin subunits (Figures 32 A – D). The expression of αV integrin 
subunit resulted in a slight increase of YFV-17D (Figure 32 A) and USUV RNA yields (Figures 32 C) in CHO-
αV+/+ cells in comparison with the CHO-K1 cells. YFV-17D and USUV replication was increased by 82.8% and 
142.5%, respectively. Statistical analysis demonstrated that those differences were highly significant in 
both cases, YFV-17D (p = 0.0045) and USUV (p = 0.0001). In contrary to the αV integrin subunit, the 
expression of β3 integrin subunit in CHO cells did neither influence YFV-17D nor USUV (p = 0.8407 for YFV-
17D and p = 0.2685 for USUV) (Figures 32 A and C).  
For LGTV however, an increase of 72.5% in replication in CHO-β3+/+ cells in comparison to CHO-K1 cells was 
observed (Figure 32 D). This increase in LGTV replication in CHO-β3+/+ cells showed to be significant (p = 
0.0069). The expression of αV integrin subunit in CHO cells did not influence LGTV replication (Figure 32 
D). Unexpectedly, in the case of WNV, the replication seemed to be more efficient in CHO-K1 cells than in 
CHO-αV+/+ cells (Figures 32 B) and this difference showed to be statistically significant (p = 0.0024). WNV 
replication in CHO-αV+/+ cells was decreased by only 24.3 % compared to wild-type CHO-K1 cells. On the 
other hand, the replication of WNV in CHO-β3+/+ cells was slightly increased compared to CHO-K1 cells 
(Figures 32 B). The increase of WNV replication was 21.58% and showed to be significant (p = 0.0251).  
In conclusion, these cell infection assays demonstrate that expression of either αV or β3 integrin subunits 






Figure 32: Replication analysis of YFV-17D (A); WNV (B); USUV (C) and LGTV (D) in CHO-K1, CHO-αV+/+ and CHO-β3+/+ 
cells. The figure shows RNA yields 48 hours post-inoculation. Cells were seeded into 12-well plates and inoculated 
with different flaviviruses at an MOI of 10. After one hour, monolayers were extensively washed and shifted to 37°C 
for 48 hours. Supernatants were harvested and total RNA was isolated and RT-qPCR was performed to determine the 
yield of viral RNA. The amount of virus genome is expressed as copy numbers per microliter (log transformed). Three 
independent experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent 
the standard deviation (mean ± standard deviation). Statistical analysis: One-Way ANOVA with Bonferroni correction; 
(*) p ≤ 0.05; (**) p ≤ 0.01; (****) p ≤ 0.0001; ns: not significant (p > 0.05). Abbreviations: YFV-17D: Yellow fever virus 
strain 17D; WNV: West Nile virus; USUV: Usutu virus; LGTV: Langat virus; CHO-K1: Chinese hamster ovary cells clone 
K1; CHO-αV+/+: Chinese hamster ovary cells expressing the mouse alpha V integrin subunit; CHO-β3+/+: Chinese 
hamster ovary cells expressing the mouse beta 3 integrin subunit. 
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4.6) Cell infection assays to investigate the effect of integrin ablation on Zika virus 
infection 
4.6.1) Influence of integrins on ZIKV binding to MEFs and MKFs 
 
First, it was evaluated whether the genomic deletion of integrins affects ZIKV binding to the surface of 
integrin deficient MEFs and MKFs. As demonstrated in Figure 33, the absence of αVβ3 integrin in MEF-
αVβ3-/- cells as well as the β1 and β3 integrin subunit in MKF-β1-/- and MEF-β3-/- cells did not influence ZIKV 
binding to the cell surface of these cells. No statistical significance was shown for any of the cells tested (p 
> 0.05).  
In conclusion, similar to other flaviviruses, the absence of integrin expression did not affect ZIKV binding 
to the surface of MEFs and MKFs. 
 
 
Figure 33. Zika virus (ZIKV) binding to the integrin deficient MEFs and MKFs and the corresponding wild-type cells. 
Cells were seeded into 12-well plates, placed on ice and inoculated with ZIKV at an MOI of 10. After one hour, 
monolayers were extensively washed, harvested and lysed with RLT buffer. Total RNA was isolated and RT-qPCR was 
performed to indirectly measure virus binding to the cell surface by detection of viral RNA. Virus binding values are 
expressed in cycle threshold (Ct) values. Three independent experiments were performed in triplicate (n=3). Bars 
represent the mean Ct values and error bars represent the standard deviation (means ± standard deviation). 
Statistical analysis: Mann-Whitney test; ns: not significant (p > 0.05). Abbreviations: MEF-WT: mouse embryonic 
fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse 
kidney fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for 
the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); 
MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit.  
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4.6.2) Influence of integrins on ZIKV internalization by MEFs and MKFs 
 
Next, we evaluated whether the lack of integrin expression could affect ZIKV internalization into MEFs and 
MKFs. As shown in Figure 34, ZIKV was equally internalized into MEFs and MKFs regardless of integrin 
expression (Figure 34). No statistically significant difference was found between MKF-β1Flox vs MKF-β1-/- 
cells (p = 0.1605; Figure 34 B). Statistical analysis however revealed a difference in ZIKV internalization 
between MEF-β3+/+R and MEF-β3-/- cells (p = 0.0341; Figure 34 C). Although the statistical analysis 
demonstrated a significant difference, the total RNA copy numbers indicating ZIKV internalization differed 
only by 2.9% for MEF-β3+/+R vs MEF-β3-/- cells (Figure 34 C). Statistical analysis also indicated significant 
differences in ZIKV internalization between MEF-αVβ3-/- and MEF-WT cells (p = 0.0007; Figure 34 A) while 
viral RNA copy numbers between MEF-αVβ3-/- vs MEF-WT cells differed only by 2.0%. Together, our results 
demonstrated that integrins are most likely not involved in ZIKV internalization. 
 
 
Figure 34: Zika virus (ZIKV) internalization by MEF-WT and MEF-αVβ3-/- (A); MKF-β1Flox and MKF-β1-/- (B) and MEF-
β3+/+R and MEF-β3-/- (C) cells. Cells were seeded into 12-well plates, placed on ice and inoculated with ZIKV at an MOI 
of 10. After one hour, monolayers were extensively washed and shifted to 37°C for 30 minutes. Cell monolayers were 
then washed once with acidic glycine (pH 2.5) and incubated for 2 minutes, washed twice with 1X PBS. Monolayers 
were harvested and lysed with RLT buffer. Total RNA was isolated and RT-qPCR was performed to determine the 
amount of internalized virus particles. The amount of virus internalization is expressed in copy numbers per microliter 
(log transformed). Three independent experiments were performed in triplicate (n=3). Dot plots represent each 
individual replicate from the three independent experiments. Statistical analysis: Unpaired Student’s t-test; (*) p ≤ 
0.05; (***) p ≤ 0.001; ns: not significant (p > 0.05). Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; 
MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-β1Flox: mouse kidney fibroblasts 
expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient for the β1 integrin 
subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); MEF-β3-/-: mouse 
embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 integrin subunit; 
β3: beta 3 integrin subunit.  
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4.6.3) Influence of integrins on ZIKV replication in MEFs, MKFs and CHO cells 
 
Subsequent experiments to evaluate the influence of integrins on ZIKV replication were performed in MEF, 
MKF and CHO cells expressing the αV and β3 integrin subunits. As demonstrated in Figure 35 C, deletion 
of β3 integrin subunit affected ZIKV replication with a reduction of ZIKV RNA yields by 54.06% in MEF-β3-
/- cells in comparison to MEF-β3+/+R cells. This reduction of ZIKV yields in MEF-β3-/- cells showed to be 
statistically significant (p = 0.0002). Surprisingly, the lack of β1 in MKF-β1-/- cells had a positive effect on 
ZIKV replication with an increase in ZIKV RNA yields of more than 77% in comparison to the MKF-β1Flox cells 
(Figure 35 B). This finding also showed to be statistically significant (p = 0.0001). On the other hand, and 
similar to what was observed for the other flaviviruses, the deletion of αVβ3 integrin in MEF-αVβ3-/- cells 
had a significant impact on ZIKV replication with a reduction of almost 98% (p = 0.0001) in ZIKV RNA yields 




Figure 35: Zika virus (ZIKV) replication analysis in MEF-WT and MEF- αVβ3-/- (A); MKF-β1Flox and MKF-β1-/- (B); MEF-
β3+/+R and MEF-β3-/- (C) cells. Cells were seeded into 12-well plates and inoculated with ZIKV at an MOI of 10. After 
one hour, monolayers were extensively washed and shifted to 37°C for 48 hours. Supernatants were harvested and 
total RNA was isolated. RT-qPCR was performed to determine the yields of viral RNA. The amount of virus genome is 
expressed as copy numbers per microliter (log transformed). Three independent experiments were performed in 
triplicate (n=3). Bars represent mean values and error bars represent the standard deviation (mean ± standard 
deviation). Statistical analysis: unpaired students t-test; (***) p ≤ 0.001; (****) p ≤ 0.0001. Abbreviations: MEF-WT: 
mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient for αVβ3 integrin; MKF-
β1Flox: mouse kidney fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts 
deficient for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R 
= rescue); MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; 
β1: beta 1 integrin subunit; β3: beta 3 integrin subunit. 
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Since MKF-β1-/- cells only showed a slight increase in ZIKV replication while MEF-β3-/- cells only displayed a 
small decrease, the ZIKV titers were not further determined by TCID50 due to the very small differences in 
RT-qPCR based RNA quantification. However, the titers of ZIKV in MEF-WT cells and MEF-αVβ3-/- cells were 
determined by TCID50 to further confirm the inhibition of ZIKV replication observed in these cells. Titers of 
ZIKV in MEF-αVβ3-/- cells were reduced by almost 2 logs in comparison to MEF-WT cells (MEF-WT vs MEF-





Figure 36: Zika virus (ZIKV) titers after inoculation of MEF-αVβ3-/- and MEF-WT cells. Cells were seeded into 12-well 
plates and infected with ZIKV at an MOI of 10. After one hour, monolayers were extensively washed and shifted to 
37°C for 48 hours. Supernatants were harvested and ZIKV titers were determined by TCID50. End-point titers were 
calculated using the Spearman-Kaerber method. Titers are expressed in log values. Experiment was performed in 
triplicate. Bars represent mean values and error bars represent the standard deviation (mean ± standard deviation). 
Abbreviations: MEF-WT: mouse embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblasts deficient 




To confirm that ablation of integrins, in particular the αVβ3 integrin, interferes in flavivirus RNA replication, 
the level of ZIKV negative-strand RNA was measured.  
As shown in Figure 37, no significant differences in the levels of ZIKV negative-strand RNA expression in 
MKF-β1-/- and the MEF-β3-/- cells in comparison to the respective wild-type cells, MKF-β1Flox and MEF-β3+/+R, 
were detected. In contrast, synthesis of ZIKV negative-strand RNA in MEF-αVβ3-/- cells was reduced almost 
1000-fold compared to MEF-WT cells (Figure 37). In conclusion, deletion of αVβ3 integrin affects ZIKV 
replication at RNA replication level. 
 
  




Figure 37. Levels of Zika virus (ZIKV) negative-strand RNA in integrin deficient MEFs and MKFs and corresponding 
wild-type cells. Cells were inoculated with ZIKV at an MOI of 10 at 37°C for 1 hour. After inoculation, cells were 
washed 6 times and incubated at 37°C for 48 hours. Monolayers were harvested 48 hours after inoculation and levels 
of ZIKV negative-strand RNA were measured by RT-qPCR. The levels of ZIKV negative-strand RNA were normalized 
against beta-actin, a housekeeping gene, and the relative gene expression was calculated by 2^ddCT method. Levels 
of ZIKV negative-strand RNA were expressed as fold amplification in relation to the housekeeping gene. Three 
independent experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent 
the standard deviation (mean ± standard deviation). Scale was log-transformed. Abbreviations: MEF-WT: mouse 
embryonic fibroblasts wild-type; MEF-αVβ3-/-: mouse embryonic fibroblast deficient for αVβ3 integrin; MKF-β1Flox: 
mouse kidney fibroblasts expressing the β1 integrin subunit (wild-type); MKF-β1-/-: mouse kidney fibroblasts deficient 
for the β1 integrin subunit; MEF-β3+/+R: mouse embryonic fibroblasts expressing the β3 integrin subunit (R = rescue); 
MEF-β3-/-: mouse embryonic fibroblasts deficient for the β3 integrin subunit; αV: alpha V integrin subunit; β1: beta 1 
integrin subunit; β3: beta 3 integrin subunit 
 
 
In order to assess whether the expression of αV and β3 integrin subunits in CHO cells could enhance ZIKV 
replication, CHO cells expressing the αV or β3 integrin subunits as well as the corresponding CHO wild-
type cells were inoculated with ZIKV. In contrast to what was observed for the other flaviviruses in the 
replication assays in CHO cells, the expression of αV or β3 integrin subunits did not enhance ZIKV 
replication in CHO cells (Figure 38 A). Statistical analysis (One-Way ANOVA) failed to demonstrate any 
statistical significance between the groups.  
Next, the level of ZIKV negative-strand RNA was measured by RT-qPCR. The levels of negative-strand ZIKV 
RNA were similar in all CHO cells tested regardless of the expression of αV or β3 integrin subunits in these 
cells (Figure 38 B). In conclusion, these results demonstrate that the ectopic expression of integrins in CHO 








Figure 38: Zika virus (ZIKV) replication analysis in CHO-K1, CHO-αV+/+ and CHO-β3+/+ cells. Figure A shows RNA yields 
after 48 hours post-inoculation and Figure B shows the level of ZIKV negative strand RNA measured by RT-qPCR. Cells 
were seeded into 12-well plates and inoculated with ZIKV at an MOI of 10. After one hour, monolayers were 
extensively washed and shifted to 37°C for 48 hours. Supernatants were harvested and total RNA was isolated. RT-
qPCR was performed to determine the yield of viral RNA. (A) The amount of virus genome is expressed as copy 
numbers per microliter (log transformed). (B) The levels of ZIKV negative-strand RNA were normalized against beta-
actin, a housekeeping gene, and the relative gene expression was calculated by 2^ddCT method. Levels of ZIKV 
negative-strand RNA were expressed as fold amplification in relation to the housekeeping gene. Three independent 
experiments were performed in triplicate (n=3). Bars represent mean values and error bars represent the standard 
deviation (mean ± standard deviation). Statistical analysis: One–way ANOVA with Bonferroni correction; ns: not 
significant (p > 0.05). Abbreviations: CHO-K1: Chinese hamster ovary cells clone K1; CHO-αV+/+: Chinese hamster 
ovary cells expressing the mouse alpha V integrin subunit CHO-β3+/+: Chinese hamster ovary cells expressing the 








Flaviviruses have an extraordinary ability to infect a huge diversity of hosts. Thus, for many years, it was 
proposed that flaviviruses use a single common receptor to infect the host cell. However, since many 
molecules have been recently characterized to function as potential flavivirus receptors in different cell 
lines from different hosts, the idea of one common receptor has been rejected (Gould et al., 2008; 
Kaufmann et al., 2011; Perera-Lecoin et al., 2013; Rodenhuis-Zybert et al., 2010b; Smit et al., 2011). Thus, 
today the main hypothesis claims that flaviviruses use multiple receptors to get access into the host cell 
and that the receptor repertoire might change according to the host and/or the cell line (Kaufmann et al., 
2011; Perera-Lecoin et al., 2013).  
Another subject that has been extensively studied over the last few years are host cell factors that 
modulate virus infection. Those host cell factors might not function as the cellular receptor but might act 
as accessory molecules that influence the virus infection (Fernandez-Garcia et al., 2009; Pastorino et al., 
2010; Wang et al., 2017).  
In the past, several groups have proposed and investigated the involvement of cell adhesion molecules, in 
particular integrins, in the flavivirus infection cycle (Chu et al., 2004b; Medigeshi et al., 2008; Protopopova 
et al., 1997) since integrins are highly conserved among vertebrate and invertebrate species and 
constitutively expressed in all cell lines (Hynes, 1992). 
A recent study by Schmidt et al. (2013) concluded that WNV entered the cells independently of the integrin 
expression and regardless of the WNV strain used. For this study, a MEF cell line lacking the expression of 
different integrin subunits was infected with different WNV strains. For all these WNV strains, the lack of 
integrin expression did not affect binding or internalization into the MEFs. However, the deletion of β1 or 
β3 integrin subunits affected WNV replication suggesting a role of integrins in WNV infection (Schmidt et 
al., 2013a). More recently, integrin αVβ3 has been demonstrated to play a role in JEV infection reinforcing 
the importance of integrins in the flavivirus infection cycle (Fan et al., 2017). 
In the present study, a similar model based on MEFs deficient for the expression of one or more integrin 
subunits and their respective wild-type cells were used to assess the influence of integrins in the flavivirus 
infection cycle. Additionally, CHO cells expressing the mouse αV or β3 integrin subunits were generated 
to investigate the involvement of these cell adhesion molecules in the flavivirus infection cycle. All these 
cell lines were used to assess their permissiveness and susceptibility to different flaviviruses, namely YFV-





5.1) Development of suitable cell models 
 
In this study, several cell models were established to investigate the involvement of integrins in the 
flavivirus infection cycle. Those models were based on (i) MEFs lacking the expression of αVβ3 integrin or 
β3 integrin subunit; (ii) MKFs lacking the expression of β1 integrin subunit and iii) CHO cells expressing 
either αV or β3 integrin subunits.  
The deletion of these specific integrin subunits in MEFs and MKFs enabled us to evaluate whether one 
specific integrin heterodimer or specific integrin subunit(s) were involved in the flavivirus infection cycle. 
The ablation of the respective integrin genes in the integrin deficient MEFs and MKFs occurred at the 
genomic level by homologous recombination (Fassler et al., 1995a; Hodivala-Dilke et al., 1999; Schmidt et 
al., 2013a). The advantage of this method is that by deleting the target genes at the DNA level, most of 
the off-target effects caused by other gene silencing methods such as siRNA are avoided and/or abrogated 
(Boettcher et al., 2015). Those effects would include residual expression of target genes and activation of 
the innate immunity by introducing foreign nucleic acids into the target cell cytoplasm (Angart et al., 2013; 
Jackson et al., 2010). Another advantage of using MEFs is that these cells are easily isolated and maintained 
and have a high rate of proliferation in vitro (Ruiz-Ojeda et al., 2016). Although no study has fully described 
the whole integrin profile in MEFs, a few studies have demonstrated that they express a diverse repertoire 
of integrins such as α5β1, α11β1, α2β1 and α1β1 (Carracedo et al., 2010; Guo et al., 2005; Lu et al., 2014; 
Popova et al., 2004; Zhu et al., 2007). Due to the embryonic origin of MEFs used in the present study, the 
expression of integrins might be substantially upregulated in these cells to mediate important cellular 
processes during embryonic stages such as migration, attachment and differentiation of the cells  (Bokel 
et al., 2002; Hertle et al., 1991; Schmid et al., 2003; Sutherland et al., 1993). 
In contrast to that, CHO cells express only a limited integrin repertoire and have been reported to be 
unsusceptible to several viral agents including members of the Flavivirus genus which makes these cells a 
suitable model to study the involvement of integrins in flavivirus infection (Berting et al., 2010; Garrigues 
et al., 2008; Symington et al., 1993; Takagi et al., 1997; Xu et al., 2011).  
Lastly, although mice and hamster are not a natural flavivirus reservoir, a number of cell lines derived from 
these species have been reported to be susceptible to flavivirus infection and support efficient replication 
(Chan et al., 2016; Rossi et al., 2016; Tesh et al., 2005; Wang et al., 2011). In this study, we demonstrated 
that some flaviviruses such as YFV-17D and USUV replicated to comparable levels in MEF-WT cells as in 
Vero cells, the most flavivirus permissive cell line. These results strongly support the usage of MEFs and 
MKFs to investigate flavivirus susceptibility and replication in vitro. 
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5.1.1) Recovery of αVβ3 integrin in MEF-αVβ3-/- cells 
 
MEFs deficient for αVβ3 integrin were subjected to recover their respective integrin genes. For that, cells 
were transfected with vectors carrying the mouse αV and β3 integrin subunit genes. Though several 
transfection strategies were followed, the expression of αVβ3 integrin in MEF-αVβ3-/- cells was not 
recovered. Different cationic lipid based transfection reagents and several transfection methods such as 
electroporation were attempted but only resulted in low transfection efficiency and high cell toxicity 
leading to excessive cell death. By transfecting the integrin subunit encoding plasmids one after another 
into MEF-αVβ3-/- cells, the recovered integrin expression was very low. After a few passages, the level of 
integrin expression even decreased which made it necessary to base the following work on MEF wild-type 
cells. Per se, primary cells such as MEFs are known to be hard to transfect and several authors have 
experienced low transfection efficiencies using cationic lipid based transfection as performed in our study 
(Han et al., 2015; Lee et al., 2017). The antibiotic selection reagents used for selection of transgenic 
resistant cells might also play a crucial role in the establishment of transgenic cell lines (Lanza et al., 2013). 
Unsuccessful recovery of expression of both integrin subunits in MEF-αVβ3-/- cells might therefore be 
attributed to the toxic effects of the antibiotics used for selection of resistant clones. However, the zeocin 
selection marker used in our study showed to be superior in selecting resistant clones compared to other 
antibiotic selection markers (Lanza et al., 2013). Since MEF-αVβ3-/- cells were transfected with two vectors 
either harboring the antibiotic resistance gene for zeocin or hygromycin, cells were selected by adding 
both antibiotics to the cell culture medium. It remains unclear whether both antibiotic resistance genes 
were expressed at their maximum level to allow complete cell resistance to both antibiotics. This might 
also explain the observation of some transfected MEF-αVβ3-/-cell populations that expressed different 
levels of αV and β3 integrin subunits and later succumbed to antibiotic selection. To transduce the target 
genes into MEF-αVβ3-/- cells and recover the expression of αVβ3 integrin, viral vector-based methods 
might be an interesting approach for future studies.  
 
5.2) Cell morphology, growth rates and viability of MKFs, MEFs and CHO cells 
 
Since MEFs and MKFs originate from different tissues, differences on cell morphology, growth rate and 
integrin expression were expected.  
The double deficient MEF-αVβ3-/- cells revealed a remarkable difference in cell morphology and growth 
rates compared to their wild-type cells. These differences in cell morphology and growth rates are certainly 
due to the genomic deletion of αVβ3 integrin. A study conducted by Cruet-Hennequart et al.,(2003) 
reported that αVβ3 and αVβ5 integrins regulate cell proliferation by activating the integrin-linked kinase 
leading to cell cycle progression. Functional blocking of these integrins by epitope blocking antibodies as 
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well as synthetic RGD peptides led to inhibition of the cell cycle with consequent reduction of cell 
proliferation (Cruet-Hennequart et al., 2003). Despite the reduction of cell growth and density, the MEF-
αVβ3-/- cells showed an abnormal morphology by forming cell aggregations. This abnormal morphology 
might be attributed to the loss of αVβ3 integrin and the increased need of the close cell-to-cell contact to 
promote growth. A number of publications have further demonstrated that the absence of αVβ3 and α5β1 
integrins disturbs cell spreading and expansion on extracellular matrices (Balcioglu et al., 2015; Charo et 
al., 1990; Cruet-Hennequart et al., 2003). These observations might also account for the formation of 
“cellular islets“ observed in MEF-αVβ3-/- cells in our study. 
Notably, the MKF-β1-/- cells displayed a more rounded shape compared to the parental cell line, the MKF-
β1Flox cells. This morphological effect is most likely attributed to the deletion of β1 integrin subunit and 
was also observed by others (Fassler et al., 1995b; Hou et al., 2016). Interestingly, in our study, the loss of 
β1 integrin subunit did not affect the MKF-β1-/- cell growth rate as observed by similar split ratios 
compared to MKF-β1Flox cells. However, their growth rate was still higher than that observed for MEFs. 
These characteristics concerning morphology and cell growth are in accordance with reports from other 
authors (Fassler et al., 1995b; Hou et al., 2016; Schmidt et al., 2013a).  
Unexpectedly, the loss of β3 integrin subunit expression in MEF-β3-/- cells did neither influence cell 
morphology nor cell growth. However, the rescued β3 expressing cells (MEF-β3+/+) showed a strong 
decrease of growth rate. This special characteristic observed in MEF-β3+/+ cells is most probably attributed 
to the usage of zeocin as antibiotic selection marker and was also observed in the CHO-β3+/+ cells treated 
with zeocin. Last, ectopic expression of either αV or β3 integrin in CHO cells did not influence cell 
morphology. However, similar to what was observed in MEF-β3+/+ cells, we experienced a decline in the 
split ratio for maintenance in the CHO-β3+/+ cells when compared to the CHO-K1 cells. Again, this effect 
might be attributed to the use of zeocin as selection antibiotic and was also reported by another author 
(Hwang et al., 2005). 
Despite the fact that the deletion of integrins might influence cell morphology, spread and growth, 
deleting one or more integrin subunits does not seem to influence cell viability in our study.  
Our metabolic viability assay (MTS assay) clearly demonstrated that loss of integrin expression did not 
affect cell viability regardless of the cell line tested. Within the course of the study and prior to infection 
experiments, cells were routinely checked by trypan blue staining which did not reveal any decrease in cell 
viability. Though several publications have reported that integrin ablation or knock-down might trigger 
apoptotic pathways consequently leading to cell death in certain cell types (Koistinen et al., 2004; Popov 
et al., 2011; Simirskii et al., 2007), we did not observe such an effect in any of our cell lines.  
This might be attributed to the expression of alternative integrin heterodimers that counterbalance the 
lack of αVβ3 integrin, β1 and β3 integrin subunits in our MEFs and MKFs. Other authors have reported that 
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expression of integrins in certain cell types rescued these cells from entering into apoptosis by triggering 
intracellular signaling with the result of cell survival (Montgomery et al., 1994; Zhang et al., 1995). 
 
5.3) Characterization of integrin expression in MEFs, MKFs and CHO cells 
 
In order to characterize the integrin expression among our cell lines, several methods were applied. 
Confocal laser microscopy analysis was performed to determine the sub-cellular localization of integrins 
and/or the loss of αVβ3 integrin and β1 and β3 integrin subunits. 
Integrins were homogeneously distributed along the cell membrane in all analyzed MEF and MKF cell lines 
which is in accordance to the literature (Geiger et al., 2011). As expected, MEF and MKF wild-type cells 
expressed αV, β3 or β1 integrin subunits in high amounts evidenced by the presence of multiple focal 
adhesion sites. The presence of these structures visualized in wild-type MEFs and MKFs indicated the 
formation of functional integrin heterodimers as reported by other authors (Schmidt et al., 2013a). 
Interestingly, by staining the integrin deficient cells, we also observed the presence of focal adhesion sites 
indicating that other functional integrin heterodimers were indeed expressed in the deficient cell lines. 
For example, the deletion of β1 in MKF-β1-/- cells did not affect the expression of αV and β3 subunits in 
these cells in our study. This fact can be explained by the structural composition of integrins as 
heterodimers that are composed of one α and one β integrin subunit (Hynes, 2002). The genomic ablation 
of β1 integrin subunit in these cells obviously impairs the formation of all β1 integrin heterodimer 
combinations at the cell surface level whereas other heterodimers remain unaffected as described by 
other groups (Fassler et al., 1995b; Hynes, 2002; Schmidt et al., 2013a). Similarly, the deletion of αVβ3 
integrin in MEF-αVβ3-/- cells disrupts the expression of six integrins (αVβ1, αVβ3, αVβ4, αVβ5, αVβ6 and 
αVβ8) while the deletion of β3 integrin subunit in MEF-β3-/- cells only impairs the expression of αVβ3 in 
this specific cell line according to the literature (Hynes, 2002; Schmidt et al., 2013a). 
Confocal microscopy analysis in CHO-β3+/+ and CHO-αV+/+ cells revealed an integrin expression at the cell 
surface similar to the pattern observed in MEFs/MKFs. This indicates the formation of integrin 
heterodimers by combining endogenous hamster integrin subunits with ectopic mouse integrin subunits. 
Due to the fact that integrins share a high similarity among the mammalian species, the formation of 
hybrid integrins is possible and was reported by other authors (Briesewitz et al., 1995; Symington et al., 
1993; Takagi et al., 1997). In the case of CHO cells expressing the mouse αV integrin subunit (CHO-αV+/+) 
the probable integrin combination is αVβ1 integrin, as a previous report showed the expression of 
endogenous β1 integrin subunit in CHO cells (Takagi et al., 1997). For CHO cells expressing the mouse β3 
integrin subunit, the only heterodimer combination possible is the αVβ3 integrin since the αIIb is 
exclusively expressed in platelets and megakaryocytes (Bennett, 2005; Hynes, 2002). 
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In order to measure the level of integrin expression in our cell lines, RT-PCR and flow cytometry analysis 
were performed. The wild-type MEFs and MKFs expressed high levels (> 90%) of αV, β1 and β3 integrin 
subunits which is in accordance with a previous report (Schmidt et al., 2013a). Concerning the integrin 
deficient cells, flow cytometry results demonstrated the total absence of either αVβ3 integrin (MEF-αVβ3-
/-), β3 (MEF-β3-/-) or β1 (MKF-β1-/-) integrin subunits in the respective cell lines which has been described 
before (Fassler et al., 1995a; Schmidt et al., 2013a).  
There have been controversies in the literature whether the deletion of one specific integrin could up- or 
down-regulate the expression of other integrins. In our study, we did not determine up- or down-
regulation of other integrin subunits in response to deletion of αV, β1 or β3 integrin subunits. However, 
our observations demonstrated that levels of β1 integrin expression in MEF-αVβ3-/- and MEF-β3-/- cells or 
αV and β3 integrin expression in MKF-β1-/- cells remained constant according to the flow cytometry 
analysis. A study using human cardiac fibroblasts reported that β3 integrin gene knock-down by siRNA 
upregulated the expression of β5 integrin subunit. The opposite effect of β3 integrin upregulation was 
observed when β5 integrin subunit was silenced, demonstrating a compensatory effect between both 
integrin subunits (Sarrazy et al., 2014). Another study showed that α2β1 integrin in keratinocytes was 
substituted by other collagen binding integrins such as α1β1 or α11β1 integrin in α2 knock-out-mice (Zhang 
et al., 2006). On the other hand, two studies reported no compensatory effects in αV and β3 integrin-null 
mice (Bader et al., 1998; Hodivala-Dilke et al., 1999). As the level of integrin subunits other than αV, β1 
and β3 was not determined in our study, a compensatory effect can only be assumed.  
Transfection of CHO cells with a vector carrying either the mouse αV or β3 integrin subunit genes resulted 
in clones stably expressing mouse αV or β3 integrin subunits as demonstrated by RT-PCR and flow 
cytometry analysis. Flow cytometry revealed expression of high levels of mouse αV and β3 integrin 
subunits. As mentioned above, CHO cells are known to express only a few integrins. However, a study 
demonstrated the expression of endogenous β1 integrin and αV integrin subunits (Takagi et al., 1997). 
Due to unknown reasons, this hamster αV integrin subunit was not expressed on the cell surface (Takagi 
et al., 1997). In our study, we assume that the ectopic expression of mouse β3 integrin subunit in CHO cells 
was able to rescue the expression of hamster αV since we detected the mouse β3 integrin subunit at the 
cell surface. This assumption is supported by the fact that β3 integrin subunit is only described to form 
heterodimers with αV or αIIb integrin subunits, the latter being exclusively expressed in megakaryocytes 
and platelets (Bennett, 2005; Hynes, 2002). The formation of hamster/mouse “hybrid” integrins such as 
α5β1, α3β1, αVβ1 and αVβ3 was also reported by other authors (Balzac et al., 1993; Felding-Habermann 
et al., 1997; Laukaitis et al., 2001; Zhang et al., 1993). 
Finally, to confirm whether the integrins expressed in CHO cells are functional and able to recognize their 
ligands, a cell adhesion assay was performed. In this assay, both CHO cell lines expressing hamster/mouse 
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hybrid integrins showed to recognize vitronectin as their integrin ligand while CHO-K1 cells bound less 
efficiently to vitronectin. This observation confirmed the functionality of the hybrid integrins expressed in 
CHO cells and is also reported by other authors (Balzac et al., 1993; Felding-Habermann et al., 1997; Zhang 
et al., 1993). 
In the same assay, integrin-deficient MEFs and MKFs bound less efficiently to vitronectin than their 
respective wild-type cells. However, binding was observed for all cell lines regardless of absence or 
presence of αV, β1 or β3 integrin subunits. Though the present study was focused on αV, β1 and β3 integrin 
subunits, these results provide evidence that MEF-αVβ3-/-, MEF-β3-/- and MKF-β1-/- cells may indeed 
express other RGD binding integrins. However, the expression level of these RGD binding integrin 
heterodimers in our MEF and MKF cell lines is unknown.  
 
5.4) Cell infection assays 
5.4.1) Flavivirus binding to the cell surface is not enhanced by the presence of integrins 
 
In order to analyze the influence of integrins in flavivirus binding to the cell surface, binding assays were 
performed by infecting the cells at 4°C which allows virus binding but prevents virus internalization. In our 
study, we clearly demonstrate that αVβ3, β1 and β3 integrin subunits are not involved in flavivirus binding 
to the cell surface of MEFs, MKFs and CHO cells expressing either αV or β3 integrin subunits. Even in the 
case of YFV-17D that harbors the RGD motif which is an integrin binding motif, the virus binding to the cell 
surface of MEF and MKF cells was not affected by the deletion of integrin subunits in the respective cells. 
Interestingly, van der Most et al.,(1999) explicitly demonstrated that, by introducing mutations in the RGD 
motif of YFV-17D, the absence of this motif had no impact on YFV-17D binding and infectivity (van der 
Most et al., 1999). These observations are consistent with the results from our study demonstrating that 
the presence of RGD motif in YFV-17D does not affect YFV-17D binding to integrins. Our results rather 
suggest that other molecules than integrins are used by flaviviruses to promote binding. Several other 
molecules were reported as flavivirus binding/attachment receptor such as laminin, DC-SIGN and GAGs 
(Perera-Lecoin et al., 2013). Among those, GAGs have been reported to mediate flavivirus binding to a 
variety of cells (Chen et al., 1997; Chien et al., 2008; Germi et al., 2002; Hilgard et al., 2000; Kim et al., 
2017; Kroschewski et al., 2003; Lee et al., 2004; Lin et al., 2002). Since GAGs are expressed in a wide variety 
of cells, including MEFs and CHO cells (Bame et al., 1989; Bernfield et al., 1999; Cuellar et al., 2007; 
Kraushaar et al., 2013; Llorente-Cortes et al., 2002), the presence of these molecules might overlap the 
interaction of integrins with flaviviruses during the early steps of infection. As a result, flaviviruses might 
preferentially bind to GAGs rather than integrins. The GAG interactions with E-DIII proteins are 
characterized by electrostatic interaction that generally lacks specificity and shows low affinity (Smit et al., 
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2011). A few studies have documented that the presence of GAGs on the cell surface of CHO cells mediate 
virus binding. A study with WNV using a derivative CHO cell line deficient for GAGs demonstrated that 
WNV binding to the cell surface was strikingly impaired in comparison with the CHO wild-type cells further 
supporting the role of GAGs in flavivirus attachment  in CHO cells (Schmidt, 2012). In addition to that, Jan 
et al.,(1999) demonstrated that Sindbis virus, an arbovirus in the Alphavirus genus (Togaviridae family) 
bound to the cell surface of CHO cells. Upon CHO cell treatment with heparinase I, virus binding was 
decreased by more than 20% compared to the untreated control, demonstrating that GAGs also act as an 
attachment factor for other arboviruses such as Sindbis virus in CHO cells (Jan et al., 1999).  
Another important issue to be mentioned is the flavivirus strains used in this study. With the exception of 
USUV and ZIKV, all other strains are considered vaccine strains (YFV-17D and WNV-chimerivax) or 
attenuated strains (LGTV). It was previously reported that serial in-vitro passages of flaviviruses raise cell 
culture-adapted viral populations with GAG binding residues in the flavivirus E-DIII protein. This 
characteristic has been attributed to virus attenuation, a desired feature in virus vaccine strains (Lee et al., 
2002; Lee et al., 2006a). In our study, we did not compare wild-type viruses with their respective 
vaccine/attenuated strains. Thus, comparisons between flavivirus vaccine strains and their respective 
virulent strains might be helpful to further elucidate a potential role of integrins in flavivirus binding to the 
host cell. So far, all our observations suggest the presence of a common attachment factor in MEFs/MKFs 
and CHO cells that mediate flavivirus binding. 
In order to verify whether other integrins are involved in flavivirus binding, we performed a binding 
inhibition assay in MEFs using three different integrin ligands: synthetic RGD peptide and vitronectin that 
bind to RGD binding integrins and type-I collagen that binds all collagen-binding integrins. Binding 
inhibition assays using integrin ligands as well as integrin epitope blocking antibodies are widely used to 
test the ability of these molecules to block integrin-mediated virus binding and internalization. For 
example, FMDV uses αvβ8 integrin to mediate binding to and internalization into SW40 cells, a human 
colon cancer cell line. Cell treatment with synthetic RGD motif as well as antibodies against the αv integrin 
subunit completely abrogated FMDV binding and infection of the cells (Jackson et al., 2004). Similarly, 
Berinstein et al.,(1995) demonstrated that αvβ3 integrin was implicated in FMDV binding to the host cell 
and internalization. In this study, antibodies against the αvβ3 integrin inhibited binding and plaque 
formation upon infection in Macaca mulatta kidney (LLC-MK) cells while antibodies against the α5β1 
integrin could not inhibit FMDV binding and plaque formation (Berinstein et al., 1995). 
In our study, cell treatment with the synthetic integrin ligands had clearly no influence on flavivirus binding 
to the cell surface of MEFs. These results strikingly contradict those of two other groups who 
demonstrated that cell treatment with synthetic RGD motif or epitope blocking antibodies inhibited WNV 
and JEV binding to Vero and BHK cells, respectively (Chu et al., 2004b; Fan et al., 2017). Instead, our results 
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are in accordance with those proposed by two groups who demonstrated that WNV binding to the target 
cells is not inhibited by integrin epitope-blocking antibodies and is rather independent of integrins 
(Medigeshi et al., 2008; Schmidt et al., 2013a). A similar assay used in our study to evaluate the ability of 
integrin ligands to inhibit virus infection was also used by other authors for different viruses (Jackson et 
al., 2002; La Linn et al., 2005; Wickham et al., 1993). Taken together, the results provided by the binding 
assay as well as by the binding inhibition assay strongly suggest that integrins are not involved in flavivirus 
binding to the cell surface. 
 
5.4.2) Lack of integrins does not abrogate flavivirus internalization 
 
Due to the fact that integrin activation promotes internalization of several viruses (Hussein et al., 2015; 
Triantafilou et al., 2001), it was hypothesized whether flaviviruses might also use this route to enter the 
host cell. In the present study, the absence of αVβ3 integrin and β1 and β3 integrin subunits did not 
abrogate flavivirus entry. However, we found evidences that the internalization of some flaviviruses into 
MEFs might be affected by the deletion of integrins. To assess the statistical significance between these 
groups, a parametric Student’s t-test was applied since the samples were unpaired and the measured 
values were normally distributed. Although statistical analyses demonstrated significant differences in 
internalization of USUV, WNV and ZIKV (p < 0.001, p < 0.0001, and p < 0.001 respectively) in MEF-WT cells 
compared to MEF-αVβ3-/- cells, the absolute differences observed were modest and have apparently a 
limited biological relevance. The same effect was observed for LGTV (p = 0.0318) in MEF-β3+/+R cells and 
for ZIKV in MEF-β3+/+R cells (p = 0.0341) and MEF-αVβ3-/- cells (p = 0.0007) compared to the respective 
integrin deficient cells. These significant differences might be explained by the fact that each of the 
compared groups had only small standard deviations among their sample values. Therefore, even small 
differences between the mean values of the two compared groups might result in statistical significance. 
Analysis of measurements from RT-qPCR showed clearly that the differences between the compared 
groups were substantially small even before log transformation.  
Since the αVβ3, β1 and β3 integrin deficient cells used in our study express other integrins, we cannot 
definitely exclude the involvement of these other integrins in flavivirus internalization. In the case of 
adenoviruses that have multiple RGD sequences displayed in the adenovirus penton base, αVβ3 and αVβ5 
integrins were shown to mediate virus internalization (Wickham et al., 1993). However, these integrins 
have no influence on adenovirus attachment suggesting that other molecules such as heparan sulfate are 
utilized as attachment factor (Wickham et al., 1993). Thus, similar to what was described for adenoviruses, 
it might be conceivable that flaviviruses first bind to an unspecific attachment factor and then 
subsequently to integrins to promote virus internalization. Another study demonstrated that upon 
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adenovirus binding, virus interaction with αV integrin subunit leads to FAK phosphorylation and virus 
internalization (Li et al., 1998). Moreover, Chu et al.,(2004a) reported that upon WNV binding to αVβ3 
integrin, FAK was phosphorylated indicating an activation of intracellular signaling (Chu et al., 2004a). In 
contrast to these results, another group demonstrated that WNV infectivity is independent of FAK 
phosphorylation by using FAK deficient mouse embryonic fibroblasts (Medigeshi et al., 2008). Whether 
other flaviviruses rather than WNV lead to FAK phosphorylation should be further investigated. 
Since integrin recognition motifs are not required for viruses to interact with integrins as described for 
hantaviruses, it might be possible that flaviviruses still use intergrins for internalization. Neither 
pathogenic nor non-pathogenic hantaviruses have integrin ligand motifs although hantavirus interaction 
with integrins was demonstrated by several studies (Gavrilovskaya et al., 1999; Gavrilovskaya et al., 1998). 
However, another study demonstrated that hantaviruses bind to another integrin region, the plexin-
semaphorin-integrin domain (PSI), which then mediates hantavirus infection in CHO cells (Raymond et al., 
2005). Whether these atypical interactions occur during flavivirus internalization is unknown and should 
be further addressed. 
Interestingly, studies demonstrated that HCMV gB and gH proteins do not display any canonical integrin 
ligand motifs such as RGD but only a highly conserved disintegrin-like domain that mediates interactions 
with integrins (Feire et al., 2004; Feire et al., 2010) and use αVβ3 integrin as co-receptor (Wang et al., 
2005). This is then followed by the activation of integrin intracellular signaling and consequent virus entry 
into human embryonic lung fibroblasts (Wang et al., 2005). Another study demonstrated that integrins are 
not involved in the attachment of HCMV but rather in a post-attachment step mediating HCMV 
internalization into the host cell (Feire et al., 2004). According to these results, one might speculate 
whether flaviviruses use integrins as co-receptor to mediate flavivirus internalization in a similar manner 
as to what was observed for HCMV. In addition, these two studies mentioned above highlight an 
interaction of viruses containing a disintegrin-like domain. According to our knowledge, the presence of a 
disintegrin-like domain in the flavivirus E protein has never been reported and should be further 
investigated.  
In sum, the results provived by our internalization assay suggest that αVβ3 integrin and β3 integrin subnit 
might be involved in the internalization of some flaviviruses (WNV, USUV, LGTV) tested in this study. 
However, the results should be interpreted carefully since i) the absolute differences between wild-type 
and integrin deficient cells were considered to be modest although statistically significant; ii) flavivirus 
species-specific differences in integrin usage might occur and iii) the involvement of other integrins in 
flavivirus internalization cannot be completely excluded. Therefore, further investigations should be 
performed in order to elucidate the role of integrins in flavivirus internalization. 
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5.4.3) Integrins modulate flavivirus replication 
 
In the viral replication kinetics assay, MEFs and MKFs were infected with different flaviviruses at a very 
low MOI which in turn allowed to analyze the permissiveness and replication efficiency in both integrin 
deficient and their respective wild-type cells. All cell lines including the integrin-deficient MEFs and MKFs 
were susceptible and permissive to flavivirus infection. Regardless of the integrin expression, viral 
infection led to production of infectious viruses that were later quantified by TCID50. In the case of CHO 
cells, infection at a very low MOI did not produce detectable viral titers confirming the hypothesis that 
CHO cells are refractory and not permissive to flavivirus infection. This resistance to flavivirus infection is 
also reported by other authors (Berting et al., 2010; Fan et al., 2017). Based on the observations in MEFs 
and MKFs in our replication kinetics experiments, we can however reject the hypothesis that αVβ3 
integrin, β1 or β3 integrin subunits act as flavivirus receptors. These observations were also reported by 
other authors (Medigeshi et al., 2008; Schmidt et al., 2013a). Although all flaviviruses in our study were 
able to infect MEF and MKF cell lines independent of the integrin expression, the replication efficiency in 
the integrin deficient cells was substantially impaired compared to the respective wild-type cells. Most 
notably, in the replication assay, ablation of integrins in MEF-αVβ3-/- cells influenced the flavivirus 
replication efficiency with a reduction of viral load by more than 90% as well as a strong decrease on virus 
titers for all the viruses tested indicating that integrins indeed play a role in flavivirus replication. The 
involvement of αVβ3 integrin in virus infection has been extensively reported for several other viruses 
such as HCMV, HHV-1, FMDV and adenoviruses (Berinstein et al., 1995; Parry et al., 2005; Wang et al., 
2005; Wickham et al., 1993).  
Moreover, we demonstrated that ablation of integrins had a negative effect on flavivirus RNA replication 
by measuring the amount of flavivirus negative-strand RNA in MEF-αVβ3-/- cells. These findings implicate 
that integrins might be indirectly involved in flavivirus RNA replication and may thus serve as a host cell 
factor. Several host cell factors have been described to influence the flavivirus RNA replication including 
the synthesis of flavivirus negative-strand RNA such as the reticulon protein (Aktepe et al., 2017) and 
AUF1p45 chaperone proteins (Friedrich et al., 2017) for DENV, ZIKV and WNV. To our knowledge, this is 
the first study reporting the involvement of αVβ3 integrin in YFV, USUV, LGTV and ZIKV RNA replication. 
Although the exact mechanism of how integrins modulate flavivirus RNA replication is currently unknown, 
we provide strong evidence that integrin expression, in particular the αVβ3 integrin, influences flavivirus 
RNA replication. The integrin-mediated modulatory effects on members of the Flaviviridae family in virus 
infection have also been explored by other authors (Fan et al., 2017; Li et al., 2014; Schmidt et al., 2013a). 
The total loss of αVβ3 integrin in MEF-αVβ3-/- cells profoundly impaired WNV replication in our study 
indicating that both integrin subunits might be fundamental for WNV replication. However, we did not 
observe a very strong inhibition in MEF-β3-/- cells infected with the WNV vaccine strain. Nonetheless, 
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Schmidt et al.,(2013a) demonstrated that the replication of four different pathogenic WNV strains was 
indeed impaired in β3 integrin knock-out MEFs suggesting that the β3 integrin subunit plays an important 
role in WNV replication. In the same study, the authors reported that rescue of β3 integrin subunit in the 
knock-out cell line enhanced viral RNA yields by more than 90% (Schmidt et al., 2013a). These 
discrepancies observed between the two studies might be explained by the different WNV strains used.  
Silencing or blocking of αV and β3 integrin subunits substantially impaired JEV replication in two different 
cell lines according to studies performed by Fan et al.,(2017). Similar to what was found in our study, the 
downregulation of either αV or β3 integrin subunits in BHK-21 cells led to a 2-4 fold decrease of JEV 
replication, stressing the importance of αVβ3 integrin in flavivirus replication (Fan et al., 2017).  
CSFV was demonstrated to profit from the expression of β3 integrin subunit enhancing infection and 
proliferation in porcine cells. One study showed that, upon infection, CSFV up-regulated the expression of 
β3 integrin subunit in porcine endothelial cells (Tang et al., 2010). In another study, the authors reported 
that CSFV replicated and proliferated efficiently in cells expressing high levels of β3 integrin subunits (Li et 
al., 2014). Moreover, silencing of β3 integrin subunit mRNA inhibited more than 90% of CSFV replication 
as well as virus dissemination indicating that expression of this specific integrin subunit is beneficial for 
CSFV replication (Li et al., 2014). It remains unclear whether the αV integrin subunit is still expressed after 
downregulation by siRNA in the porcine cell line used in this study and at which step of the CSFV infection 
cycle integrins are required. However, these results are consistent with the results from our study 
suggesting that αVβ3 integrin might be an important mutual factor that modulates replication efficiency 
of certain members within the Flaviviridae family.  
The replication assay with MKF-β1-/- cells demonstrated that deletion of β1 integrin subunit negatively 
affected the replication of YFV-17D and WNV. To our knowledge, besides the present study and the study 
by Schmidt et al.,(2013a) who demonstrated that β1 integrin subunit is important for WNV replication, 
there are no publications highlighting the importance of β1 integrin subunit in flavivirus infection. 
Interestingly, USUV, LGTV and ZIKV did not require the expression of β1 integrin subunit for their 
replication. On the contrary, LGTV and ZIKV replication in MKF-β1-/- cells was clearly increased compared 
to MKF-β1Flox cells resulting in a higher viral load and viral titers. Similar results were described by another 
group for the deletion of β3 integrin subunit in MEFs which led to higher WNV titers in comparison to the 
wild-type cells (Medigeshi et al., 2008). One possible explanation for these effects might be the presence 
of αVβ3 integrin expression in MKF-β1-/- cells as demonstrated by flow cytometry and 
immunofluorescence assay in this study. Further, the replication assays indicated that αVβ3 integrin 
expression is of great importance for the replication of all investigated flaviviruses. Thus, one might 
speculate whether the expression of αVβ3 integrin in MKF-β1-/- cells might compensate for the lack of β1 
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integrin subunit expression thus enhancing the replication of LGTV and ZIKV. Additionally, the deletion of 
β1 integrin might upregulate other integrins potentially affecting replication of LGTV and ZIKV.  
In sum, the results provided from the replication assays indicate that integrins, in particular the αVβ3 
integrin, are of great importance for flavivirus replication in mouse fibroblasts. 
 
We also investigated the involvement of integrins in flavivirus infection by generating CHO cells expressing 
either mouse αV or β3 integrin subunits. Our results demonstrated that flaviviruses are able to bind to 
CHO cells, regardless of the expression of integrins indicating that a binding receptor or attachment factor 
for flaviviruses is present in CHO cells. Replication of investigated flaviviruses in CHO-K1 wild-type cells 
was substantially impaired which is in accordance to the literature where CHO cells are described to be 
non-permissive to several viral agents including flaviviruses (Berting et al., 2010). Interestingly, upon 
ectopic expression of mouse αV or β3 integrin subunits in CHO cells, the flavivirus replication was slightly 
increased upon inoculation with a high MOI (10). The expression of αV integrin subunit increased the 
replication of USUV and YFV-17D whereas expression of β3 integrin subunit increased replication of WNV 
and LGTV. For ZIKV, ectopic expression of either αV or β3 integrin subunits in CHO cells did not enhance 
replication. Similar to our results, Fan et al.,(2017) demonstrated slightly increased JEV replication in CHO 
cells expressing the β3 integrin subunit suggesting a beneficial effect of β3 integrin subunit in JEV 
replication (Fan et al., 2017).  
Genomic analysis revealed that CHO cells lack the expression of 158 important genes that are involved in 
virus entry and replication including integrin genes (Xu et al., 2011). The absence of all these genes in CHO 
cells might explain their remarkable resistance to viral agents including flaviviruses as previously reported 
by Berting et al.,(2010). Taking that into account, we assume that flavivirus entry and replication in CHO 
cells cannot be fully recovered only by ectopic expression of integrins. Thus, in the specific case of CHO 
cells, integrins might only play a minor role in CHO cell susceptibility and permissiveness to flaviviruses. 
Although our results demonstrate that integrin expression in CHO cells increases flavivirus replication, 
these effects were only modest and should be interpreted carefully. Further studies should be performed 
in order to elucidade the CHO cell resistance to flaviviruses, and to determine at which step of flavivirus 
infection cycle the blockade occurs. 
It is well-understood that integrins control several cellular downstream pathways that might culminate in 
diverse cellular responses such as cytoskeleton rearrangments and changes in the cellular environment 
(Harburger et al., 2009). In this sense, it might be possible that the expression of several host cell factors 
which influence virus replication might be directly or indirectly under control of the integrin expression. 
For example, Ebola virus (EBOV - Filoviridae family, Ebolavirus genus) was shown to benefit from the 
expression of integrins to complete its replication cycle. Although integrins are not required for EBOV 
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binding and internalization, integrins regulate the expression of cathepsin B and L, two proteases that are 
necessary to prime EBOV glycoprotein triggering virus fusion with the host cell (Schornberg et al., 2009). 
These results stress the possible influence of integrins on other cellular organelles and in regulating the 
expression of certain genes that may influence the outcome of a viral infection. The magnitude of 
interactions between integrins and several cellular molecules have been continuously describled in the 
literature: these interactions are described as the so-called “Integrin adhesome” which comprises more 
than 200 molecules resulting in more than 690 interactions of integrins with numerous cellular proteins 
(Horton et al., 2016; Zaidel-Bar et al., 2007). Based on these facts, it is easily conceivable that other cellular 
proteins affecting flavivirus replication might be under the control of integrins.  
Taken together, the expression of integrins clearly affected flavivirus replication in the investigated cell 
lines from our study suggesting integrins as a new flavivirus host cell factor. A mechanism of how integrins 
influence flavivirus replication in MEFs, MKFs or CHO cells has not yet been elucidated. However, in this 
study, the integrin-mediated modulation of flavivirus replication in different integrin deficient cells was 
clearly demonstrated by the following findings:  
(i) the deletion of αVβ3 integrin significantly affected the replication of YFV-17D, WNV, USUV, 
LGTV and ZIKV with a reduction of more than 90% on viral RNA yields;  
(ii) the levels of flavivirus negative-strand RNA were strongly reduced in αVβ3 integrin deficient 
cells; 
(iii) the deletion of β1 or β3 integrin subunits had a small and/or no effect on flavivirus replication 
depending on the flavivirus tested and 
(iv) although ectopic expression of integrins in CHO cell had no impact on flavivirus binding, their 
expression slightly increased flavivirus replication 
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5.5) Conclusions and outlook 
 
The present study is the first that demonstrates the involvement of integrins in flavivirus infection for four 
medically relevant flaviviruses (YFV, USUV, LGTV and ZIKV) while this had been described for WNV and JEV 
before. The major findings of the present study are: 
(i) the deletion of either αVβ3 integrin, β3 or β1 integrin subunit in MEFs and MKFs did not affect 
flavivirus binding to the cell surface; 
(ii) the expression of either αV or β3 integrin subunit in CHO cells did not enhance flavivirus 
binding to the cell surface; 
(iii) the internalization of some flaviviruses was impaired by the deletion of αVβ3 integrin and β3 
integrin subunit while the deletion of β1 integrin subunit had no effect; 
(iv) the replication of all flaviviruses tested in this study was strongly inhibited in αVβ3 integrin 
deficient cells with a reduction of more than 90% on viral load; 
(v) the deletion of β1 or β3 integrin subunits resulted only in slightly reduced flavivirus replication;  
(vi) the ectopic expression of αV or β3 integrin subunits in CHO cells slightly increased the 
replication of some flaviviruses. 
The mechanism of how integrins modulate flavivirus replication has not yet been completely elucidated. 
There are some specific aspects in regard to integrins and their modulation of flavivirus infection that 
should be addressed in future: 
(i) to analyze whether the activation of integrin-associated intracellular pathways is triggered 
upon flavivirus infection; 
(ii) to investigate whether the downregulation or ablation of integrins, in particular αVβ3 integrin, 
impairs or downregulates the expression of other molecules that will influence flavivirus 
infection/replication; 
(iii) to examine whether the replication of other flaviviruses including virulent and low-passage 
strains is also disrupted by integrin knock-out; 
(iv) to investigate whether the integrin-mediated effect on flavivirus replication also applies to 
other cell lines from different host species and 
(v) to closely monitor flavivirus replication by usage of replicon systems in order to better 
understand how integrins modulate flavivirus RNA replication.  
In conclusion, the results achieved in the present study provided strong evidence that integrins play a role 
in flavivirus infection, particularly in replication and thus might act as a new flavivirus host cell factor 
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Appendix I: Chemicals 
1) Chemicals 
Name Manufacturer 
Acetic acid, 100 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Acetone, Rotipuran®, ≥ 99.8 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Agar, Bacteriological Grade MP Biomedicals Inc., Solon, OH, USA 
Agarose, Ultra Pure Invitrogen GmbH, Darmstadt, Germany 
Ammonium chloride, ≥ 99.5 % Carl Roth GmbH & Co, Karlsruhe, Germany 
Ampicillin sodium salt Carl Roth GmbH & Co, Karlsruhe, Germany 
Bovine Serum Albumin fraction V, Chemical grade Merck KGAA, Darmstadt, Germany 
Bromphenol blue, powder Sigma-Aldrich Chemie GmbH, Munich, Germany 
Calcium chloride dihydrate, ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Citric acid, ≥99.5 %, p.a., anhydrous Carl Roth GmbH & Co, Karlsruhe, Germany 
Crystal Violet, powder (Dye content ≥90 %) Sigma-Aldrich Chemie GmbH, Munich, Germany 
4’,6-Diamidino-2-phenylindoldihydrochloride (DAPI) Sigma-Aldrich Chemie GmbH, Munich, Germany 
Dimethyl sulfoxide (DMSO), ≥ 99.5, for microbiology Carl Roth GmbH & Co, Karlsruhe, Germany 
Disodium hydrogen phosphate (Na2HPO4), ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Ethanol, ≥ 96 %, denatured with 1 % MEK ethyl alcohol Carl Roth GmbH & Co, Karlsruhe, Germany 
Ethanol, >99.8%, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Ethidium bromide, solution in water, for electrophoresis 
(10g/l) 
Merck KGAA, Darmstadt, Germany 
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Name Manufacturer 
Ethylenediamine tetraacetatic acid (EDTA), pure, powder Serva Feinbiochemica GmbH & Co, Heidelberg, 
Germany 
Formaldehyde, 37 % (Formalin), p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Glycerine, ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Glycine, ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Hydrochloric Acid, reagent grade, 37% Sigma-Aldrich Chemie GmbH, Munich, Germany 
Kanamycin disulfate salt Carl Roth GmbH & Co, Karlsruhe, Germany 
Magnesium chloride (MgCl2)  hexahydrate, ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Mangan (II) chloride monohydrate Carl Roth GmbH & Co, Karlsruhe, Germany 
2-Mercaptoethanol, 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Methanol, , ≥ 99.9 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Paraformaldehyde, ≥ 95 %, pure,powder Carl Roth GmbH & Co, Karlsruhe, Germany 
Polyethylene glycol 6000 Carl Roth GmbH & Co, Karlsruhe, Germany 
Potassium chloride (KCl), ≥ 99.5 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Potassium dihydrogen phosphate (KH2PO4), ≥ 99.5 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
2-Propanol, ≥ 99.8 % Carl Roth GmbH & Co, Karlsruhe, Germany 
Skim milk powder, MAMIPU Hobbybäcker-Versand, Bellenberg, Germany 
BD-Difco Skim Milk BD-Becton-Dickinson,New Jersey, USA 
Sodium azide, ≥ 99 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Sodium carbonate (Na2CO3), p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 




Sodium dihydrogen phosphate (NaH2PO4) dihydrate, ≥ 99 
%, p.a. 
Carl Roth GmbH & Co, Karlsruhe, Germany 
Sodium hydrogen carbonate (NaHCO3), ≥ 99.5 %, p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Sucrose Carl Roth GmbH & Co, Karlsruhe, Germany 
Tris(hydroxymethyl)-aminomethane (TRIS), Ultra Pure Invitrogen GmbH, Darmstadt, Germany 
Triton® X-100 Sigma-Aldrich Chemie GmbH, Munich, Germany 
Trypton, Casein Hydrolysate Oxoid Deutschland GmbH, Wesel, Germany 
Tween®20, Polyoxyethylene sorbitan monolaureate Sigma-Aldrich Chemie GmbH, Munich, Germany 
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Appendix II: Buffers, solutions, media and antibiotics 
1) Buffers and Solutions 
 
Buffer Composition Storage 
10X Phosphate Buffered Saline (PBS) pH 
7.2 
80 g NaCl 
2.0 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4 
 add 1 liter distilled water 
RT 
1M Calcium Buffer (stock solution) 
1.1 g CaCl2 
 add 100 ml distilled water 
RT 
1M Magnesium Buffer (stock Solution) 
508.26 mg MgCl2 
 add 100 ml distilled water 
RT 
Calcium-Magnesium Buffer 
7.5 ml CaCl2 (1M stock solution) 
2.5 ml MgCl2 (1M stock solution) 
add 100 ml distilled water 
RT 
Tris-Acetate- EDTA buffer 50X (pH 8.3) 
242 g Tris-base 
18.61 g Disodiumn EDTA 
57.1 ml Glacial Acetic Acid 
add 1 liter distilled water 
RT 
6X loading Dye buffer 
1 mg/ml Bromphenol blue 
2 mg/ml Xylene cyanol blue 
2 mg/ml Orange G 
10 g Sucrose 
20 mM EDTA 
add 20 ml distilled water 
+4°C 
Trypsin solution (pH 7.2) 
8.5 g NaCl  
0.4 g KCl  
1.0 g Dextrose   
0.58 g NaHCO3   
0.5 g Trypsin 1:250 
0.2 g EDTA  
add 1 liter distilled water  
+4°C 
DAPI stock solution 
2 g 4´, 6-diamidino-2´-phenylindole, 
dihydrochloride (DAPI) 




Buffer Composition Storage 
3 % Paraformaldehyde (pH 7.3) 
 
3 g Paraformadehyde, powder 
 add 100 ml distilled water 
-20°C 
Tris-Natrium-EDTA buffer (pH 7.4) (TNE)  
 
50 mM Tris–HCl (pH 7.4) 
100 mM NaCl 
0.1 mM EDTA 
add 1 liter distilled water 
+4°C 
30% sucrose buffer 
30 g Sucrose 
add 100 ml TNE buffer 
+4°C 
60% sucrose buffer 
60 g Sucrose 
add 100 ml TNE buffer 
+4°C 
Luria Bertani medium (LB medium) 
10 g Tryptone 
10 g NaCl 
5 g Yeast extract 
 add distilled water to 1 liter 
+4°C 
Luria Bertani agar (LB agar) 
10 g Tryptone 
10 g NaCl 
5 g Yeast extract 
 add distilled water to 1 liter 
+4°C 
1M EDTA stock solution (pH 8.0) 
372.2 g EDTA (ethylenediamenetetraacetic 
acid) 
 add 1 liter distilled water 
RT/+4°C 
50 mM EDTA solution (pH 7.4) 
5 ml 1M EDTA stock solution 
95 ml 1X PBS 
+4°C 
10 % buffered formalin 
100 ml formalin 
900 ml 1X PBS 
RT 
1% crystal violet fixative/staining solution 
solution 
1 g crystal violet powder 
100 ml 10% buffered formalin 
RT 
1 M ammonium chloride stock solution 
53.5 g ammonium chloride (NH4Cl) 
1 liter distilled water 
RT 
1% crystal violet staining  solution 
1 g crystal violet powder 
20 ml Methanol 
80 ml 1X PBS 
 
RT 
50 mM NH4Cl quenching solution (for 
immunofluorescence) 
5 ml 1 M Ammonium Chloride solution 
95 ml 1X PBS 
RT 
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Buffer Composition Storage 
100 mM acid glycine solution (pH 2.5) 
7.5 g Glycine 
1X PBS to 100 ml 
+4°C 
1M sodium citrate buffer (pH 4.5) 
214.10 g Sodium Citrate 
1 liter distilled water 
+4°C 
Dye removal solution (pH 4.5) 
50 ml Ethanol (absolute) 
10ml 1M sodium citrate buffer 
40 ml 1X PBS 
RT 
Tris-EDTA (TE) buffer (pH 8.0) 
10 ml 1M tTris-HCl 
1 ml 1 M EDTA 
1 liter distilled water 
RT 
RNA Safe Buffer (RSB) – Provide by Dr. Bernard 
Hoffmann (IVD – FLI) 
50 µM Carrier RNA (poly A) 
0.2 µM Tween 20 
0.2 µM sodium acid 
1 liter RNAse free water 
-20°C 
 
2) Cell culture media 
Name Manufacturer Cat n° 
Dulbecco’s Modified Eagle Medium (DMEM), 
powder, high glucose, pyruvate 
ThermoFisher, 
Whaltham, MA, USA 
12800017 
Eagle’s Minimun Essential Medium (E-MEM), 
with Non-essential Amino acids (NEAA), 
powder 
ThermoFisher, 




Name Manufacturer Cat n° 
Penicillin-Streptomycin 























Appendix III: Antibodies and cell sorting system 
1) Antibodies used for indirect  immunofluorescence (IF) 
Antibody Host Target Dilution/Concentration Manufacturer 
LEAF™ Purified anti-mouse 
Anti-CD51 (αV integrin) 
Rat Mouse 1:50 
Biolegends, San 
Diego, CA, USA 
LEAF™ Purified anti-mouse 
Anti-CD61 (β3 integrin) 
Hamster Mouse 1:10 
Biolegends, San 
Diego, CA, USA 
LEAF™ Purified anti-mouse 
Anti-CD29 (β1 integrin) 
Hamster Mouse 1:25 
Biolegends, San 
Diego, CA, USA 
AffiniPure Goat Anti-Rat IgG 
Cyanine Cy3 
Goat Rat 1:100 
Jackson 
ImmunoResearch, 
West Grove, PA, 
USA 
AffiniPure Goat Anti-
Armenian Hamster IgG 
Alexa-488 
Goat Hamster 1:400 
Jackson 
ImmunoResearch, 




2) Antibodies used for flow cytometry analysis (FCA) 
Antibody Host Target Dilution/Concentration Manufacturer 
LEAF™ Purified anti-mouse 
Anti-CD51 (αV integrin) 
Rat Mouse 0,5 µl per 106 cells 
Biolegends, San 
Diego, CA, USA 
LEAF™ Purified anti-mouse 
Anti-CD61 (β3 integrin) 
Hamster Mouse 1 µl per 106 cells 
Biolegends, San 
Diego, CA, USA 
LEAF™ Purified anti-mouse 
Anti-CD29 (β1 integrin) 
Hamster Mouse 1 µl per 106 cells 
Biolegends, San 
Diego, CA, USA 
AffiniPure Goat Anti-Rat 
IgG Alexa-647 
Goat Rat 1:400 
Jackson 
ImmunoResearch, 
West Grove, PA, 
USA 
AffiniPure Goat Anti-
Armenian Hamster IgG 
Alexa-488 
Goat Hamster 1:400 
Jackson 
ImmunoResearch, 
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3) Antibodies used for cell sorting 
Antibody Host Target Dilution/Concentration Manufacturer 
Biotin anti-mouse CD51 (αV 
integrin) 
Rat Mouse 1 µg/107 cells 
Biolegends, San 
Diego, CA, USA 
Biotin anti-mouse/rat CD61 
Antibody (β3 integrin) 
Hamster Mouse 1 µg/107 cells 
Biolegends, San 
Diego, CA, USA 






4) Cell sorting system and related reagents 
Name Manufacturer Cat n° 
MS Columns Miltenyi Biotec,Teterow, Germany 130-042-201 
OctoMACS Separator Miltenyi Biotec,Teterow, Germany 130-042-109 
Anti-Biotin MicroBeads Miltenyi Biotec,Teterow, Germany 130-090-485 
autoMACS Pro Washing Solution Miltenyi Biotec,Teterow, Germany 130-092-987 
autoMACS Running Buffer – MACS 
Separation Buffer 












Appendix IV: Kits  
1) Kits 
Name Manufacturer Cat n° 
Rapid DNA Ligation Kit 
ThermoFisher 
Whaltham, MA, USA 
K1422 




SuperScript® III One-Step RT-PCR System 
with Platinum® Taq DNA Polymerase 
ThermoFisher, 
Whaltham, MA, USA 
12574026 
DreamTaq™ Hot Start DNA Polymerase  
(5 U/µl) 
ThermoFisher, 
Whaltham, MA, USA 
EP0701 
Maxima Reverse Transcriptase  
(200 U/µL) 
ThermoFisher, 
Whaltham, MA, USA 
EP0742 
Phusion High-Fidelity PCR Master Mix with 
GC Buffer 
ThermoFisher 
Whaltham, MA, USA 
F532S 




























GeneJET Gel Extraction Kit 
ThermoFisher, 
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Appendix V: Vector systems and restriction endonucleases. 
1) Vector systems  
Name Company Cat n° 
pcDNA 3.1 (+) Hygromycin 
ThermoFisher, 
Whaltham, MA, USA 
V87020 
pcDNA 3.1 (+) Zeocin 
ThermoFisher, 
Whaltham, MA, USA 
V86020 
 
2) Restriction Endonucleases and Buffers 
Name Company Cat n° 
BamHI-High Fidelity® 
(20,000 units/ml) 

























3) Vector: pcDNA 3.1 (+) Hygro  
Source: ThermoFisher, Whaltham, MA, USA 
Catalog Number: V87020 
Plasmid Type: Mammalian Expression 
Promotor:  Cytomegalovirus (CMV) 
Size: 5597 base pairs 
Bacterial Resistance: Ampicillin 
Selectable Marker: Hygromycin 
Notes: Constitutive system, suitable for transient and stable expression 
 
 
Informations about the vector were taken from the manufacturer’s website 
(http://www.thermofisher.com/order/catalog/product/V87020). 
Vector map was designed based on the original sequence available in the above mentioned 
website using the Geneious software. 
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4) Vector: pcDNA 3.1 (+) Zeo  
Source: ThermoFisher, Whaltham, MA, USA 
Catalog Number: V86020 
Plasmid Type: Mammalian Expression 
Promotor:  Cytomegalovirus (CMV) 
Size: 5015 base pairs 
Bacterial Resistance: Ampicillin 
Selectable Marker: Zeocin 
Notes: Constitutive system, suitable for transient and stable expression 
 
Informations about the vector were taken from the manufacturer’s website 
(http://www.thermofisher.com/order/catalog/product/V86020). 
Vector map was designed based on the original sequence available in the above mentioned 




Appendix VI: Primers and probes 
1) Primers, probe used for WNV RT-qPCR. 
Orientation Sequence (5’-3’) Target region Reference 
FWR TCAGCGATCTCTCCACCAAAG 1160-1180 
Lanciotti et al., 2000 
REV GGGTCAGCACGTTTGTCATTG 1229-1209 
 Oligonucleotide Probe  
 FAM-TGCCCGACCATGGGAGAAGCTC-TAMRA 1186-1207 
FWR: forward; REV: reverse; FAM: 6-carboxyfluorescein; TAMRA: tetramethylrhodamine 
 
 
2) Primers and probe used for USUV RT-qPCR 
Orientation Sequence (5’-3’) Target region Reference 
FWR CGTTCTCGACTTTGACTA 3294-3311 
Jöst et al., 2011 
REV GCTAGTAGTAGTTCTTATGGA 3384-3364 
 Oligonucleotide Probe  
 HEX-ACCGTCACAATCACTGAAGCAT-BHQ1 3325-3346 
FWR: forward; REV: reverse; HEX: hexachloro-fluorescein; BHQ1: black hole quencher 1 
 
 
3) Primers and probe used for YFV RT-qPCR 
Orientation Sequence (5’-3’) Target region Reference 
FWR TACAACATGATGGGAAAGAGAGAGAARAA 8968-8996** 
Vina-Rodriguez et 
al., 2017* 
REV GTGTCCCAKCCRGCTGTGTCATC 9223-9211** 
 Oligonucleotide Probe  
 FAM-TCAGAGACCTGGCTGCAATGGATGGT-TAMRA 9170-1195* 
FWR: forward; REV: reverse; FAM: 6-carboxyfluorescein; TAMRA: tetramethylrhodamine 
*Probes were designed separately; ** target regions according to YFV virus strain 17D (Genbank: JX949181.1)  
 
 
4) Primers and probe used for LGTV RT-qPCR 
Orientation Sequence (5’-3’) Target region Reference 
FWR TACAACATGATGGGAAAGAGAGAGAARAA 9020-9048** 
Vina-Rodriguez et 
al., 2017* 
REV GTGTCCCAKCCRGCTGTGTCATC 9263-9285** 
 Oligonucleotide Probe  
 FAM-TGAAAAAACTGGCTTCCTTGAGTGGT-BHQ1 9222-9247* 
FWR: forward; REV: reverse; FAM: 6-carboxyfluorescein; BHQ1: black hole quencher 1 
*Probes were designed separately; ** target regions according to Langat virus strain TP21 (Genbank: NC_003690.1) 
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5) Primers and probe used for ZIKV RT-qPCR 
Orientation Sequence (5’-3’) Target region Reference 
FWR CCGCTGCCCAACACAAG 1086-1102 
Lanciotti et 
al., 2008 
REV CCACTAACGTTCTTTTGCAGACAT 1062-1039 
 Oligonucleotide Probe  
 FAM- AGCCTACCTTGACAAGCAGTCAGACACTCAA-TAMRA 1107-1137 
FWR: forward; REV: reverse; FAM: 6-carboxyfluorescein; TAMRA: tetramethylrhodamine 
 
6) Primers and probe used for Beta actin RT-qPCR 
Orientation Sequence (5’-3’) Target region Reference 
FWR CAGCACAATGAAGATCAAGATCATC 1005-1029 
Toussaint et al., 
2007 
REV CGGACTCATCGTACTCCTGCTT 1135-1114 
 Oligonucleotide Probe  
 VIC-TCGCTGTCCACCTTCCAGCAGATGT-TAMRA 1081-1105 
FWR: forward; REV: reverse; VIC: VIC fluorescent dye (ABI) TAMRA: tetramethylrhodamine 
 
7) Primers and PCR cycle used for detection of mouse αV integrin 
*According to the sequence NM_008402.3 
 
8) Primers and PCR cycle used for detection of mouse β3 integrin 
*According to the sequence NM_016780.2 
9) Primers and PCR cycle used for detection of mouse β1 integrin 
*According to the sequence NM_010578.2 
 
Orientation Sequence (5’-3’) Target region Amplicon Size 
FWR CTCCGGCCAACGTCAGTCGG 2173-2192* 
300 bp 
REV CGCACACCACCTGCCGAGTTT 2472-2453* 
Orientation Sequence (5’-3’) Target region Amplicon Size 
FWR GGCTGCCCCCAGGAGAAGGAGCC 1377-1396* 
200 bp 
REV CACATGGACCCCAGCCAGCC 1576-1557* 
Orientation Sequence (5’-3’) Target region Amplicon Size 
FWR GCCAGTCCCAAGTGCCATGAGG 1723-1724* 
500 bp 
REV ACGCCAAGGCAGGTCTGACAGCC 2222-2203* 
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Centrifuge 5415D Eppendorf AG, Hamburg, Germany  
Centrifuge 5460 Eppendorf AG, Hamburg, Germany  
Centrifuge Rotina 380 Hettich, Ebersberg, Germany 
Micro-Centrifuge 0.2 ml tube Neo-Lab Migge GmbH, Heidelberg, Germany 
Micro-Centrifuge 1.5 ml tube Neo-Lab Migge GmbH, Heidelberg, Germany 
96-well plates centrifuge MPS-1000 Labnet International, Edison, New Jersey, USA 
Ultracentrifuge Optima L-100 XP Beckman Coulter GmbH, Krefeld, Germany  
Ultracentrifuge TL-100 Beckman Coulter GmbH, Krefeld, Germany  
 
2) Electrophoresis system 
 
Instrument/Equipment Manufacturer 
Agarose gel chamber system Bio-Rad Laboratories GmbH, Munich, Germany 
PowerPac 300 Basic Power Supply Bio-Rad Laboratories GmbH, Munich, Germany 
 
3) Counting Chamber 
 
Instrument/Equipment Manufacturer 
Improved Neubauer chamber Neo-Lab Migge GmbH, Heidelberg, Germany 
 
4) ELISA/microplate reader 
 
Instrument/Equipment Manufacturer 
Tecan Infinite 200 PRO Tecan, Männedorf, Switzerland 
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5) Flow Cytometer 
 
Instrument/Equipment Manufacturer 





Incucell (Bacteria)  
MMM Medcenter Einrichtungen GmbH, Planegg, 
Germany  
Thermo Forma 3851 CO2 incubator ThermoFisher Scientific Inc., Waltham, MA, USA 
 
7) Refrigerator, freezer, ultra low temperature tanks and storage equipment 
 
Instrument/Equipment Manufacturer 
Liebherr Premium  Liebherr-Hausgeräte Lienz GmbH,Lienz, Austria  
Liebherr Profi Line  Liebherr-Hausgeräte Lienz GmbH,Lienz, Austria  
High Efficiency Ultra Low temperature freezer 
(-80°C) 
New Brunswick Scientific-Eppendorf 
GmbH,Wesseling-Berzdorf, Germany 
Mr Frosty™, freezing container for cell culture ThermoFisher Scientific Inc., Waltham, MA, USA 
Dewar flasks  for liquid nitrogen KGW Isotherm, Karlsruhe, Germany 
Cryotherm-BIOSAFE, liquid nitrogen tank Cryotherm, Kirchen/Sieg, Germany 
 
 
8) Magnetic stander 
 
Instrument/Equipment Manufacturer 










Light microscope, Zeiss, Axiovert 25, inverted Carl Zeiss GmbH, Jena, Germany  
Fluorescence microscope Axiovert 200, 
inverted 
Carl Zeiss GmbH, Jena, Germany 
CLSM Leica TCS SP5 setup with inverted 
microscope Leica DMI600 CS  
Leica Camera Microsystems, Mannheim, Germany 
 
10) Pipette, automatic pipette  and  multi-dispenser 
 
Instrument/Equipment Manufacturer 
Pipetboy® comfort IBS Integra Biosciences, Fernwald, Germany 
Pipette 0.5-10μl Eppendorf AG, Hamburg, Germany 
Pipette 2-20μl Eppendorf AG, Hamburg, Germany 
Pipette 10-100μl Eppendorf AG, Hamburg, Germany 
Pipette 20-200μl Eppendorf AG, Hamburg, Germany 
Pipette 100-1000 µl Eppendorf AG, Hamburg, Germany 
Pipette multi-channel 20-200μl Brand, Wertheim, Germany 
Pipette multi-channel 0.5-10μl Brand, Wertheim, Germany 
 
11) Scales, pH meter and spectrophotometer 
 
Instrument/Equipment Manufacturer 
Sartorius M-Power Analytical Scale Sartorius AG, Göttingen, Germany 
pH Meter HI221  Hanna Instruments GmbH, Kehl a. Rhein, Germany  
NanoDrop®  2000c ThermoFisher Scientific Inc., Waltham, MA, USA 
Bio-Photometer 8,5 mm  Eppendorf AG, Hamburg, Germany  
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12) Shakers, rocker, mixers and magnetic stirrer 
 
Instrument/Equipment Manufacturer 
Incubated/Refrigerated Stackable Shaker 
MaxQ 8000 
ThermoFisher Scientific Inc., Waltham, MA, USA 
HulaMixer® Sample Mixer ThermoFisher Scientific Inc., Waltham, MA, USA 
Shaker, horizontal GFL 3006 GFL, Burgwedel, Germany  
Minishaker MS2  IKA, Staufen im Breisgau, Germany  
Stuart Vortex Mixer  Cole Parmer, Staffordshire, ST15 OSA, UK,  
Thermomixer/Thermoblock comfort Eppendorf AG, Hamburg, Germany  
Thermomixer/Thermoblock 5436 Eppendorf AG, Hamburg, Germany 
Magnetic Stirrer VWR VWR/IKA Radnor,PA, USA 




CFX96-Real-Time PCR Detection System Bio-Rad Laboratories GmbH, Munich, Germany 
Thermal cycler C1000TM Bio-Rad Laboratories GmbH, Munich, Germany 
Biometra T3 Thermal Cycler Biometra GmhH, Göttingen, Germany 
 
14) Transilluminator system and documentation apparatus 
Instrument/Equipment Manufacturer 
Transilluminator UV light pulse AGS, Heidelberg, Germany 
Coupled Camera device (CCD) - UV light 
documentation system 
Hama, Monheim, Germany 
Thermal Printer DPU-414 Seiko Instruments GmbH, Neu-Isenburg, Germany 







Waterbath 0-100°C GFL GmbH, Burgwendel, Germany 
 
16) Workstations, laminar flow and safety cabinets 
 
Instrument/Equipment Manufacturer 
Thermo Herasafe KS12 Sterile Hood (Laminar 
flow) 
ThermoFisher Scientific Inc., Waltham, MA, USA 
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Appendix VIII: Cell lines and bacteria strains 
1) Mammalian cell lines 
Name Organism Tissue Background Source ATCC n° 
Vero 76  Chlorocebus aethiops Kidney 
A clone 
derivative from 
the original Vero 
cells 
FLI-Cell Bank CRL-1587 
Vero Chlorocebus aethiops Kidney - FLI-Cell Bank CCL-81 
Vero E6 Chlorocebus aethiops Kidney 
A clone 
derivatived from 
the original Vero 
76 cells 
FLI Cell Bank CRL-1586 
Vero-B4 Chlorocebus sabaeus Kidney - FLI-Cell Bank Unknown 
Chinese Hamster 
Ovary Cell (CHO) 
clone K1 
Cricetulus griseus Ovary - FLI-Cell Bank CCL-61 








MEF 8.1 β3-/- Mus musculus Embryonal C57/BL6 
Dr. Kairbaan 





MKF β1flox Mus musculus Kidney C57BL6X 129SV 
Dr. Reinhard 






MKF β1-/- Mus musculus Kidney C57BL6X 129SV 
Dr. Reinhard 














Source Cat n° 
Escherichia coli  DH5α 
F– endA1 glnV44 
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Appendix IX: Softwares and databases 
1) Softwares 
Name Application Version Developer 
Graphpad Prism Graphing 6.0 GraphPad Software,La Jolla, CA, USA 





Biomatters Limited, Auckland, New 
Zealand 





Carl Zeiss, Micro-Imaging GmbH, 
Göttingen, Germany 
LAS AF, Leica Application Suite  
 
Confocal Microscopy 2.4 Leica Microsystems CMS GmbH, 
Mannheim, Germany 
Flowing Software Flow Cytometry Analysis 2.5.1 
University of Turku, Cell Imaging 
Core, Turku Centre for 
Biotechnology, Turku, Finland 
Bio-Rad CFX Manager® 
Software  






Wayne Rasband, National Institute 
of Health – NIH, Bethesda, MD, USA 
 
2) Database 
Name Developer URL 
PubMed  
United States National 
Library of Medicine (NLM), 
Bethesda, USA 
www.pubmed.com 
GenBank, NCBI Data base  




















Appendix X: Sequences  
1) YFV-17D synthetic RNA synthesis 
       Accession number: JX949181.1 
 
1 10 20 30 40 50 










2) WNV synthetic RNA synthesis 
       Accession number: AF260967.1 
 
1 10 20 30 40 50 
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3) USUV synthetic RNA synthesis 
       Accession number: KM659877.1 
 
 
1 10 20 30 40 50 








4) LGTV synthetic RNA synthesis 
       Accession number: NC_003690.1 
 
 
1 10 20 30 40 50 















5) ZIKV and MVEV synthetic RNA synthesis 
       Accession number: AY632535 
 
 
1 10 20 30 40 50 
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